Inhibitor enzima (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Inhibitor enzima" in Serbian language version.
refsWebsite
Global rank
Serbian rank
149th place
283rd place
120th place
187th place
5th place
12th place
274th place
510th place
8,929th place
low place
857th place
569th place
3rd place
2nd place
234th place
287th place
4,489th place
7,024th place
206th place
1,594th place
507th place
889th place
low place
low place
3,867th place
3,436th place
121st place
30th place
610th place
653rd place
1,389th place
438th place
low place
low place
8,869th place
8,510th place
6,663rd place
3,586th place
731st place
793rd place
1,425th place
900th place
low place
low place
1,523rd place
2,120th place
low place
5,160th place
low place
9,321st place
low place
low place
6,348th place
6,618th place
low place
low place
2,189th place
3,901st place
low place
low place
low place
low place
18th place
28th place
low place
8,195th place
low place
low place
105th place
313th place
low place
low place
low place
low place
504th place
366th place
low place
low place
low place
low place
low place
6,813th place
887th place
632nd place
low place
low place
low place
low place
low place
6,691st place
low place
low place
low place
low place
low place
low place
3,608th place
3,815th place
3,763rd place
4,019th place
aacrjournals.org
cancerres.aacrjournals.org
- Chitambar, C. R.; Narasimhan, J.; Guy, J.; Sem, D. S.; O’Brien, W. J. (1991). „Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells”. Cancer Res. 51: 6199—6201. PMID 1933878.
- Nocentini, G.; Federici, F.; Grifantini, M.; Barzi, A. (1992). „2,2'-Bipyridyl-6-carbothioamide and Its Ferrous Complex: Their in Vitro Antitumoral Activity Related to the Inhibition of Ribonucleotide Reductase R2 Subunit” (PDF). Pharmacol. Res. 25: 312—313. PMID 8416745.
aappublications.org
pediatrics.aappublications.org
- Galbraith, R.; Drummond, G.; Kappas, A. (1992). „Suppression of Bilirubin Production in the Crigler-Najjar Type I Syndrome: Studies with the Heme Oxygenase Inhibitor Tin-Mesoporphyrin”. Pediatrics. 89: 175—182. PMID 1734381.
academia.edu
- Vallier, H.; Rodgers, P.; Stevenson, D. (1993). „Inhibition of heme oxygenase after oral vs intraperitoneal administration of chromium porphyrins”. Life Sci. 52: PL79—PL84. PMID 8445977. doi:10.1016/0024-3205(93)90521-4.
- Meyer-Fernandes, J. R.; Dutra, P. M. L.; Rodrigues, C. O.; Saad-Nehme, J.; Lopes, A. H. C. S. (1997). „Mg-dependent ecto-ATPase activity in Leishmania tropica”. Arch. Biochem. Biophys. 341: 40—46. PMID 9143351.
- Meyer-Fernandes, J. R.; Dutra, P. M. L.; Rodrigues, C. O.; Saad-Nehme, J.; Lopes, A. H. C. S. (1997). „Mg-dependent ecto-ATPase activity in Leishmania tropica”. Arch. Biochem. Biophys. 341: 40—46. PMID 9143351.
acs.org
pubs.acs.org
- Shapiro, R; Vallee, BL (1991). „Interaction of human placental ribonuclease with placental ribonuclease inhibitor”. Biochemistry. 30 (8): 2246—55. PMID 1998683. doi:10.1021/bi00222a030.
- Dixon, M.; Webb, E.C.; Thorne, C.J.R.; Tipton K.F. (1979). Enzymes (III izd.). London: Longman. str. 126. ASIN B001MVGNNO.
- Mendel Friedman (2006). „Potato Glycoalkaloids and Metabolites: Roles in the Plant and in the Diet”. J. Agric. Food Chem. 54 (23): 8655—8681. doi:10.1021/jf061471t.
- Angelique Y. Louie; Thomas J. Meade (1999). „Metal Complexes as Enzyme Inhibitors”. Chem. Rev. 99: 2711—2734. doi:10.1021/cr9804285.
- Harding, M. M.; Long, G. V. (1997). „Solution conformation of the antitumor drug streptonigrin”. Curr. Med. Chem. 4: 405—420. PMID 8230091. doi:10.1021/jm00073a003.
- Byrnes, R. W.; Mohan, M.; Antholine, W. E.; Xe, R. X.; Petering, D. H. (1990). „Oxidative stress induced by a copper-thiosemicarbazone complex”. Biochemistry. 29: 7046—7053. PMID 2171640. doi:10.1021/bi00482a014.
- Köpf-Maier, P.; Köpf, H. (1987). „Non-platinum group metal antitumor agents. History, current status, and perspectives”. Chem. Rev. 87: 1137—1152. doi:10.1021/cr00081a012.
- Harding, M. M.; Prodigalidad, M.; Lynch, M. J. (1996). „Organometallic Anticancer Agents. 2. Aqueous Chemistry and Interaction of Niobocene Dichloride with Nucleic Acid Constituents and Amino Acids”. J. Med. Chem. 39: 5012—5016. PMID 8960562. doi:10.1021/jm9603678.
- Harding, M. M.; Mokdsi, G.; Mackay, J. P.; Prodigalidad, M.; Lucas, C. W. (1998). „Interactions of the Antitumor Agent Molybdocene Dichloride with Oligonucleotides”. Inorg. Chem. 37: 2432—2437. doi:10.1021/ic971205k.
- Scheich, L. A.; Gosling, P.; Brown, S. J.; Olmstead, M. M.; Mascharak, P. K. (1991). „Synthetic analog approach to metallobleomycins: possibility of coordination of the carboxamide group of the .beta.-aminoalaninamide moiety of bleomycin to copper in copper(II) bleomycin at physiological pH”. Inorg. Chem. 30: 1677—1680. doi:10.1021/ic00007a052.
- Angelique Y. Louie; Thomas J. Meade (1999). „Metal Complexes as Enzyme Inhibitors”. Chemical Reviews. 99 (9): 2711—2734. doi:10.1021/cr9804285.
- Persechini A, McMillan K, Masters BS (1995). „Inhibition of Nitric Oxide Synthase Activity by Zn2+ Ion”. Biochemistry. 34: 15091—15095. PMID 7578122. doi:10.1021/bi00046a015.
- Pandurangi, R. S.; Katti, K. V.; Stillwell, L.; Barnes, C. L. (1998). „Retention of Inhibitory Potency of an ACE Inhibitor Conjugated with Rh(III) and Pd(II) (Iminophosphorano)phosphines. Synthesis and X-ray Structural Investigations”. J. Am. Chem Soc. 120: 11364—11373. doi:10.1021/ja9802403.
- Takeuchi, T.; Bottcher, A.; Quezada, C.; Simon, M.; Meade, T.; Gray, H. (1998). „Selective Inhibition of Human α-Thrombin by Cobalt(III) Schiff Base Complexes”. J. Am. Chem. Soc. 120: 8555—8556. doi:10.1021/ja981191x.
- Böttcher, A.; Takeuchi, T.; Hardcastle, K.; Meade, T.; Gray, H.; Cwikel, D.; Kapon, M.; Dori, Z. (1997). „Spectroscopy and Electrochemistry of Cobalt(III) Schiff Base Complexes”. Inorg. Chem. 36: 2498—2504. doi:10.1021/ic961146v.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1992). „Identification of serine and histidine adducts in complexes of trypsin and trypsinogen with peptide and nonpeptide boronic acid inhibitors by proton NMR spectroscopy”. Biochemistry. 31: 12839—12846. PMID 1463754. doi:10.1021/bi00166a019.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1993). „Boron-11 NMR spectroscopy of peptide boronic acid inhibitor complexes of .alpha.-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes”. Biochemistry. 32: 12651—12655. PMID 8251483. doi:10.1021/bi00210a013.
- Katz, B.; Finermoore, J.; Mortezaei, R.; DH, R.; Stroud, R. (1995). „Episelection: Novel Ki .apprx. Nanomolar Inhibitors of Serine Proteases Selected by Binding or Chemistry on an Enzyme Surface”. Biochemistry. 34: 8264—8280. doi:10.1021/bi00026a008.
- Babine, R. E.; Bender, S. L. (1997). „Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design”. Chem. Rev. 97: 1359—1472. PMID 11851455. doi:10.1021/cr960370z.
- Bone, R.; Frank, D.; Kettner, C. A.; Agard, D. A. (1989). „Structural analysis of specificity: .alpha.-lytic protease complexes with analogs of reaction intermediates”. Biochemistry. 28: 7600—7609. PMID 2611204. doi:10.1021/bi00445a015.
- Sugumoto, H.; Iimura, Y.; Yamanishi, Y.; Yamatsu, K. (1995). „Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds”. J. Med. Chem. 38: 4821—4829. PMID 7490731. doi:10.1021/jm00024a009.
- Zhang, Z. Y.; Reardon, I. M.; Hui, J. O.; O’Connell, K. L.; Poorman, R. A.; Heinrikson, R. L. (1991). „Zinc inhibition of renin and the protease from human immunodeficiency virus type 1”. Biochemistry. 30: 8717—8721. PMID 1888732. doi:10.1021/bi00100a001.
- Das K, Bauman JD, Rim AS, Dharia C, Clark AD Jr, Camarasa MJ, Balzarini J, Arnold E (28. 04. 2011). „Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket”. J Med Chem. 54 (8): 2727—37. PMID 21446702. doi:10.1021/jm101536x.
- Wells, T. N. C.; Scully, P.; Paravicini, G.; Proudfoot, A. E. I.; Payton, M. A. (1995). „Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine”. Biochemistry. 34: 7896—7903. PMID 7794901. doi:10.1021/bi00024a014.
- Tsao, D.; Maki, A. (1991). „Optically detected magnetic resonance study of the interaction of an arsenic(III) derivative of cacodylic acid with EcoRI methyltransferase”. Biochemistry. 30: 4565—4572. PMID 2021649. doi:10.1021/bi00232a029.
- Lam, W.; Tsao, D.; Maki, A.; Maegley, K.; Reich, N. (1992). „Spectroscopic studies of arsenic(III) binding to Escherichia coli RI methyltransferase and to two mutants, C223S and W183F”. Biochemistry. 31: 10438—10442. PMID 1420162. doi:10.1021/bi00158a004.
- Porter, D. W.; Nelson, V. C.; Fivash, M. J. J.; Kasprzak, K. S. (1996). „Mechanistic studies of the inhibition of MutT dGTPase by the carcinogenic metal Ni(II)”. Chem. Res. Toxicol. 9: 1375—1381. PMID 8951243. doi:10.1021/tx9600816.
- Persechini A, McMillan K, Masters BS (1995). „Inhibition of Nitric Oxide Synthase Activity by Zn2+ Ion”. Biochemistry. 34: 15091—15095. PMID 7578122. doi:10.1021/bi00046a015.
- Pandurangi, R. S.; Katti, K. V.; Stillwell, L.; Barnes, C. L. (1998). „Retention of Inhibitory Potency of an ACE Inhibitor Conjugated with Rh(III) and Pd(II) (Iminophosphorano)phosphines. Synthesis and X-ray Structural Investigations”. J. Am. Chem Soc. 120: 11364—11373. doi:10.1021/ja9802403.
- Takeuchi, T.; Bottcher, A.; Quezada, C.; Simon, M.; Meade, T.; Gray, H. (1998). „Selective Inhibition of Human α-Thrombin by Cobalt(III) Schiff Base Complexes”. J. Am. Chem. Soc. 120: 8555—8556. doi:10.1021/ja981191x.
- Böttcher, A.; Takeuchi, T.; Hardcastle, K.; Meade, T.; Gray, H.; Cwikel, D.; Kapon, M.; Dori, Z. (1997). „Spectroscopy and Electrochemistry of Cobalt(III) Schiff Base Complexes”. Inorg. Chem. 36: 2498—2504. doi:10.1021/ic961146v.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1992). „Identification of serine and histidine adducts in complexes of trypsin and trypsinogen with peptide and nonpeptide boronic acid inhibitors by proton NMR spectroscopy”. Biochemistry. 31: 12839—12846. PMID 1463754. doi:10.1021/bi00166a019.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1993). „Boron-11 NMR spectroscopy of peptide boronic acid inhibitor complexes of .alpha.-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes”. Biochemistry. 32: 12651—12655. PMID 8251483. doi:10.1021/bi00210a013.
- Katz, B.; Finermoore, J.; Mortezaei, R.; DH, R.; Stroud, R. (1995). „Episelection: Novel Ki .apprx. Nanomolar Inhibitors of Serine Proteases Selected by Binding or Chemistry on an Enzyme Surface”. Biochemistry. 34: 8264—8280. doi:10.1021/bi00026a008.
- Babine, R. E.; Bender, S. L. (1997). „Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design”. Chem. Rev. 97: 1359—1472. PMID 11851455. doi:10.1021/cr960370z.
- Bone, R.; Frank, D.; Kettner, C. A.; Agard, D. A. (1989). „Structural analysis of specificity: .alpha.-lytic protease complexes with analogs of reaction intermediates”. Biochemistry. 28: 7600—7609. PMID 2611204. doi:10.1021/bi00445a015.
- Sugumoto, H.; Iimura, Y.; Yamanishi, Y.; Yamatsu, K. (1995). „Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds”. J. Med. Chem. 38: 4821—4829. PMID 7490731. doi:10.1021/jm00024a009.
- Zhang, Z. Y.; Reardon, I. M.; Hui, J. O.; O’Connell, K. L.; Poorman, R. A.; Heinrikson, R. L. (1991). „Zinc inhibition of renin and the protease from human immunodeficiency virus type 1”. Biochemistry. 30: 8717—8721. PMID 1888732. doi:10.1021/bi00100a001.
- Das K, Bauman JD, Rim AS, Dharia C, Clark AD Jr, Camarasa MJ, Balzarini J, Arnold E (28. 04. 2011). „Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket”. J Med Chem. 54 (8): 2727—37. PMID 21446702. doi:10.1021/jm101536x.
- Wells, T. N. C.; Scully, P.; Paravicini, G.; Proudfoot, A. E. I.; Payton, M. A. (1995). „Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine”. Biochemistry. 34: 7896—7903. PMID 7794901. doi:10.1021/bi00024a014.
- Tsao, D.; Maki, A. (1991). „Optically detected magnetic resonance study of the interaction of an arsenic(III) derivative of cacodylic acid with EcoRI methyltransferase”. Biochemistry. 30: 4565—4572. PMID 2021649. doi:10.1021/bi00232a029.
- Lam, W.; Tsao, D.; Maki, A.; Maegley, K.; Reich, N. (1992). „Spectroscopic studies of arsenic(III) binding to Escherichia coli RI methyltransferase and to two mutants, C223S and W183F”. Biochemistry. 31: 10438—10442. PMID 1420162. doi:10.1021/bi00158a004.
- Porter, D. W.; Nelson, V. C.; Fivash, M. J. J.; Kasprzak, K. S. (1996). „Mechanistic studies of the inhibition of MutT dGTPase by the carcinogenic metal Ni(II)”. Chem. Res. Toxicol. 9: 1375—1381. PMID 8951243. doi:10.1021/tx9600816.
ahajournals.org
hyper.ahajournals.org
- Robert A. Johnson; Manuel Lavesa; Bardia Askari; Nader G. Abraham; Alberto Nasjletti (1995). „A Heme Oxygenase Product, Presumably Carbon Monoxide, Mediates a Vasodepressor Function in Rats”. Hypertension. 25: 166—169. PMID 7843765. doi:10.1161/01.HYP.25.2.166.
ajtmh.org
- Saenz, R. E.; Rodriguez, C. C. D.; Johnson, C. M.; Berman, J. D. (1991). „Efficacy and toxicity of pentostam against Panamanian mucosal leishmaniasis”. Am. J. Trop. Med. 44: 394—398. PMID 1645930.
- Saenz, R. E.; Rodriguez, C. C. D.; Johnson, C. M.; Berman, J. D. (1991). „Efficacy and toxicity of pentostam against Panamanian mucosal leishmaniasis”. Am. J. Trop. Med. 44: 394—398. PMID 1645930.
amazon.com
- Dixon, M.; Webb, E.C.; Thorne, C.J.R.; Tipton K.F. (1979). Enzymes (III izd.). London: Longman. str. 126. ASIN B001MVGNNO.
annualreviews.org
- Robert M. Stroud; Anthony A. Kossiakoff; John L. Chambers (1977). „Mechanisms of Zymogen Activation”. Annual Review of Biophysics and Bioengineering. 6: 177—193. doi:10.1146/annurev.bb.06.060177.001141.
- Sly WS, Hu PY (1995). „Human carbonic anhydrases and carbonic anhydrase deficiencies”. Annu. Rev. Biochem. 64: 375—401. PMID 7574487. doi:10.1146/annurev.bi.64.070195.002111.
- Sly WS, Hu PY (1995). „Human carbonic anhydrases and carbonic anhydrase deficiencies”. Annu. Rev. Biochem. 64: 375—401. PMID 7574487. doi:10.1146/annurev.bi.64.070195.002111.
asm.org
jvi.asm.org
- LaFemina, R. L.; Schneider, C. L.; Robbins, H. L.; Callahan, P. L.; LeGrow, K.; Roth, E.; Schleif, W. A.; Emini, E. A. (1992). „Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells”. J. Virol. 66: 7414—7419. PMID 1433523.
- Hazuda, D. J.; Felock, P. J.; Hastings, J. C.; Prmanik, B.; Wolfe, A. L. (1997). „Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase” (PDF). J. Virol. 71: 7005—7011. PMID 9261430.
- LaFemina, R. L.; Schneider, C. L.; Robbins, H. L.; Callahan, P. L.; LeGrow, K.; Roth, E.; Schleif, W. A.; Emini, E. A. (1992). „Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells”. J. Virol. 66: 7414—7419. PMID 1433523.
- Hazuda, D. J.; Felock, P. J.; Hastings, J. C.; Prmanik, B.; Wolfe, A. L. (1997). „Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase” (PDF). J. Virol. 71: 7005—7011. PMID 9261430.
aac.asm.org
- Farnet, C. M.; Wang, B.; Hansen, M.; Lipford, J. R.; Zalkow, L.; Robinson, W. E. J.; Siegel, J.; Bushman, F. (1998). „Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism”. Antimicrob. Agents Chemother. 42: 2245—2253. PMID 9736543.
- Farnet, C. M.; Wang, B.; Hansen, M.; Lipford, J. R.; Zalkow, L.; Robinson, W. E. J.; Siegel, J.; Bushman, F. (1998). „Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism”. Antimicrob. Agents Chemother. 42: 2245—2253. PMID 9736543.
aspetjournals.org
jpet.aspetjournals.org
- Maines, M.; Trakshel, G. (1992). „Tin-protoporphyrin: a potent inhibitor of hemoprotein-dependent steroidogenesis in rat adrenals and testes”. J. Pharmacol. Exp. Ther. 260: 909—916. PMID 1371161.
- Russo, S.; Pepe, J.; Donohue, S.; Cable, E.; Lambrecht, R.; Bonkovsy, H. (1995). „Tissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase”. J. Pharmacol. Exp. Ther. 272: 766—774. PMID 7853192.
barnesandnoble.com
- Kendrick, M. J.; May, M. T.; Plishka, M. J.; Robinson, K. D. (1992). „Metals in Biological Systems”. New York: Ellis Horwood. ISBN 978-0-13-577727-5.
- Kendrick, M. J.; May, M. T.; Plishka, M. J.; Robinson, K. D. (1992). „Metals in Biological Systems”. New York: Ellis Horwood. ISBN 978-0-13-577727-5.
biochemj.org
- Moore, P.; Jones, C.; Mahmood, N.; Evans, I.; Goff, M.; Cooper, R.; Hay, A. (1995). „Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase” (PDF). Biochem. J. 307: 129—134. PMID 7536411.
- Moore, P.; Jones, C.; Mahmood, N.; Evans, I.; Goff, M.; Cooper, R.; Hay, A. (1995). „Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase” (PDF). Biochem. J. 307: 129—134. PMID 7536411.
biologyreference.com
- „Secondary metabolites - Knowledge Encyclopedia”. www.biologyreference.com. Pristupljeno 10. 05. 2016.
bioscience.org
- Oliver, CJ; Shenolikar, S (1998). „Physiologic importance of protein phosphatase inhibitors”. Frontiers in Bioscience. 3: D961—72. PMID 9727084.
bmj.com
gut.bmj.com
- Tsai, H.; Dwarakanath, A.; Hart, C.; Milton, J.; Rhodes, J. (1995). „Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment” (PDF). Gut. 36: 570—576. PMID 7737566.
- Tsai, H.; Dwarakanath, A.; Hart, C.; Milton, J.; Rhodes, J. (1995). „Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment” (PDF). Gut. 36: 570—576. PMID 7737566.
books.google.com
- Price, N.; Hames, B.; Rickwood, D., ur. (1996). Proteins LabFax. Academic Press. ISBN 978-0-12-564710-6.
- Gualerzi, Claudio O.; Brandi, Letizia; Fabbretti, Attilio; Pon, Cynthia L. (04. 12. 2013). Antibiotics: Targets, Mechanisms and Resistance. John Wiley & Sons. ISBN 9783527333059.
- Bal Ram Singh; Anthony T. Tu, ur. (1996). Natural Toxins 2: Structure, Mechanism of Action, and Detection (NATO Asi Series) (v. 2). Springer. ISBN 978-0-06-093436-1.
- Hay, R. W. (1984). Bio-inorganic Chemistry. New York: Ellis Horwood Limited. ISBN 978-0-85312-200-5.
- Sorenson, J. R. J. (1982). Sigel, H.; Marcel Dekker, ur. Metal ions in biological systems. 14. New York. ISBN 9780824715694.
- Hay, R. W. (1984). Bio-inorganic Chemistry. New York: Ellis Horwood Limited. ISBN 978-0-85312-200-5.
- Sorenson, J. R. J. (1982). Sigel, H.; Marcel Dekker, ur. Metal ions in biological systems. 14. New York. ISBN 9780824715694.
boundless.com
caltech.edu
authors.library.caltech.edu
- Lippard, S. J. (1994). Bertini, I.; Gray, H. B.; Lippard, S. J.; Valentine, J. S., ur. Bioinorganic Chemistry (PDF). Mill Valle, CA,: University Science Books.
cas.cz
cccc.uochb.cas.cz
- Ibrahim, S. A.; El-Gyar, S. A.; El-Gahani, M. A. (1991). „Metal complexes of nitrogen-oxygen donor ligands as potential drugs”. Collect. Czech. Chem. Commun. 56: 1333—1339. doi:10.1135/cccc19911333.
- Ibrahim, S. A.; El-Gyar, S. A.; El-Gahani, M. A. (1991). „Metal complexes of nitrogen-oxygen donor ligands as potential drugs”. Collect. Czech. Chem. Commun. 56: 1333—1339. doi:10.1135/cccc19911333.
cas.org
chemport.cas.org
- Turkmen H, Durgun M, Yilmaztekin S, Emul M, Innocenti A, Vullo D, Scozzafava A, Supuran CT (1997). „Carbonic anhydrase inhibitors. Part 50. Interaction of isoenzymes I and II of carbonic anhydrase with Ge(IV) and Sb(III) derivatives”. Main Group Met. Chem. 20: 641—647. PMID 15603956. doi:10.1016/j.bmcl.2004.10.070.
- Kureya, P.; Beevers, D. G. (1991). „The mechanisms of hypertension and the role of ACE inhibitors”. J. Human Hypertension. 5: 3—8. PMID 1791616.
- Fitzgerald, D. J.; Maggio, J. E.; Esler, W. P.; Stinson, E. R.; Jennings, J. M.; Ghilardi, J. R.; Mantyh, P. W.; Bush, A. I.; Moir, R. D.; Rosenkranz, K. M.; Tanzi, R. E. (1995). „Zinc and Alzheimer's disease”. Science. 268: 1920—1923. PMID 7604268.
- Bush, A. I.; Pettingell, W. H.; Multhaup, G.; Paradis, M. D.; Vonsattel, J. P.; Gusella, J. F.; Beyreuther, K.; Masters, C. L.; Tanzi, R. E. (1994). „Rapid induction of Alzheimer A beta amyloid formation by zinc”. Science. 265: 1464—1467. PMID 8073293.
- Danning, C. L.; Boumpas, D. T. (1998). „Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis: an update on mechanisms of action”. Clin. Exp. Rheumatol. 16: 595—604. PMID 9779311.
- Pugh, M. C.; Pugh, C. B. (1987). „Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis”. Clin. Pharm. 6: 475—491. PMID 3319362.
- Baker, D. G.; Rabinowitz, J. L. (1986). „Current concepts in the treatment of rheumatoid arthritis”. J. Clin. Pharmacol. 26: 2—21. PMID 3512617.
- York, D. M.; Darden, T. A.; Pedersen, L. G.; Anderson, M. W. (1993). „Molecular modeling studies suggest that zinc ions inhibit HIV-1 protease by binding at catalytic aspartates”. Environ. Health Perspect. 101: 246—250. PMID 8404763.
- Garg, R. K.; Sharma, L. M. J. Indian Chem. Soc. (1995). „Binuclear transition metal complexes of some novel Schiff bases derived from dapsone (an antileprotic drug). Part II. Zinc(II) complexes”. 72: 231—234. ISSN 0019-4522.
- Hyppo¨nen, S.; Kohila, T.; Tahti, H. (1993). „The effects of cadmium, lead and aluminum on neural cell membrane adenosinetriphosphatase activity”. Neurosci. Res. Commun. 12: 77—84.
- Yang, S. W.; Becker, F. F.; Chan, J. Y. H. (1996). „Inhibition of human DNA ligase I activity by zinc and cadmium and the fidelity of ligation”. Environ. Health Perspect. 28: 19—25. PMID 8698042. doi:10.1002/(SICI)1098-2280(1996)28:1<19::AID-EM5>3.0.CO;2-9.
- Turkmen H, Durgun M, Yilmaztekin S, Emul M, Innocenti A, Vullo D, Scozzafava A, Supuran CT (1997). „Carbonic anhydrase inhibitors. Part 50. Interaction of isoenzymes I and II of carbonic anhydrase with Ge(IV) and Sb(III) derivatives”. Main Group Met. Chem. 20: 641—647. PMID 15603956. doi:10.1016/j.bmcl.2004.10.070.
- Kureya, P.; Beevers, D. G. (1991). „The mechanisms of hypertension and the role of ACE inhibitors”. J. Human Hypertension. 5: 3—8. PMID 1791616.
- Fitzgerald, D. J.; Maggio, J. E.; Esler, W. P.; Stinson, E. R.; Jennings, J. M.; Ghilardi, J. R.; Mantyh, P. W.; Bush, A. I.; Moir, R. D.; Rosenkranz, K. M.; Tanzi, R. E. (1995). „Zinc and Alzheimer's disease”. Science. 268: 1920—1923. PMID 7604268.
- Bush, A. I.; Pettingell, W. H.; Multhaup, G.; Paradis, M. D.; Vonsattel, J. P.; Gusella, J. F.; Beyreuther, K.; Masters, C. L.; Tanzi, R. E. (1994). „Rapid induction of Alzheimer A beta amyloid formation by zinc”. Science. 265: 1464—1467. PMID 8073293.
- Danning, C. L.; Boumpas, D. T. (1998). „Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis: an update on mechanisms of action”. Clin. Exp. Rheumatol. 16: 595—604. PMID 9779311.
- Pugh, M. C.; Pugh, C. B. (1987). „Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis”. Clin. Pharm. 6: 475—491. PMID 3319362.
- Baker, D. G.; Rabinowitz, J. L. (1986). „Current concepts in the treatment of rheumatoid arthritis”. J. Clin. Pharmacol. 26: 2—21. PMID 3512617.
- York, D. M.; Darden, T. A.; Pedersen, L. G.; Anderson, M. W. (1993). „Molecular modeling studies suggest that zinc ions inhibit HIV-1 protease by binding at catalytic aspartates”. Environ. Health Perspect. 101: 246—250. PMID 8404763.
- Garg, R. K.; Sharma, L. M. J. Indian Chem. Soc. (1995). „Binuclear transition metal complexes of some novel Schiff bases derived from dapsone (an antileprotic drug). Part II. Zinc(II) complexes”. 72: 231—234. ISSN 0019-4522.
- Hyppo¨nen, S.; Kohila, T.; Tahti, H. (1993). „The effects of cadmium, lead and aluminum on neural cell membrane adenosinetriphosphatase activity”. Neurosci. Res. Commun. 12: 77—84.
- Yang, S. W.; Becker, F. F.; Chan, J. Y. H. (1996). „Inhibition of human DNA ligase I activity by zinc and cadmium and the fidelity of ligation”. Environ. Health Perspect. 28: 19—25. PMID 8698042. doi:10.1002/(SICI)1098-2280(1996)28:1<19::AID-EM5>3.0.CO;2-9.
cell.com
- Bredt, D. S.; Snyder, S. H. (1992). „Nitric oxide, a novel neuronal messenger”. Neuron. 8: 3—11. PMID 1370373. doi:10.1016/0896-6273(92)90104-L.
- Marletta, M. A. (1994). „Nitric oxide synthase: Aspects concerning structure and catalysis” (PDF). Cell. 78: 927—930. PMID 7522970. doi:10.1016/0092-8674(94)90268-2.
- Thorpe, H. H. (1998). „Bioinorganic chemistry and drug design: here comes zinc again”. Chem. Biol. 5: R125—R127. PMID 9653544. doi:10.1016/S1074-5521(98)90166-1.
- Menard, H. A.; Amine, M. E. (1996). „The calpain-calpastatin system in rheumatoid arthritis”. Immunol. Today. 17: 545—547. PMID 8991283. doi:10.1016/S0167-5699(96)30064-9.
- West, M. L.; Fairlie, D. P. (1995). „Targeting HIV-1 protease: a test of drug-design methodologies”. Trends Pharmacol. Sci. 16: 67—75. PMID 7762084. doi:10.1016/S0165-6147(00)88980-4.
- Bredt, D. S.; Snyder, S. H. (1992). „Nitric oxide, a novel neuronal messenger”. Neuron. 8: 3—11. PMID 1370373. doi:10.1016/0896-6273(92)90104-L.
- Marletta, M. A. (1994). „Nitric oxide synthase: Aspects concerning structure and catalysis” (PDF). Cell. 78: 927—930. PMID 7522970. doi:10.1016/0092-8674(94)90268-2.
- Thorpe, H. H. (1998). „Bioinorganic chemistry and drug design: here comes zinc again”. Chem. Biol. 5: R125—R127. PMID 9653544. doi:10.1016/S1074-5521(98)90166-1.
- Menard, H. A.; Amine, M. E. (1996). „The calpain-calpastatin system in rheumatoid arthritis”. Immunol. Today. 17: 545—547. PMID 8991283. doi:10.1016/S0167-5699(96)30064-9.
- West, M. L.; Fairlie, D. P. (1995). „Targeting HIV-1 protease: a test of drug-design methodologies”. Trends Pharmacol. Sci. 16: 67—75. PMID 7762084. doi:10.1016/S0165-6147(00)88980-4.
crcnetbase.com
- L., Lundblad R. (2004). Chemical Reagents for Protein Modification. CRC Press Inc. ISBN 978-0-8493-1983-9.
crcpress.com
- Lippard, S. (1996). Sigel, A.; Sigel, H., ur. „Metal ions in Biology”. 32. New York: M. Dekker.
degruyter.com
- Supuran, C. T. (1996). „Complexes with biologically active ligands. Part 3. Synthesis of coordination compounds of chlorothiazide with divalent metal ions”. Main Group Met. Chem. 19: 347—353. doi:10.1515/MGMC.1996.19.6.339.
- Supuran, C. T. (1996). „Complexes with biologically active ligands. Part 3. Synthesis of coordination compounds of chlorothiazide with divalent metal ions”. Main Group Met. Chem. 19: 347—353. doi:10.1515/MGMC.1996.19.6.339.
docslide.us
- Yano, S.; Inoue, S.; Nouchi, R.; Mogami, K.; Shinohara, Y.; Yasuda, Y.; Kato, M.; Tanase, T.; Kakuchi, T.; Mikata, Y.; Suzuki, T.; Yamamoto, Y. (1998). „Antifungal nickel(II) complexes derived from amino sugars against pathogenic yeast, Candida albicans”. J. Inorg. Biochem. 69: 15—23. PMID 9606935.
- Yano, S.; Inoue, S.; Nouchi, R.; Mogami, K.; Shinohara, Y.; Yasuda, Y.; Kato, M.; Tanase, T.; Kakuchi, T.; Mikata, Y.; Suzuki, T.; Yamamoto, Y. (1998). „Antifungal nickel(II) complexes derived from amino sugars against pathogenic yeast, Candida albicans”. J. Inorg. Biochem. 69: 15—23. PMID 9606935.
doi.org
- Robert A. Copeland (06. 05. 2013). Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists (II izd.). ISBN 9781118488133. doi:10.1002/9781118540398.
- Shapiro, R; Vallee, BL (1991). „Interaction of human placental ribonuclease with placental ribonuclease inhibitor”. Biochemistry. 30 (8): 2246—55. PMID 1998683. doi:10.1021/bi00222a030.
- Cleland WW (1963). „The kinetics of enzyme-catalyzed reactions with two or more substrates or products. II. Inhibition: nomenclature and theory”. Biochim. Biophys. Acta. 67: 173—87. PMID 14021668. doi:10.1016/0926-6569(63)90226-8.
- Leatherbarrow, RJ (1990). „Using linear and non-linear regression to fit biochemical data”. Trends in Biochemical Sciences. 15 (12): 455—8. PMID 2077683. doi:10.1016/0968-0004(90)90295-M.
- Tseng, SJ; Hsu, JP (1990). „A comparison of the parameter estimating procedures for the Michaelis-Menten model”. Journal of Theoretical Biology. 145 (4): 457—64. PMID 2246896. doi:10.1016/S0022-5193(05)80481-3.
- Walsh, R.; Martin, E.; Darvesh, S. (2011). „Limitations of conventional inhibitor classifications”. Integrative Biology. Royal Society of Chemistry. 3 (12): 1197—1201. PMID 22038120. doi:10.1039/c1ib00053e.
- Walsh, R.; Martin, E.; Darvesh, S. (2007). „A versatile equation to describe reversible enzyme inhibition and activation kinetics: Modeling β-galactosidase and butyrylcholinesterase”. Biochimica et Biophysica Acta (BBA) – General Subjects. 1770 (5): 733—746. PMID 17307293. doi:10.1016/j.bbagen.2007.01.001.
- John F. Morrison (1982). „The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions”. Trends in Biochemical Sciences. 7 (3): 102—105. doi:10.1016/0968-0004(82)90157-8.
- Hsu, JT; Wang, HC; Chen, GW; Shih, SR (2006). „Antiviral drug discovery targeting to viral proteases”. Current pharmaceutical design. 12 (11): 1301—14. PMID 16611117. doi:10.2174/138161206776361110.
- Lew W, Chen X, Kim CU (2000). „Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor”. Curr. Med. Chem. 7 (6): 663—72. PMID 10702632. doi:10.2174/0929867003374886.
- PM, Fischer (2003). „The design, synthesis and application of stereochemical and directional peptide isomers: a critical review”. Curr. Protein Pept. Sci. 4 (5): 339—56. PMID 14529528. doi:10.2174/1389203033487054.
- Bogoyevitch, MA; Barr, RK; Ketterman, AJ (2005). „Peptide inhibitors of protein kinases-discovery, characterisation and use”. Biochimica et Biophysica Acta. 1754 (1—2): 79—99. PMID 16182621. doi:10.1016/j.bbapap.2005.07.025.
- Adam, GC; Cravatt, BF; Sorensen, EJ (2001). „Profiling the specific reactivity of the proteome with non-directed activity-based probes”. Chemistry & Biology. 8 (1): 81—95. PMID 11182321. doi:10.1016/S1074-5521(00)90060-7.
- Maurer, T; Fung, HL (2000). „Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: application to nitric oxide synthase”. AAPS PharmSci. 2 (1): 68—77. PMC 2751003
. PMID 11741224. doi:10.1208/ps020108. - Loo JA, DeJohn DE, Du P, Stevenson TI, Ogorzalek LR (1999). „Application of mass spectrometry for target identification and characterization”. Med Res Rev. 19 (4): 307—19. PMID 10398927. doi:10.1002/(SICI)1098-1128(199907)19:4<307::AID-MED4>3.0.CO;2-2.
- Szedlacsek, SE; Duggleby, RG (1995). „Kinetics of slow and tight-binding inhibitors”. Enzyme Kinetics and Mechanism Part D: Developments in Enzyme Dynamics. Methods in Enzymology. 249. str. 144—80. ISBN 978-0-12-182150-0. PMID 7791610. doi:10.1016/0076-6879(95)49034-5.
- Stone, SR; Morrison, JF (1986). „Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues”. Biochimica et Biophysica Acta. 869 (3): 275—85. PMID 3511964. doi:10.1016/0167-4838(86)90067-1.
- Pick, FM; McGartoll, MA; Bray, RC (1971). „Reaction of formaldehyde and of methanol with xanthine oxidase”. European Journal of Biochemistry / FEBS. 18 (1): 65—72. PMID 4322209. doi:10.1111/j.1432-1033.1971.tb01215.x.
- Cohen, J.A.; Oosterbaan, R.A.; Berends, F. (1967). „[81] Organophosphorus compounds”. Enzyme Structure. Methods in Enzymology. 11. str. 686. ISBN 978-0-12-181860-9. doi:10.1016/S0076-6879(67)11085-9.
- Saravanamuthu, A; Vickers, TJ; Bond, CS; Peterson, MR; Hunter, WN; Fairlamb, AH (2004). „Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design”. The Journal of Biological Chemistry. 279 (28): 29493—500. PMC 3491871 . PMID 15102853. doi:10.1074/jbc.M403187200.
- Koppitz M, Eis K; Eis (2006). „Automated medicinal chemistry”. Drug Discov. Today. 11 (11—12): 561—8. PMID 16713909. doi:10.1016/j.drudis.2006.04.005.
- G, Scapin (2006). „Structural biology and drug discovery”. Curr. Pharm. Des. 12 (17): 2087—97. PMID 16796557. doi:10.2174/138161206777585201.
- Gohlke H, Klebe G; Klebe (2002). „Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors”. Angew. Chem. Int. Ed. Engl. 41 (15): 2644—76. PMID 12203463. doi:10.1002/1521-3773(20020802)41:15<2644::AID-ANIE2644>3.0.CO;2-O.
- Glen RC, Allen SC; Allen (2003). „Ligand-protein docking: cancer research at the interface between biology and chemistry”. Curr. Med. Chem. 10 (9): 763—7. PMID 12678780. doi:10.2174/0929867033457809.
- VG, Box (1997). „The Molecular Mechanics of Quantized Valence Bonds”. J Mol Model. 3 (3): 124—41. doi:10.1007/s008940050026.
- Peters GJ, van der Wilt CL, van Moorsel CJ, Kroep JR, Bergman AM, Ackland SP (2000). „Basis for effective combination cancer chemotherapy with antimetabolites”. Pharmacol. Ther. 87 (2—3): 227—53. PMID 11008002. doi:10.1016/S0163-7258(00)00086-3.
- Silvaggi, N.R.; Josephine, H.R.; Kuzin, A.P.; Nagarajan, R.; Pratt, R.F.; Kelly, J.A. (2005). „Crystal structures of complexes between the R61 DD-peptidase and peptidoglycan-mimetic beta-lactams: a non-covalent complex with a "perfect penicillin"”. J.Mol.Biol. 345: 521—533. PMID 15581896. doi:10.1016/j.jmb.2004.10.076.
- Park BK, Breckenridge AM (1981). „Clinical implications of enzyme induction and enzyme inhibition.”. Clin Pharmacokinet. 6 (1): 1—24. PMID 6113907. doi:10.2165/00003088-198106010-00001.
- Maggi, M; Filippi, S; Ledda, F; Magini, A; Forti, G (2000). „Erectile dysfunction: from biochemical pharmacology to advances in medical therapy”. European Journal of Endocrinology. Bioscientifica. 143 (2): 143—54. PMID 10913932. doi:10.1530/eje.0.1430143.
- McGuire, JJ (2003). „Anticancer antifolates: current status and future directions”. Current pharmaceutical design. 9 (31): 2593—613. PMID 14529544. doi:10.2174/1381612033453712.
- Katz, AH; Caufield, CE (2003). „Structure-based design approaches to cell wall biosynthesis inhibitors”. Current pharmaceutical design. 9 (11): 857—66. PMID 12678870. doi:10.2174/1381612033455305.
- Tan, Siang Yong; Tatsumura, Yvonne (01. 07. 2015). „Alexander Fleming (1881—1955): Discoverer of penicillin”. Singapore Medical Journal. 56 (7): 366—367. ISSN 0037-5675. PMC 4520913 . PMID 26243971. doi:10.11622/smedj.2015105.
- Srivastava A, Talaue M, Liu S, Degen D, Ebright RY, Sineva E, Chakraborty A, Druzhinin SY, Chatterjee S, Mukhopadhyay J, Ebright YW, Zozula A, Shen J, Sengupta S, Niedfeldt RR, Xin C, Kaneko T, Irschik H, Jansen R, Donadio S, Connell N, Ebright RH (2011). „New target for inhibition of bacterial RNA polymerase: 'switch region'”. Curr. Opin. Microbiol. 14 (5): 532—43. PMC 3196380 . PMID 21862392. doi:10.1016/j.mib.2011.07.030.
- Romano, AH; Conway, T (1996). „Evolution of carbohydrate metabolic pathways”. Res Microbiol. 147 (6—7): 448—55. PMID 9084754. doi:10.1016/0923-2508(96)83998-2.
- Wegener G, Krause U (2002). „Different modes of activating phosphofructokinase, a key regulatory enzyme of glycolysis, in working vertebrate muscle”. Biochem. Soc. Trans. 30 (2): 264—270. PMID 12023862. doi:10.1042/bst0300264.
- Okar, DA; Lange, AJ (1999). „Fructose-2,6-bisphosphate and control of carbohydrate metabolism in eukaryotes”. BioFactors (Oxford, England). 10 (1): 1—14. PMID 10475585. doi:10.1002/biof.5520100101.
- Robert M. Stroud; Anthony A. Kossiakoff; John L. Chambers (1977). „Mechanisms of Zymogen Activation”. Annual Review of Biophysics and Bioengineering. 6: 177—193. doi:10.1146/annurev.bb.06.060177.001141.
- Rawlings ND, Barrett AJ (1994). „Families of serine peptidases”. Meth. Enzymol. Methods in Enzymology. 244: 19—61. ISBN 978-0-12-182145-6. PMID 7845208. doi:10.1016/0076-6879(94)44004-2.
- Levilliers, J.; Péron; Arrio; Pudles (1970). „On the mechanism of action of proteolyticinhibitors: IV. Effect of 8murea on the stability of trypsin in trypsin-lnhibitor complexes”. Archives of Biochemistry and Biophysics. 140 (2): 474—483. PMID 5528741. doi:10.1016/0003-9861(70)90091-3.
- S., Dreon M.; Ituarte S.; Heras H. (2010). „The Role of the Proteinase Inhibitor Ovorubin in Apple Snail Eggs Resembles Plant Embryo Defense against Predation”. PLoS ONE. 5 (12): e15059. PMID 21151935. doi:10.1371/journal.pone.0015059.
- Smyth, TP (2004). „Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors”. Bioorganic & Medicinal Chemistry. 12 (15): 4081—8. PMID 15246086. doi:10.1016/j.bmc.2004.05.041.
- Hartley, RW (1989). „Barnase and barstar: two small proteins to fold and fit together”. Trends in Biochemical Sciences. 14 (11): 450—4. PMID 2696173. doi:10.1016/0968-0004(89)90104-7.
- Serrano L, Kellis JT, Cann P, Matouschek A, Fersht AR (1992). „The folding of an enzyme. II. Substructure of barnase and the contribution of different interactions to protein stability”. J. Mol. Biol. 224 (3): 783—804. PMID 1569557. doi:10.1016/0022-2836(92)90562-X.
- Serrano L, Matouschek A, Fersht AR (1992). „The folding of an enzyme. III. Structure of the transition state for unfolding of barnase analysed by a protein engineering procedure”. J. Mol. Biol. 224 (3): 805—18. PMID 1569558. doi:10.1016/0022-2836(92)90563-Y.
- Matouschek A, Serrano L, Fersht AR (1992). „The folding of an enzyme. IV. Structure of an intermediate in the refolding of barnase analysed by a protein engineering procedure”. J. Mol. Biol. 224 (3): 819—35. PMID 1569559. doi:10.1016/0022-2836(92)90564-Z.
- Quinn DM (1987). „Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states”. Chemical Reviews. 87 (5): 955—79. doi:10.1021/cr00081a005.
- Taylor P, Radić Z (1994). „The cholinesterases: from genes to proteins”. Annual Review of Pharmacology and Toxicology. 34: 281—320. PMID 8042853. doi:10.1146/annurev.pa.34.040194.001433.
- Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I (1991). „Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein”. Science. 253 (5022): 872—9. Bibcode:1991Sci...253..872S. PMID 1678899. doi:10.1126/science.1678899.
- Sussman JL, Harel M, Silman I (1993). „Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs”. Chem. Biol. Interact. 87 (1—3): 187—97. PMID 8343975. doi:10.1016/0009-2797(93)90042-W.
- Mehndiratta, Man Mohan; Pandey, Sanjay; Kuntzer, Thierry (13. 10. 2014). Acetylcholinesterase inhibitor treatment for myasthenia gravis. John Wiley & Sons, Ltd. doi:10.1002/14651858.CD006986.pub3.
- Kumar, Vikas; Kaminski, Henry J. (07. 10. 2010). „Treatment of Myasthenia Gravis”. Current Neurology and Neuroscience Reports. 11 (1): 89—96. ISSN 1528-4042. PMID 20927659. doi:10.1007/s11910-010-0151-1.
- V Priya Nair; Jennifer M Hunter (2004). „Anticholinesterases and anticholinergic drugs”. Contin Educ Anaesth Crit Care Pain. 4 (5): 164—168. doi:10.1093/bjaceaccp/mkh045.
- J. Susan Van Dyk; Brett Pletschke (2011). „Review on the use of enzymes for the detection of organochlorine, organophosphate and carbamate pesticides in the environment”. Chemosphere. 82 (3): 291—307. doi:10.1016/j.chemosphere.2010.10.033.
- S, Tan; Evans R; Singh B (2006). „Herbicidal inhibitors of amino acid biosynthesis and herbicide-tolerant crops”. Amino Acids. 30 (2): 195—204. PMID 16547651. doi:10.1007/s00726-005-0254-1.
- Steinrücken HC, Amrhein N (1980). „The herbicide glyphosate is a potent inhibitor of 5-enolpyruvyl-shikimic acid-3-phosphate synthase”. Biochemical and Biophysical Research Communications. 94 (4): 1207—12. PMID 7396959. doi:10.1016/0006-291X(80)90547-1.
- Lamberth C, Jeanmart S, Luksch T, Plant A (2013). „Current Challenges and Trends in the Discovery of Agrochemicals”. Science. 341 (6147): 742—6. PMID 23950530. doi:10.1126/science.1237227.
- Hugh M. Brown (1990). „Mode of action, crop selectivity, and soil relations of the sulfonylurea herbicides”. 29 (3): 263—281. doi:10.1002/ps.2780290304.
- Frosch, S.; Jabben, M.; Bergfeld, R.; H. Kleinig; H. Mohr (1979). „Inhibition of carotenoid biosynthesis by the herbicide SAN 9789 and its consequences for the action of phytochrome on plastogenesis”. Planta. 145: 497. doi:10.1007/BF00380105.
- SO, Duke (1990). „Overview of herbicide mechanisms of action”. Environ. Health Perspect. Brogan. 87: 263—71. JSTOR 3431034. PMC 1567841 . PMID 1980104. doi:10.2307/3431034.
- Tan, G; Gyllenhaal, C; Soejarto, DD (2006). „Biodiversity as a source of anticancer drugs”. Current drug targets. 7 (3): 265—77. PMID 16515527. doi:10.2174/138945006776054942.
- Laurie C. Dolan; Ray A. Matulka; George A. Burdock (2010). „Naturally Occurring Food Toxins”. Toxins. Basel. 2 (9): 2289—2332. PMID 3153292. doi:10.3390/toxins2092289.
- Peltier, Sandra; Oger, Jean-Michel; Lagarce, Frédéric; Couet, William; Benoît, Jean-Pierre (2006). „Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules”. Pharmaceutical Research. 23 (6): 1243—50. PMID 16715372. doi:10.1007/s11095-006-0022-2.
- Abal, M; Andreu, JM; Barasoain, I (2003). „Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action”. Current cancer drug targets. 3 (3): 193—203. PMID 12769688. doi:10.2174/1568009033481967.
- Bharadwaj, Rajnish; Yu, Hongtao (2004). „The spindle checkpoint, aneuploidy, and cancer”. Oncogene. 23 (11): 2016—27. PMID 15021889. doi:10.1038/sj.onc.1207374.
- Brito, D. A.; Yang, Z.; Rieder, C. L. (2008). „Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied”. The Journal of Cell Biology. 182 (4): 623—9. PMC 2518701 . PMID 18710927. doi:10.1083/jcb.200805072.
- Hostettmann, K.; Borloz, A.; Urbain, A.; Marston, A. (2006). „Natural Product Inhibitors of Acetylcholinesterase”. Current Organic Chemistry. 10 (8): 825—847. doi:10.2174/138527206776894410.
- Mendel Friedman (2006). „Potato Glycoalkaloids and Metabolites: Roles in the Plant and in the Diet”. J. Agric. Food Chem. 54 (23): 8655—8681. doi:10.1021/jf061471t.
- Defrates, LJ; Hoehns, JD; Sakornbut, EL; Glascock, DG; Tew, AR (2005). „Antimuscarinic intoxication resulting from the ingestion of moonflower seeds”. The Annals of pharmacotherapy. 39 (1): 173—6. PMID 15572604. doi:10.1345/aph.1D536.
- Hallen, H.; Luo; J.S. Scott-Craig; J.D. Walton (2007). „A gene family encoding the major toxins of lethal Amanita mushrooms.”. Proceedings of the National Academy of Sciences of the United States of America. 104 (48): 19097—19101. PMC 2141914 . PMID 18025465. doi:10.1073/pnas.0707340104.
- Vetter, J (1998). „Toxins of Amanita phalloides”. Toxicon. 36 (1): 13—24. PMID 9604278. doi:10.1016/S0041-0101(97)00074-3.
- Holmes, CF; Maynes, JT; Perreault, KR; Dawson, JF; James, MN (2002). „Molecular enzymology underlying regulation of protein phosphatase-1 by natural toxins”. Current medicinal chemistry. 9 (22): 1981—9. PMID 12369866. doi:10.2174/0929867023368827.
- Henrissat B, Callebaut I, Mornon JP, Fabrega S, Lehn P, Davies G (1995). „Conserved catalytic machinery and the prediction of a common fold for several families of glycosyl hydrolases”. Proc. Natl. Acad. Sci. U.S.A. 92 (15): 7090—7094. PMC 41477 . PMID 7624375. doi:10.1073/pnas.92.15.7090.
- Henrissat B, Davies G (1995). „Structures and mechanisms of glycosyl hydrolases”. Structure. 3 (9): 853—859. PMID 8535779. doi:10.1016/S0969-2126(01)00220-9.
- Hartley, MR; Lord, JM (2004). „Cytotoxic ribosome-inactivating lectins from plants”. Biochimica et Biophysica Acta. 1701 (1—2): 1—14. PMID 15450171. doi:10.1016/j.bbapap.2004.06.004.
- Angelique Y. Louie; Thomas J. Meade (1999). „Metal Complexes as Enzyme Inhibitors”. Chem. Rev. 99: 2711—2734. doi:10.1021/cr9804285.
- Waldron, K. J.; Robinson, N. J. (2009). „How do bacterial cells ensure that metalloproteins get the correct metal?”. Nat. Rev. Microbiol. 7 (1): 25—35. PMID 19079350. doi:10.1038/nrmicro2057.
- Thomson, A. J.; Gray, H. B. (1998). „Bioinorganic chemistry”. Current Opinion in Chemical Biology. 2: 155—158. doi:10.1016/S1367-5931(98)80056-2.
- Mital, R.; Shah, G. M.; Srivastava, T. S.; Bhattacharya, R. K. (1992). „The effect of some new platinum (II) and palladium (II) coordination complexes on rat hepatic nuclear transcription in vitro”. Life Sci. 50: 781—790. PMID 1371326. doi:10.1016/0024-3205(92)90183-P.
- Ganeva, R. L.; Spassovska, N. C.; Genchev, D. D. J. (1991). „The effect of some platinum compounds on the activity of the CTP synthetase of Ehrlich ascites tumor cells: in vitro and in vivo studies”. Inorg. Biochem. 43: 717—722. PMID 1779227. doi:10.1016/0162-0134(91)80042-G.
- Koch, T.; Gloddek, B. (1991). „Inhibition of adenylate-cyclase-coupled G protein complex by ototoxic diuretics and cis-platinum in the inner ear of the guinea pig”. Eur. Arch. Oto-Rhino-Laryngol. 248: 459—464. PMID 1662964. doi:10.1007/BF00627634.
- Ho, B. T.; Huo, Y. Y.; Lee, J. H.; Levin, V. A. (1991). „Inhibition of adenylate cyclase by tetraplatin”. Anti-Cancer Drugs. 2: 267—268. PMID 1802021. doi:10.1097/00001813-1991.
- Myette, M. S.; Elford, H. L.; Chitambar, C. R. (1998). „Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells”. Cancer Lett. 129: 199—204. PMID 9719462. doi:10.1016/S0304-3835(98)00104-9.
- Nocentini, G.; Barzi, A. (1996). „The 2,2′-Bipyridyl-6-carbothioamide copper (II) complex differs from the iron (II) complex in its biochemical effects in tumor cells, suggesting possible differences in the mechanism leading to cytotoxicity”. Biochem. Pharm. 52: 65—71. PMID 8678909. doi:10.1016/0006-2952(96)00139-6.
- Monti, E.; Monzini, F.; Morazzoni, F.; Perletti, G.; Piccini, F. (1993). „Interaction of Cu(II) and Cu(II)-anthracycline complexes with protein kinase C. Spectromagnetic assessment of the inhibitory effect”. Inorg. Chim. Acta. 205: 181—184. doi:10.1016/S0020-1693(00)85536-X.
- Gopalakrishna, R.; Gundimeda, U.; Chen, Z. H. (1997). „Cancer-Preventive Selenocompounds Induce a Specific Redox Modification of Cysteine-Rich Regions in Ca2+- Dependent Isoenzymes of Protein Kinase C”. Arch. Biochem. Biophys. 348: 25—36. PMID 9390171. doi:10.1006/abbi.1997.0334.
- Gopalakrishna, R.; Chen, Z. H.; Gundimeda, U. (1997). „Selenocompounds Induce a Redox Modulation of Protein Kinase C in the Cell, Compartmentally Independent from Cytosolic Glutathione: Its Role in Inhibition of Tumor Promotion”. Arch. Biochem. Biophys. 348: 37—48. PMID 9390172. doi:10.1006/abbi.1997.0335.
- Harding, M. M.; Long, G. V. (1997). „Solution conformation of the antitumor drug streptonigrin”. Curr. Med. Chem. 4: 405—420. PMID 8230091. doi:10.1021/jm00073a003.
- Perry, D. K.; Smyth, M. J.; Stennicke, H. R.; Salvesen, G. S.; Duriez, P.; Poiriez, G. G.; Hannun, Y. A. (1997). „Zinc Is a Potent Inhibitor of the Apoptotic Protease, Caspase-3 - A novel target for zink in the inhibition of apoptosis”. J. Biol. Chem. 30: 18530—18533. PMID 9228015. doi:10.1074/jbc.272.30.18530.
- Maret, W.; Jacob, C.; Vallee, B. L.; Fischer, E. H. (1999). „Inhibitory sites in enzymes: Zinc removal and reactivation by thionein”. Proc. Natl. Acad. Sci. 96: 1936—1940. PMID 10051573. doi:10.1073/pnas.96.5.1936.
- Morinville, A.; Maysinger, D.; Shaver, A. (1998). „From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signalling”. Trends Pharmacol. Sci. 19: 452—460. PMID 9850609. doi:10.1016/S0165-6147(98)01257-7.
- Faure, R.; Vincent, M.; Dufour, M.; Shaver, A.; Posner, B. I. J. (1995). „Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: Studies on a neuronal and a glial cell line”. Cell Biochem. 58: 389—401. PMID 8567756. doi:10.1002/jcb.240590310.
- Cha, J.; Pedersen, M. V.; Auld, D. S. (1996). „Metal and pH dependence of heptapeptide catalysis by human matrilysin”. Biochemistry. 35: 15831—13838. PMID 8961947. doi:10.1021/bi962085f.
- Nocentini, G.; Barzi, A. (1997). „Antitumor activity of 2,2′-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitor”. Gen. Pharmac. 29: 701—706. PMID 9347313. doi:10.1016/S0306-3623(97)00011-6.
- Byrnes, R. W.; Mohan, M.; Antholine, W. E.; Xe, R. X.; Petering, D. H. (1990). „Oxidative stress induced by a copper-thiosemicarbazone complex”. Biochemistry. 29: 7046—7053. PMID 2171640. doi:10.1021/bi00482a014.
- Hubbard, S. R.; Bishop, W. R.; Kirschmeier, P.; George, S. J.; Cramer, S. P.; Hendrickson, W. A. (1991). „Identification and characterization of zinc binding sites in protein kinase C”. Science. 254: 1776—1779. PMID 1763327. doi:10.1126/science.1763327.
- V. Ashutosh Raocorresponding (10. 03. 2013). „Iron Chelators with Topoisomerase-Inhibitory Activity and Their Anticancer Applications”. Antioxid Redox Signal. 18 (8): 930—955. PMC 3557438 . doi:10.1089/ars.2012.4877.
- Köpf-Maier, P.; Köpf, H. (1987). „Non-platinum group metal antitumor agents. History, current status, and perspectives”. Chem. Rev. 87: 1137—1152. doi:10.1021/cr00081a012.
- Harding, M. M.; Prodigalidad, M.; Lynch, M. J. (1996). „Organometallic Anticancer Agents. 2. Aqueous Chemistry and Interaction of Niobocene Dichloride with Nucleic Acid Constituents and Amino Acids”. J. Med. Chem. 39: 5012—5016. PMID 8960562. doi:10.1021/jm9603678.
- Harding, M. M.; Mokdsi, G.; Mackay, J. P.; Prodigalidad, M.; Lucas, C. W. (1998). „Interactions of the Antitumor Agent Molybdocene Dichloride with Oligonucleotides”. Inorg. Chem. 37: 2432—2437. doi:10.1021/ic971205k.
- Scheich, L. A.; Gosling, P.; Brown, S. J.; Olmstead, M. M.; Mascharak, P. K. (1991). „Synthetic analog approach to metallobleomycins: possibility of coordination of the carboxamide group of the .beta.-aminoalaninamide moiety of bleomycin to copper in copper(II) bleomycin at physiological pH”. Inorg. Chem. 30: 1677—1680. doi:10.1021/ic00007a052.
- Trakshel, G.; Sluss, P.; Maines, M. (1992). „Comparative effects of tin- and zinc-protoporphyrin on steroidogenesis: tin-protoporphyrin is a potent inhibitor of cytochrome P-450-dependent activities in the rat adrenals”. Pediatr. Res. 31: 196—201. PMID 1542552. doi:10.1203/00006450-199202000-00022.
- Maines, M.; Trakshel, G. (1992). „Differential regulation of heme oxygenase isozymes by Sn- and Zn-protoporphyrins: possible relevance to suppression of hyperbilirubinemia”. Biochim. Biophys. Acta. 1131: 166—174. PMID 1610897. doi:10.1016/0167-4781(92)90072-8.
- Robert A. Johnson; Manuel Lavesa; Bardia Askari; Nader G. Abraham; Alberto Nasjletti (1995). „A Heme Oxygenase Product, Presumably Carbon Monoxide, Mediates a Vasodepressor Function in Rats”. Hypertension. 25: 166—169. PMID 7843765. doi:10.1161/01.HYP.25.2.166.
- Keino, H.; Banno, T.; Mimura, S.; Kashiwamata, S. (1993). „Cobalt-Mesoporphyrin Inhibits Heme Oxygenase Activity but It Does Not Induce Lipid Peroxidation in Rat Brain Membranes during Photoirradiation”. Biol. Neonate. 63: 285—289. PMID 8353156. doi:10.1159/000243943.
- Vallier, H.; Rodgers, P.; Stevenson, D. (1993). „Inhibition of heme oxygenase after oral vs intraperitoneal administration of chromium porphyrins”. Life Sci. 52: PL79—PL84. PMID 8445977. doi:10.1016/0024-3205(93)90521-4.
- Drummond, G.; Rosenberg, D.; Kappas, A. (1992). „Intestinal heme oxygenase inhibition and increased biliary iron excretion by metalloporphyrins”. Gastroenterology. 102: 1170—1175. PMID 1551526. doi:10.1016/0016-5085(92)70011-Y.
- Angelique Y. Louie; Thomas J. Meade (1999). „Metal Complexes as Enzyme Inhibitors”. Chemical Reviews. 99 (9): 2711—2734. doi:10.1021/cr9804285.
- Cannon, J. B. (1993). „Pharmaceutics and drug delivery aspects of heme and porphyrin therapy”. J. Pharm. Sci. 82: 435—446. PMID 8360819. doi:10.1002/jps.2600820502.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Marks, J. A.; Maines, M. D. (1992). „Tin-Protoporphyrin-Mediated Disruption In Vivo of Heme Oxygenase-2 Protein Integrity and Activity in Rat Brain” (PDF). Pediatr. Res. 32: 324—329. PMID 1408470. doi:10.1203/00006450-199209000-00016.
- Cable, E.; Cable, J.; Bonkovsky, H. (1993). „Repression of hepatic δ-aminolevulinate synthase by heme and metalloporphyrins: Relationship to inhibition of heme oxygenase”. Hepatology. 18: 119—127. PMID 8325603. doi:10.1002/hep.1840180119.
- Lathrop, J. T.; Timko, M. P. (1993). „Regulation by heme of mitochondrial protein transport through a conserved amino acid moti”. Science. 259: 522—525. PMID 8424176. doi:10.1126/science.8424176.
- Serfass, L.; Burstyn, J. (1998). „Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity”. Arch. Biochem. Biophys. 359: 8—16. PMID 9799554. doi:10.1006/abbi.1998.0887.
- Luo, D.; Vincent, S. (1994). „Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo”. Eur. J. Pharmacol.-Mol. Pharmacol. Sec. 267: 263—267. PMID 7522180. doi:10.1016/0922-4106(94)90149-X.
- Mariotto, S.; Cuzzolin, L.; Adami, A.; DelSoldato, P.; Suzuki, H.; Benoni, G. (1995). „Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils”. Brit. J. Pharmacol. 114: 1105—1106. PMID 7542530. doi:10.1111/j.1476-5381.1995.tb13320.x.
- Vickroy, T.; Malphurs, W. (1995). „Inhibition of nitric oxide synthase activity in cerebral cortical synaptosomes by nitric oxide donors: evidence for feedback autoregulation”. Neurochem. Res. 20: 299—304. PMID 7541898. doi:10.1007/BF00969546.
- Perry, J.; Marletta, M. (1998). „Effects of transition metals on nitric oxide synthase catalysis”. PNAS. 95: 11101—11106. PMID 9736696. doi:10.1073/pnas.95.19.11101.
- Persechini A, McMillan K, Masters BS (1995). „Inhibition of Nitric Oxide Synthase Activity by Zn2+ Ion”. Biochemistry. 34: 15091—15095. PMID 7578122. doi:10.1021/bi00046a015.
- Nicolaou, A.; Waterfield, C.; Kenyon, S.; Gibbons, W. (1997). „The Inactivation of Methionine Synthase in Isolated Rat Hepatocytes by Sodium Nitroprusside”. Eur. J. Biochem. 244: 8876—882. PMID 9108260. doi:10.1111/j.1432-1033.1997.00876.x.
- Sato, T.; Kamata, Y.; Irifune, M.; Nishikawa, T. (1995). „Inhibition of purified (Na+,K+)-ATPase activity from porcine cerebral cortex by NO generating drugs”. Brain Res. 704: 117—120. PMID 8750971. doi:10.1016/0006-8993(95)01165-X.
- Bredt, D. S.; Snyder, S. H. (1992). „Nitric oxide, a novel neuronal messenger”. Neuron. 8: 3—11. PMID 1370373. doi:10.1016/0896-6273(92)90104-L.
- Jaffrey, S. R.; Snyder, S. H. (1996). „PIN: An associated protein inhibitor of neuronal nitric oxide synthase”. Science. 274: 774—777. PMID 8864115. doi:10.1126/science.274.5288.774.
- Marletta, M. A. (1994). „Nitric oxide synthase: Aspects concerning structure and catalysis” (PDF). Cell. 78: 927—930. PMID 7522970. doi:10.1016/0092-8674(94)90268-2.
- Moore, P. K.; Handy, R. L. C. (1997). „Selective inhibitors of neuronal nitric oxide synthase – is no NOS really good NOS for the nervous system?”. Trends Pharm. Sci. 18: 204— 211. PMID 9226999. doi:10.1016/S0165-6147(97)01064-X.
- Bredt, D. S.; Snyder, S. H. (1990). „Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme”. PNAS. 87: 682—685. PMID 1689048. doi:10.1073/pnas.87.2.682.
- Weiss, G.; Lutton, J.; Fuchs, D.; Wernerfelmayer, G.; Bock, G.; Abraham, N.; Kappas, A.; Levere, R.; Wachter, H. (1993). „Comparative Effects of Heme and Metalloporphyrins on Interferon-γ-Mediated Pathways in Monocytic Cells (THP-1)”. Proc. Soc. Exp. Biol. Med. 202: 470—475. PMID 8456113. doi:10.3181/00379727-202-43561.
- Meffert, M.; Haley, J.; Schulman, E.; Schulman, H.; Madison, D. (1994). „Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins”. Neuron. 13: 1225—1233. PMID 7524564. doi:10.1016/0896-6273(94)90060-4.
- Bing, O.; Grundemar, L.; Ny, L.; Moller, C.; Heilig, M. (1995). „Modulation of carbon monoxide production and enhanced spatial learning by tin protoporphyrin”. Neuroreport. 6: 1369—1372. PMID 7488726. doi:10.1097/00001756-199507100-00002.
- Pedregosa, J. C.; Casanova, J.; Alzuet, G.; Borras, J.; Garcia-Granda, S.; Diaz, M. R.; Guttierez-Rodriguez, A. (1995). „Metal complexes of 5-tertbutyloxycarbonylamido-1,3,4-thiadiazole-2-sulfonamide (B-H2ats), a carbonic anhydrase inhibitor. Synthesis and characterization of the copper(II) complex. Crystal structures of B-H2ats and the [Cu(B-ats)(NH3)2]2 dimer complex”. Inorg. Chim. Acta. 232: 117—124. doi:10.1016/0020-1693(94)04376-7.
- Supuran, C. T.; Mincione, F.; Scozzafava, A.; Briganti, F.; Mincione, G.; Ilies, M. A. (1998). „Carbonic anhydrase inhibitors — Part 52. Metal complexes of heterocyclic sulfonamides: A new class of strong topical intraocular pressure-lowering agents in rabbits”. Eur. J. Med. Chem. 22: 247—254. doi:10.1016/S0223-5234(98)80059-7.
- Supuran CT, Scozzafava A, Saramet I, Banciu MD (1998). „Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes”. J. Enzyme Inhib. 13: 177—194. PMID 9629536. doi:10.3109/14756369809028339.
- Turkmen H, Durgun M, Yilmaztekin S, Emul M, Innocenti A, Vullo D, Scozzafava A, Supuran CT (1997). „Carbonic anhydrase inhibitors. Part 50. Interaction of isoenzymes I and II of carbonic anhydrase with Ge(IV) and Sb(III) derivatives”. Main Group Met. Chem. 20: 641—647. PMID 15603956. doi:10.1016/j.bmcl.2004.10.070.
- Supuran, C. T. (1996). „Complexes with biologically active ligands. Part 3. Synthesis of coordination compounds of chlorothiazide with divalent metal ions”. Main Group Met. Chem. 19: 347—353. doi:10.1515/MGMC.1996.19.6.339.
- Koppenho¨fer, A.; Hartmann, U.; Vahrenkamp, H. (1995). „Zinc Complexes of Drugs Containing Nitrogen Heterocycles”. Chem. Ber. 128: 779—785. doi:10.1002/cber.19951280807.
- Gonzalez, E. B.; Farkas, E.; Soudi, A. A.; Tan, T.; Yanovsky, A. I.; Nolan, K. B. (1997). „Metal complexes of the angiotensin-converting enzyme inhibitor,lisinopril. Solution studies and the crystal and molecular structure ofa dimeric copper(II)-lisinopril complex”. J. Chem. Soc., Dalton Trans.: 2377—2379. doi:10.1039/A701500C.
- Abrams MJ, Murrer BA (1993). „Metal compounds in therapy and diagnosis”. Science. 261: 725—730. PMID 8102010. doi:10.1126/science.8102010.
- Sly WS, Hu PY (1995). „Human carbonic anhydrases and carbonic anhydrase deficiencies”. Annu. Rev. Biochem. 64: 375—401. PMID 7574487. doi:10.1146/annurev.bi.64.070195.002111.
- Bergenhem, N. (1996). „Chromatographic and electrophoretic methods related to the carbonic anhydrase isozymes”. J. Chromatogr. B. 684: 289—305. PMID 8906478. doi:10.1016/0378-4347(95)00566-8.
- Heagerty, A. M. (1991). „Functional and structural effects of ACE inhibitors on the cardiovascular system”. Cardiology. 79: 3—9. PMID 1913721. doi:10.1159/000174899.
- Pandurangi, R. S.; Katti, K. V.; Stillwell, L.; Barnes, C. L. (1998). „Retention of Inhibitory Potency of an ACE Inhibitor Conjugated with Rh(III) and Pd(II) (Iminophosphorano)phosphines. Synthesis and X-ray Structural Investigations”. J. Am. Chem Soc. 120: 11364—11373. doi:10.1021/ja9802403.
- Bagger, S.; Wagner, K. J. (1998). „Molecular recognition of cobalt(III)-ligated peptides by serine proteases: the role of electrostatic effects”. Peptide Res. 52: 273—282. PMID 9832305. doi:10.1111/j.1399-3011.1998.tb01241.x.
- Takeuchi, T.; Bottcher, A.; Quezada, C.; Simon, M.; Meade, T.; Gray, H. (1998). „Selective Inhibition of Human α-Thrombin by Cobalt(III) Schiff Base Complexes”. J. Am. Chem. Soc. 120: 8555—8556. doi:10.1021/ja981191x.
- Böttcher, A.; Takeuchi, T.; Hardcastle, K.; Meade, T.; Gray, H.; Cwikel, D.; Kapon, M.; Dori, Z. (1997). „Spectroscopy and Electrochemistry of Cobalt(III) Schiff Base Complexes”. Inorg. Chem. 36: 2498—2504. doi:10.1021/ic961146v.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1992). „Identification of serine and histidine adducts in complexes of trypsin and trypsinogen with peptide and nonpeptide boronic acid inhibitors by proton NMR spectroscopy”. Biochemistry. 31: 12839—12846. PMID 1463754. doi:10.1021/bi00166a019.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1993). „Boron-11 NMR spectroscopy of peptide boronic acid inhibitor complexes of .alpha.-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes”. Biochemistry. 32: 12651—12655. PMID 8251483. doi:10.1021/bi00210a013.
- Suenaga, H.; Nakashima, K.; Shinkai, S. (1995). „Sugars intensify the inhibitory effect of phenylboronic acid on the hydrolytic activity of α-chymotrypsin”. J. Chem. Soc., Chem. Commun.: 29—30. doi:10.1039/C39950000029.
- Katz, B.; Finermoore, J.; Mortezaei, R.; DH, R.; Stroud, R. (1995). „Episelection: Novel Ki .apprx. Nanomolar Inhibitors of Serine Proteases Selected by Binding or Chemistry on an Enzyme Surface”. Biochemistry. 34: 8264—8280. doi:10.1021/bi00026a008.
- Katz, B.; Clark, J.; Finer-Moore, J.; Jenkins, T.; Johnson, C.; Ross, M.; Luong, C.; Moore, W.; Stroud, R. (1998). „Design of potent selective zinc-mediated serine protease inhibitors”. Nature. 391: 608—612. PMID 9468142. doi:10.1038/35422.
- Thorpe, H. H. (1998). „Bioinorganic chemistry and drug design: here comes zinc again”. Chem. Biol. 5: R125—R127. PMID 9653544. doi:10.1016/S1074-5521(98)90166-1.
- Duffy, B.; Schwietert, C.; France, A.; Mann, N.; Culbertson, K.; Harmon, B.; McCue, J. P. (1998). „Transition metals as protease inhibitors”. Biol. Trace Element Res. 64: 197—213. PMID 9845474. doi:10.1007/BF02783336.
- Babine, R. E.; Bender, S. L. (1997). „Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design”. Chem. Rev. 97: 1359—1472. PMID 11851455. doi:10.1021/cr960370z.
- Bone, R.; Frank, D.; Kettner, C. A.; Agard, D. A. (1989). „Structural analysis of specificity: .alpha.-lytic protease complexes with analogs of reaction intermediates”. Biochemistry. 28: 7600—7609. PMID 2611204. doi:10.1021/bi00445a015.
- Louie, A. Y.; Meade, T. J. (1998). „A cobalt complex that selectively disrupts the structure and function of zinc fingers”. PNAS. 95: 6663—6668. PMID 9618469. doi:10.1073/pnas.95.12.6663.
- Mork, A. (1993). „Actions of Lithium on the Cyclic AMP Signalling System in Various Regions of the Brain - Possible Relations to its Psychotropic Actions -: A Study on the Adenylate Cyclase in Rat Cerebral Cortex, Corpus Striatum and Hippocampus”. Pharmacol. Toxicol. 71: 1—47. doi:10.1111/j.1600-0773.1993.tb01704.x.
- Rao, K. S. J.; Rao, G. V. (1994). „Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study”. Mol. Cell. Biochem. 137: 57—60. PMID 7845378. doi:10.1007/BF00926039.
- Nixon, R. A.; Clarke, J. F.; Logvinenko, K. B.; Tan, M. K. H.; Hoult, M.; Grynspan, F. (1990). „Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes”. J. Neurochem. 55: 1950—1959. PMID 2121904. doi:10.1111/j.1471-4159.1990.tb05781.x.
- Joshi, J. G.; Dhar, M.; Clauberg, M.; Chauthaiwale, V. (1994). „Iron and aluminum homeostasis in neural disorders”. Environ. Health Perspect. 102: 207—213. PMID 7843099. doi:10.2307/3431788.
- Lee, B. H.; Park, M. B.; Yu, B. S. (1998). „Inhibition of electric eel acetylcholinesterase by porphin compounds”. Bioinorg. Med. Chem. Lett. 8: 1467—1470. PMID 9873371. doi:10.1016/S0960-894X(98)00236-4.
- Falkous, G.; Harris, J. B.; Mantle, D. (1995). „Effect of neurotoxic metal ions in vitro on proteolytic enzyme activities in human cerebral cortex”. Clin. Chim. Acta. 238: 125—135. PMID 7586572. doi:10.1016/0009-8981(95)06081-N.
- Cuajungco, M. P.; Lees, G. K. (1997). „Zinc metabolism in the brain: relevance to human neurodegenerative disorders”. Neurobiol. Dis. 4: 137—169. PMID 9361293. doi:10.1006/nbdi.1997.0163.
- Atwood, C. S.; Moir, R. D.; Huang, X. D.; Scarpa, R. C.; Bacarra, N. M. E.; Romano, D. M.; Hartshorn, M. K.; Tanzi, R. E.; Bush, A. I. (1998). „Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis”. J. Biol. Chem. 273: 12817—12826. PMID 9582309. doi:10.1074/jbc.273.21.12817.
- Mantyh, P. W.; Ghilardi, J. R.; Rogers, S.; Demaster, E.; Allen, C. J.; Stimson, E. R.; Maggio, J. E. (1993). „Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide”. J. Neurochem. 61: 1171—1174. PMID 8360682. doi:10.1111/j.1471-4159.1993.tb03639.x.
- Huang, X. D.; Atwood, C. S.; Moir, R. D.; Hartshorn, M. A.; Vonsattel, J. P.; Tanzi, R. E.; Bush, A. I. (1997). „Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors”. J. Biol. Chem. 272: 26464—26470. PMID 9334223. doi:10.1074/jbc.272.42.26464.
- Bondy, S. C.; Guo-Ross, S. X.; Truong, A. T. (1998). „Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid”. Brain Res. 799: 91—96. PMID 9666089. doi:10.1016/S0006-8993(98)00461-2.
- Cuajungco, M. P.; Lees, G. (1997). „Zinc and Alzheimer's disease: is there a direct link?”. J. Brain Res. Rev. 23: 219—236. PMID 9164672. doi:10.1016/S0165-0173(97)00002-7.
- Sugumoto, H.; Iimura, Y.; Yamanishi, Y.; Yamatsu, K. (1995). „Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds”. J. Med. Chem. 38: 4821—4829. PMID 7490731. doi:10.1021/jm00024a009.
- Hashimoto, K.; Whitehurst, C. E.; Matsubara, T.; Hirohata, K.; Lipsky, P. E. (1992). „Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C”. J. Clin. Invest. 89: 1839—1848. PMID 1351061. doi:10.1172/JCI115788.
- Rajendran, K. G.; Sood, A.; Spielvogel, B. F.; Hall, I. H.; III, V. M. N.; Morse, K. W. (1995). „Anti-Osteoporotic activity of metal complexes of amine carboxyboranes”. Appl. Organomet. Chem. 9: 111—119. doi:10.1002/aoc.590090204.
- Zhang, Z. Y.; Reardon, I. M.; Hui, J. O.; O’Connell, K. L.; Poorman, R. A.; Heinrikson, R. L. (1991). „Zinc inhibition of renin and the protease from human immunodeficiency virus type 1”. Biochemistry. 30: 8717—8721. PMID 1888732. doi:10.1021/bi00100a001.
- Hall, I. H.; Chen, S. Y.; Rajendran, K. G.; Sood, A.; Spielvogel, B. F.; Shih, J. (1994). „Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes”. Environ. Health Perspect. 102: 21—30. PMID 7889876. doi:10.2307/3431958.
- Naughton, D. P.; Knappitt, J.; Fairburn, K.; Gaffney, K.; Blake, D. R.; Grootveld, M. (1995). „Detection and investigation of the molecular nature of low-molecular-mass copper ions in isolated rheumatoid knee-joint synovial fluid”. FEBS Lett. 362: 167—172. PMID 7698317. doi:10.1016/0014-5793(95)00165-6.
- Miche, H.; Brumas, V.; Berthon, G. (1997). „Copper(II) interactions with nonsteroidal antiinflammatory agents. II. Anthranilic acid as a potential. OH-inactivating ligand”. J. Inorg. Biochem. 68: 27—38. PMID 9379178. doi:10.1016/S0162-0134(97)00005-6.
- Menard, H. A.; Amine, M. E. (1996). „The calpain-calpastatin system in rheumatoid arthritis”. Immunol. Today. 17: 545—547. PMID 8991283. doi:10.1016/S0167-5699(96)30064-9.
- Zhang, H.; Johnson, P. (1992). „Differential effects of aluminum ion on smooth muscle calpain I and calpain II activities”. Int. J. Biochem. 24: 1773—1778. PMID 1451912. doi:10.1016/0020-711X(92)90127-M.
- Frolich, J. C. (1997). „A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes”. Trends Pharm. Sci. 18: 30—34. PMID 9114728. doi:10.1016/S0165-6147(96)01017-6.
- Casas, J.; Rodriguez-Arguelles, M.; Russo, U.; Sanchez, A.; Sordo, J.; Vazquez-Lopez, A.; Pinelli, S.; Lunghi, P.; Bonati, A.; Albertini, R. (1998). „Diorganotin(IV) complexes of pyridoxal thiosemicarbazone: synthesis, spectroscopic properties and biological activity”. J. Inorg. Biochem. 69: 283—292. PMID 9654752. doi:10.1016/S0162-0134(98)00004-X.
- Woon, T.; Brinkworth, R.; Fairlie, D. (1992). „Inhibition of HIV-1 proteinase by metal ions”. Int. J. Biochem. 24: 911—914. PMID 1612181. doi:10.1016/0020-711X(92)90096-J.
- Davis, D. A.; Branca, A. A.; Pallenberg, A. J.; Marschner, T. M.; Patt, L. M.; Chatlynne, L. G.; Humphrey, R. W.; Yarchoan, R.; Levine, R. L. (1995). „Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+”. Arch. Biochem. Biophys. 322: 127—134. PMID 7574666. doi:10.1006/abbi.1995.1444.
- Lebon, F.; deRosny, E.; Reboud-Ravauz, M.; Durant, F. (1998). „De novo drug design of a new copper chelate molecule acting as HIV-1 protease inhibitor”. Eur. J. Med. Chem. 33: 733—737. doi:10.1016/S0223-5234(98)80032-9.
- Mazumder, A.; Gupta, M.; Perrin, D. M.; Sigman, C. S.; Ranbinovitz, M.; Pommier, Y. (1995). „Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor”. AIDS Res. Hum. Retroviruses. 11: 1. PMID 7734182. doi:10.1089/aid.1995.11.1.
- Huang, H.; Chopra, R.; Verdine, G. L.; Harrison, S. C. (1998). „Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance”. Science. 282: 1669—1675. PMID 9831551. doi:10.1126/science.282.5394.1669.
- Ferrari, M. B.; Fava, G. G.; Tarasconi, R.; Albertini, S.; Pinelli, R.; Starcich, J. (1994). „Synthesis, spectroscopic and structural characterization, and biological activity of aquachloro (pyridoxal thiosemicarbazone) copper(II) chloride”. J. Inorg. Biochem. 53: 13. PMID 8133248. doi:10.1016/0162-0134(94)80017-0.
- Das K, Bauman JD, Rim AS, Dharia C, Clark AD Jr, Camarasa MJ, Balzarini J, Arnold E (28. 04. 2011). „Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket”. J Med Chem. 54 (8): 2727—37. PMID 21446702. doi:10.1021/jm101536x.
- Spence, R. A.; Kati, W. M.; Anderson, K. S.; Johnson, K. A. (1995). „Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors”. Science. 267: 988—993. PMID 7532321. doi:10.1038/nsb0495-303.
- West, M. L.; Fairlie, D. P. (1995). „Targeting HIV-1 protease: a test of drug-design methodologies”. Trends Pharmacol. Sci. 16: 67—75. PMID 7762084. doi:10.1016/S0165-6147(00)88980-4.
- Serra, M.; Pintar, A.; Casella, L.; Sabbioni, E. (1992). „Vanadium effect on the activity of horseradish peroxidase, catalase, glutathione peroxidase, and superoxide dismutase in vitro”. J. Inorg. Biochem. 46: 161—174. PMID 1325536. doi:10.1016/0162-0134(92)80027-S.
- DeZwart, M.; vanderGoot, H.; Timmerman, H. (1991). „Influence of Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) on growth inhibition and enzyme activity of Mycoplasma gallisepticum in the absence or presence of a 2,2′-bipyridyl type ligand”. Eur. J. Med. Chem. 26: 101—108. doi:10.1016/0223-5234(91)90218-C.
- Wells, T. N. C.; Scully, P.; Paravicini, G.; Proudfoot, A. E. I.; Payton, M. A. (1995). „Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine”. Biochemistry. 34: 7896—7903. PMID 7794901. doi:10.1021/bi00024a014.
- Cunningham, M. L.; Zvelebil, M. J. J. M.; Fairlamb, A. H. (1994). „Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals”. Eur. J. Biochem. 221: 285—295. PMID 8168518. doi:10.1111/j.1432-1033.1994.tb18740.x.
- Su, J. J.; Mansour, J. M.; Mansour, T. E. (1996). „Purification, kinetics and inhibition by antimonials of recombinant phosphofructokinase from Schistosoma mansoni”. Mol. Biochem. Parasitol. 81: 171—178. PMID 8898332. doi:10.1016/0166-6851(96)02702-8.
- Bult, A. (1983). Sigel, H., ur. Metal ions in biological systems. 16. New York: Marcel Dekker. doi:10.1080/00945718208063132.
- Hueso-Urena, F.; Moreno-Carretero, M. N.; Romero-Molina, M. A.; Salas-Peregrin, J. M.; Sanchez-Sanchez, M. P.; Cienfuegos-Lopez, G. A. D.; Faure, R. J. (1993). „Transition metal complexes with monodeprotonated isoorotic and 2-thioisoorotic acids: Crystal structure, spectral and magnetic study, and antimicrobial activity”. Inorg. Biochem. 51: 613—632. doi:10.1016/0162-0134(93)85033-5.
- Ibrahim, S. A.; El-Gyar, S. A.; El-Gahani, M. A. (1991). „Metal complexes of nitrogen-oxygen donor ligands as potential drugs”. Collect. Czech. Chem. Commun. 56: 1333—1339. doi:10.1135/cccc19911333.
- Beil, W.; Birkholz, C.; Wagner, S.; Sewing, K. (1995). „Bismuth subcitrate and omeprazole inhibit Helicobacter pyloriF1-ATPase”. Pharmacology. 50: 333—337. PMID 7667394. doi:10.1159/000139299.
- Schroeder, T.; Caspers, M. (1996). „Kinetics of aluminum-induced inhibition of delta-aminolevulinic acid dehydratase in vitro”. Biochem. Pharmacol. 52: 927—931. PMID 8781512. doi:10.1016/0006-2952(96)00449-2.
- Exley, C.; Price, N.; Birchall, J. (1994). „Aluminum inhibition of hexokinase activity in vitro: a study in biological availability”. J. Inorg. Biochem. 54: 297—304. PMID 8014638. doi:10.1016/0162-0134(94)80035-9.
- Canesi, L.; Ciacci, C.; Piccoli, G.; Stocchi, V.; Viarengo, A.; Gallo, G. (1998). „In vitro and in vivo effects of heavy metals on mussel digestive gland hexokinase activity: the role of glutathione”. Comp. Biochem. Physiol. C. 120 (2): 261—268. PMID 9827040. doi:10.1016/S0742-8413(98)10004-X.
- Yoshino, M.; Murakami, K.; Kawano, K. (1998). „Interaction of aluminum ion with ATP. Mechanism of the aluminum inhibition of glycerol kinase and its reversal by spermine”. Biometals. 11: 63—67. doi:10.1023/A:1009213508942.
- Yager, J. W.; Wiencke, J. K. (1997). „Inhibition of poly(ADP-ribose) polymerase by arsenite”. Mutat. Res. 386: 345—351. PMID 9219571. doi:10.1016/S1383-5742(97)00011-2.
- Hu, Y.; Su, L.; Snow, E. T. (1998). „Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes”. Mutat. Res. 408: 203—218. PMID 9806419. doi:10.1016/S0921-8777(98)00035-4.
- Tsao, D.; Maki, A. (1991). „Optically detected magnetic resonance study of the interaction of an arsenic(III) derivative of cacodylic acid with EcoRI methyltransferase”. Biochemistry. 30: 4565—4572. PMID 2021649. doi:10.1021/bi00232a029.
- Lam, W.; Tsao, D.; Maki, A.; Maegley, K.; Reich, N. (1992). „Spectroscopic studies of arsenic(III) binding to Escherichia coli RI methyltransferase and to two mutants, C223S and W183F”. Biochemistry. 31: 10438—10442. PMID 1420162. doi:10.1021/bi00158a004.
- Styblo, M.; Thomas, D. (1995). „In vitro inhibition of glutathione reductase by arsenotriglutathione”. Biochem. Pharmacol. 49: 971—977. PMID 7741769. doi:10.1016/0006-2952(95)00008-N.
- Snow, E.; Xu, L.; Kinney, P. (1993). „Effects of nickel ions on polymerase activity and fidelity during DNA replication in vitro”. Chem.-Biol. Interact. 88: 155—173. PMID 8403077. doi:10.1016/0009-2797(93)90089-H.
- Yang, S. W.; Becker, F. F.; Chan, J. Y. H. (1996). „Inhibition of human DNA ligase I activity by zinc and cadmium and the fidelity of ligation”. Environ. Health Perspect. 28: 19—25. PMID 8698042. doi:10.1002/(SICI)1098-2280(1996)28:1<19::AID-EM5>3.0.CO;2-9.
- Hartwig, A. (1994). „Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review”. Environ. Health Perspect. 102: 45—50. PMID 7843136. doi:10.2307/3431762.
- Porter, D. W.; Nelson, V. C.; Fivash, M. J. J.; Kasprzak, K. S. (1996). „Mechanistic studies of the inhibition of MutT dGTPase by the carcinogenic metal Ni(II)”. Chem. Res. Toxicol. 9: 1375—1381. PMID 8951243. doi:10.1021/tx9600816.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
- SI, Beale (1990). „Biosynthesis of the Tetrapyrrole Pigment Precursor, delta-Aminolevulinic Acid, from Glutamate”. Plant Physiol. 93 (4): 1273—9. PMC 1062668 . PMID 16667613. doi:10.1104/pp.93.4.1273.
- O’Halloran, T. V. (1993). „Transition metals in control of gene expression”. Science. 261: 715—725. PMID 8342038. doi:10.1126/science.8342038.
- Cannon, J. B. (1993). „Pharmaceutics and drug delivery aspects of heme and porphyrin therapy”. J. Pharm. Sci. 82: 435—446. PMID 8360819. doi:10.1002/jps.2600820502.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Marks, J. A.; Maines, M. D. (1992). „Tin-Protoporphyrin-Mediated Disruption In Vivo of Heme Oxygenase-2 Protein Integrity and Activity in Rat Brain” (PDF). Pediatr. Res. 32: 324—329. PMID 1408470. doi:10.1203/00006450-199209000-00016.
- Cable, E.; Cable, J.; Bonkovsky, H. (1993). „Repression of hepatic δ-aminolevulinate synthase by heme and metalloporphyrins: Relationship to inhibition of heme oxygenase”. Hepatology. 18: 119—127. PMID 8325603. doi:10.1002/hep.1840180119.
- Lathrop, J. T.; Timko, M. P. (1993). „Regulation by heme of mitochondrial protein transport through a conserved amino acid moti”. Science. 259: 522—525. PMID 8424176. doi:10.1126/science.8424176.
- Serfass, L.; Burstyn, J. (1998). „Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity”. Arch. Biochem. Biophys. 359: 8—16. PMID 9799554. doi:10.1006/abbi.1998.0887.
- Luo, D.; Vincent, S. (1994). „Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo”. Eur. J. Pharmacol.-Mol. Pharmacol. Sec. 267: 263—267. PMID 7522180. doi:10.1016/0922-4106(94)90149-X.
- Mariotto, S.; Cuzzolin, L.; Adami, A.; DelSoldato, P.; Suzuki, H.; Benoni, G. (1995). „Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils”. Brit. J. Pharmacol. 114: 1105—1106. PMID 7542530. doi:10.1111/j.1476-5381.1995.tb13320.x.
- Vickroy, T.; Malphurs, W. (1995). „Inhibition of nitric oxide synthase activity in cerebral cortical synaptosomes by nitric oxide donors: evidence for feedback autoregulation”. Neurochem. Res. 20: 299—304. PMID 7541898. doi:10.1007/BF00969546.
- Perry, J.; Marletta, M. (1998). „Effects of transition metals on nitric oxide synthase catalysis”. PNAS. 95: 11101—11106. PMID 9736696. doi:10.1073/pnas.95.19.11101.
- Persechini A, McMillan K, Masters BS (1995). „Inhibition of Nitric Oxide Synthase Activity by Zn2+ Ion”. Biochemistry. 34: 15091—15095. PMID 7578122. doi:10.1021/bi00046a015.
- Nicolaou, A.; Waterfield, C.; Kenyon, S.; Gibbons, W. (1997). „The Inactivation of Methionine Synthase in Isolated Rat Hepatocytes by Sodium Nitroprusside”. Eur. J. Biochem. 244: 8876—882. PMID 9108260. doi:10.1111/j.1432-1033.1997.00876.x.
- Sato, T.; Kamata, Y.; Irifune, M.; Nishikawa, T. (1995). „Inhibition of purified (Na+,K+)-ATPase activity from porcine cerebral cortex by NO generating drugs”. Brain Res. 704: 117—120. PMID 8750971. doi:10.1016/0006-8993(95)01165-X.
- Bredt, D. S.; Snyder, S. H. (1992). „Nitric oxide, a novel neuronal messenger”. Neuron. 8: 3—11. PMID 1370373. doi:10.1016/0896-6273(92)90104-L.
- Jaffrey, S. R.; Snyder, S. H. (1996). „PIN: An associated protein inhibitor of neuronal nitric oxide synthase”. Science. 274: 774—777. PMID 8864115. doi:10.1126/science.274.5288.774.
- Marletta, M. A. (1994). „Nitric oxide synthase: Aspects concerning structure and catalysis” (PDF). Cell. 78: 927—930. PMID 7522970. doi:10.1016/0092-8674(94)90268-2.
- Moore, P. K.; Handy, R. L. C. (1997). „Selective inhibitors of neuronal nitric oxide synthase – is no NOS really good NOS for the nervous system?”. Trends Pharm. Sci. 18: 204— 211. PMID 9226999. doi:10.1016/S0165-6147(97)01064-X.
- Bredt, D. S.; Snyder, S. H. (1990). „Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme”. PNAS. 87: 682—685. PMID 1689048. doi:10.1073/pnas.87.2.682.
- Weiss, G.; Lutton, J.; Fuchs, D.; Wernerfelmayer, G.; Bock, G.; Abraham, N.; Kappas, A.; Levere, R.; Wachter, H. (1993). „Comparative Effects of Heme and Metalloporphyrins on Interferon-γ-Mediated Pathways in Monocytic Cells (THP-1)”. Proc. Soc. Exp. Biol. Med. 202: 470—475. PMID 8456113. doi:10.3181/00379727-202-43561.
- Meffert, M.; Haley, J.; Schulman, E.; Schulman, H.; Madison, D. (1994). „Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins”. Neuron. 13: 1225—1233. PMID 7524564. doi:10.1016/0896-6273(94)90060-4.
- Bing, O.; Grundemar, L.; Ny, L.; Moller, C.; Heilig, M. (1995). „Modulation of carbon monoxide production and enhanced spatial learning by tin protoporphyrin”. Neuroreport. 6: 1369—1372. PMID 7488726. doi:10.1097/00001756-199507100-00002.
- Pedregosa, J. C.; Casanova, J.; Alzuet, G.; Borras, J.; Garcia-Granda, S.; Diaz, M. R.; Guttierez-Rodriguez, A. (1995). „Metal complexes of 5-tertbutyloxycarbonylamido-1,3,4-thiadiazole-2-sulfonamide (B-H2ats), a carbonic anhydrase inhibitor. Synthesis and characterization of the copper(II) complex. Crystal structures of B-H2ats and the [Cu(B-ats)(NH3)2]2 dimer complex”. Inorg. Chim. Acta. 232: 117—124. doi:10.1016/0020-1693(94)04376-7.
- Supuran, C. T.; Mincione, F.; Scozzafava, A.; Briganti, F.; Mincione, G.; Ilies, M. A. (1998). „Carbonic anhydrase inhibitors — Part 52. Metal complexes of heterocyclic sulfonamides: A new class of strong topical intraocular pressure-lowering agents in rabbits”. Eur. J. Med. Chem. 22: 247—254. doi:10.1016/S0223-5234(98)80059-7.
- Supuran CT, Scozzafava A, Saramet I, Banciu MD (1998). „Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes”. J. Enzyme Inhib. 13: 177—194. PMID 9629536. doi:10.3109/14756369809028339.
- Turkmen H, Durgun M, Yilmaztekin S, Emul M, Innocenti A, Vullo D, Scozzafava A, Supuran CT (1997). „Carbonic anhydrase inhibitors. Part 50. Interaction of isoenzymes I and II of carbonic anhydrase with Ge(IV) and Sb(III) derivatives”. Main Group Met. Chem. 20: 641—647. PMID 15603956. doi:10.1016/j.bmcl.2004.10.070.
- Supuran, C. T. (1996). „Complexes with biologically active ligands. Part 3. Synthesis of coordination compounds of chlorothiazide with divalent metal ions”. Main Group Met. Chem. 19: 347—353. doi:10.1515/MGMC.1996.19.6.339.
- Koppenho¨fer, A.; Hartmann, U.; Vahrenkamp, H. (1995). „Zinc Complexes of Drugs Containing Nitrogen Heterocycles”. Chem. Ber. 128: 779—785. doi:10.1002/cber.19951280807.
- Gonzalez, E. B.; Farkas, E.; Soudi, A. A.; Tan, T.; Yanovsky, A. I.; Nolan, K. B. (1997). „Metal complexes of the angiotensin-converting enzyme inhibitor,lisinopril. Solution studies and the crystal and molecular structure ofa dimeric copper(II)-lisinopril complex”. J. Chem. Soc., Dalton Trans.: 2377—2379. doi:10.1039/A701500C.
- Abrams MJ, Murrer BA (1993). „Metal compounds in therapy and diagnosis”. Science. 261: 725—730. PMID 8102010. doi:10.1126/science.8102010.
- Abrams MJ, Murrer BA (1993). „Metal compounds in therapy and diagnosis”. Science. 261: 725—730. PMID 8102010. doi:10.1126/science.8102010.
- Sly WS, Hu PY (1995). „Human carbonic anhydrases and carbonic anhydrase deficiencies”. Annu. Rev. Biochem. 64: 375—401. PMID 7574487. doi:10.1146/annurev.bi.64.070195.002111.
- Bergenhem, N. (1996). „Chromatographic and electrophoretic methods related to the carbonic anhydrase isozymes”. J. Chromatogr. B. 684: 289—305. PMID 8906478. doi:10.1016/0378-4347(95)00566-8.
- Heagerty, A. M. (1991). „Functional and structural effects of ACE inhibitors on the cardiovascular system”. Cardiology. 79: 3—9. PMID 1913721. doi:10.1159/000174899.
- Pandurangi, R. S.; Katti, K. V.; Stillwell, L.; Barnes, C. L. (1998). „Retention of Inhibitory Potency of an ACE Inhibitor Conjugated with Rh(III) and Pd(II) (Iminophosphorano)phosphines. Synthesis and X-ray Structural Investigations”. J. Am. Chem Soc. 120: 11364—11373. doi:10.1021/ja9802403.
- Bagger, S.; Wagner, K. J. (1998). „Molecular recognition of cobalt(III)-ligated peptides by serine proteases: the role of electrostatic effects”. Peptide Res. 52: 273—282. PMID 9832305. doi:10.1111/j.1399-3011.1998.tb01241.x.
- Takeuchi, T.; Bottcher, A.; Quezada, C.; Simon, M.; Meade, T.; Gray, H. (1998). „Selective Inhibition of Human α-Thrombin by Cobalt(III) Schiff Base Complexes”. J. Am. Chem. Soc. 120: 8555—8556. doi:10.1021/ja981191x.
- Böttcher, A.; Takeuchi, T.; Hardcastle, K.; Meade, T.; Gray, H.; Cwikel, D.; Kapon, M.; Dori, Z. (1997). „Spectroscopy and Electrochemistry of Cobalt(III) Schiff Base Complexes”. Inorg. Chem. 36: 2498—2504. doi:10.1021/ic961146v.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1992). „Identification of serine and histidine adducts in complexes of trypsin and trypsinogen with peptide and nonpeptide boronic acid inhibitors by proton NMR spectroscopy”. Biochemistry. 31: 12839—12846. PMID 1463754. doi:10.1021/bi00166a019.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1993). „Boron-11 NMR spectroscopy of peptide boronic acid inhibitor complexes of .alpha.-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes”. Biochemistry. 32: 12651—12655. PMID 8251483. doi:10.1021/bi00210a013.
- Suenaga, H.; Nakashima, K.; Shinkai, S. (1995). „Sugars intensify the inhibitory effect of phenylboronic acid on the hydrolytic activity of α-chymotrypsin”. J. Chem. Soc., Chem. Commun.: 29—30. doi:10.1039/C39950000029.
- Katz, B.; Finermoore, J.; Mortezaei, R.; DH, R.; Stroud, R. (1995). „Episelection: Novel Ki .apprx. Nanomolar Inhibitors of Serine Proteases Selected by Binding or Chemistry on an Enzyme Surface”. Biochemistry. 34: 8264—8280. doi:10.1021/bi00026a008.
- Katz, B.; Clark, J.; Finer-Moore, J.; Jenkins, T.; Johnson, C.; Ross, M.; Luong, C.; Moore, W.; Stroud, R. (1998). „Design of potent selective zinc-mediated serine protease inhibitors”. Nature. 391: 608—612. PMID 9468142. doi:10.1038/35422.
- Thorpe, H. H. (1998). „Bioinorganic chemistry and drug design: here comes zinc again”. Chem. Biol. 5: R125—R127. PMID 9653544. doi:10.1016/S1074-5521(98)90166-1.
- Duffy, B.; Schwietert, C.; France, A.; Mann, N.; Culbertson, K.; Harmon, B.; McCue, J. P. (1998). „Transition metals as protease inhibitors”. Biol. Trace Element Res. 64: 197—213. PMID 9845474. doi:10.1007/BF02783336.
- Duffy, B.; Schwietert, C.; France, A.; Mann, N.; Culbertson, K.; Harmon, B.; McCue, J. P. (1998). „Transition metals as protease inhibitors”. Biol. Trace Element Res. 64: 197—213. PMID 9845474. doi:10.1007/BF02783336.
- Babine, R. E.; Bender, S. L. (1997). „Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design”. Chem. Rev. 97: 1359—1472. PMID 11851455. doi:10.1021/cr960370z.
- Bone, R.; Frank, D.; Kettner, C. A.; Agard, D. A. (1989). „Structural analysis of specificity: .alpha.-lytic protease complexes with analogs of reaction intermediates”. Biochemistry. 28: 7600—7609. PMID 2611204. doi:10.1021/bi00445a015.
- Louie, A. Y.; Meade, T. J. (1998). „A cobalt complex that selectively disrupts the structure and function of zinc fingers”. PNAS. 95: 6663—6668. PMID 9618469. doi:10.1073/pnas.95.12.6663.
- Mork, A. (1993). „Actions of Lithium on the Cyclic AMP Signalling System in Various Regions of the Brain - Possible Relations to its Psychotropic Actions -: A Study on the Adenylate Cyclase in Rat Cerebral Cortex, Corpus Striatum and Hippocampus”. Pharmacol. Toxicol. 71: 1—47. doi:10.1111/j.1600-0773.1993.tb01704.x.
- Rao, K. S. J.; Rao, G. V. (1994). „Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study”. Mol. Cell. Biochem. 137: 57—60. PMID 7845378. doi:10.1007/BF00926039.
- Nixon, R. A.; Clarke, J. F.; Logvinenko, K. B.; Tan, M. K. H.; Hoult, M.; Grynspan, F. (1990). „Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes”. J. Neurochem. 55: 1950—1959. PMID 2121904. doi:10.1111/j.1471-4159.1990.tb05781.x.
- Joshi, J. G.; Dhar, M.; Clauberg, M.; Chauthaiwale, V. (1994). „Iron and aluminum homeostasis in neural disorders”. Environ. Health Perspect. 102: 207—213. PMID 7843099. doi:10.2307/3431788.
- Lee, B. H.; Park, M. B.; Yu, B. S. (1998). „Inhibition of electric eel acetylcholinesterase by porphin compounds”. Bioinorg. Med. Chem. Lett. 8: 1467—1470. PMID 9873371. doi:10.1016/S0960-894X(98)00236-4.
- Lee, B. H.; Park, M. B.; Yu, B. S. (1998). „Inhibition of electric eel acetylcholinesterase by porphin compounds”. Bioinorg. Med. Chem. Lett. 8: 1467—1470. PMID 9873371. doi:10.1016/S0960-894X(98)00236-4.
- Falkous, G.; Harris, J. B.; Mantle, D. (1995). „Effect of neurotoxic metal ions in vitro on proteolytic enzyme activities in human cerebral cortex”. Clin. Chim. Acta. 238: 125—135. PMID 7586572. doi:10.1016/0009-8981(95)06081-N.
- Cuajungco, M. P.; Lees, G. K. (1997). „Zinc metabolism in the brain: relevance to human neurodegenerative disorders”. Neurobiol. Dis. 4: 137—169. PMID 9361293. doi:10.1006/nbdi.1997.0163.
- Atwood, C. S.; Moir, R. D.; Huang, X. D.; Scarpa, R. C.; Bacarra, N. M. E.; Romano, D. M.; Hartshorn, M. K.; Tanzi, R. E.; Bush, A. I. (1998). „Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis”. J. Biol. Chem. 273: 12817—12826. PMID 9582309. doi:10.1074/jbc.273.21.12817.
- Mantyh, P. W.; Ghilardi, J. R.; Rogers, S.; Demaster, E.; Allen, C. J.; Stimson, E. R.; Maggio, J. E. (1993). „Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide”. J. Neurochem. 61: 1171—1174. PMID 8360682. doi:10.1111/j.1471-4159.1993.tb03639.x.
- Huang, X. D.; Atwood, C. S.; Moir, R. D.; Hartshorn, M. A.; Vonsattel, J. P.; Tanzi, R. E.; Bush, A. I. (1997). „Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors”. J. Biol. Chem. 272: 26464—26470. PMID 9334223. doi:10.1074/jbc.272.42.26464.
- Bondy, S. C.; Guo-Ross, S. X.; Truong, A. T. (1998). „Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid”. Brain Res. 799: 91—96. PMID 9666089. doi:10.1016/S0006-8993(98)00461-2.
- Cuajungco, M. P.; Lees, G. (1997). „Zinc and Alzheimer's disease: is there a direct link?”. J. Brain Res. Rev. 23: 219—236. PMID 9164672. doi:10.1016/S0165-0173(97)00002-7.
- Sugumoto, H.; Iimura, Y.; Yamanishi, Y.; Yamatsu, K. (1995). „Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds”. J. Med. Chem. 38: 4821—4829. PMID 7490731. doi:10.1021/jm00024a009.
- Hashimoto, K.; Whitehurst, C. E.; Matsubara, T.; Hirohata, K.; Lipsky, P. E. (1992). „Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C”. J. Clin. Invest. 89: 1839—1848. PMID 1351061. doi:10.1172/JCI115788.
- Rajendran, K. G.; Sood, A.; Spielvogel, B. F.; Hall, I. H.; III, V. M. N.; Morse, K. W. (1995). „Anti-Osteoporotic activity of metal complexes of amine carboxyboranes”. Appl. Organomet. Chem. 9: 111—119. doi:10.1002/aoc.590090204.
- Zhang, Z. Y.; Reardon, I. M.; Hui, J. O.; O’Connell, K. L.; Poorman, R. A.; Heinrikson, R. L. (1991). „Zinc inhibition of renin and the protease from human immunodeficiency virus type 1”. Biochemistry. 30: 8717—8721. PMID 1888732. doi:10.1021/bi00100a001.
- Hall, I. H.; Chen, S. Y.; Rajendran, K. G.; Sood, A.; Spielvogel, B. F.; Shih, J. (1994). „Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes”. Environ. Health Perspect. 102: 21—30. PMID 7889876. doi:10.2307/3431958.
- Naughton, D. P.; Knappitt, J.; Fairburn, K.; Gaffney, K.; Blake, D. R.; Grootveld, M. (1995). „Detection and investigation of the molecular nature of low-molecular-mass copper ions in isolated rheumatoid knee-joint synovial fluid”. FEBS Lett. 362: 167—172. PMID 7698317. doi:10.1016/0014-5793(95)00165-6.
- Miche, H.; Brumas, V.; Berthon, G. (1997). „Copper(II) interactions with nonsteroidal antiinflammatory agents. II. Anthranilic acid as a potential. OH-inactivating ligand”. J. Inorg. Biochem. 68: 27—38. PMID 9379178. doi:10.1016/S0162-0134(97)00005-6.
- Menard, H. A.; Amine, M. E. (1996). „The calpain-calpastatin system in rheumatoid arthritis”. Immunol. Today. 17: 545—547. PMID 8991283. doi:10.1016/S0167-5699(96)30064-9.
- Zhang, H.; Johnson, P. (1992). „Differential effects of aluminum ion on smooth muscle calpain I and calpain II activities”. Int. J. Biochem. 24: 1773—1778. PMID 1451912. doi:10.1016/0020-711X(92)90127-M.
- Frolich, J. C. (1997). „A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes”. Trends Pharm. Sci. 18: 30—34. PMID 9114728. doi:10.1016/S0165-6147(96)01017-6.
- Casas, J.; Rodriguez-Arguelles, M.; Russo, U.; Sanchez, A.; Sordo, J.; Vazquez-Lopez, A.; Pinelli, S.; Lunghi, P.; Bonati, A.; Albertini, R. (1998). „Diorganotin(IV) complexes of pyridoxal thiosemicarbazone: synthesis, spectroscopic properties and biological activity”. J. Inorg. Biochem. 69: 283—292. PMID 9654752. doi:10.1016/S0162-0134(98)00004-X.
- Woon, T.; Brinkworth, R.; Fairlie, D. (1992). „Inhibition of HIV-1 proteinase by metal ions”. Int. J. Biochem. 24: 911—914. PMID 1612181. doi:10.1016/0020-711X(92)90096-J.
- Davis, D. A.; Branca, A. A.; Pallenberg, A. J.; Marschner, T. M.; Patt, L. M.; Chatlynne, L. G.; Humphrey, R. W.; Yarchoan, R.; Levine, R. L. (1995). „Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+”. Arch. Biochem. Biophys. 322: 127—134. PMID 7574666. doi:10.1006/abbi.1995.1444.
- Lebon, F.; deRosny, E.; Reboud-Ravauz, M.; Durant, F. (1998). „De novo drug design of a new copper chelate molecule acting as HIV-1 protease inhibitor”. Eur. J. Med. Chem. 33: 733—737. doi:10.1016/S0223-5234(98)80032-9.
- Mazumder, A.; Gupta, M.; Perrin, D. M.; Sigman, C. S.; Ranbinovitz, M.; Pommier, Y. (1995). „Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor”. AIDS Res. Hum. Retroviruses. 11: 1. PMID 7734182. doi:10.1089/aid.1995.11.1.
- Huang, H.; Chopra, R.; Verdine, G. L.; Harrison, S. C. (1998). „Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance”. Science. 282: 1669—1675. PMID 9831551. doi:10.1126/science.282.5394.1669.
- Ferrari, M. B.; Fava, G. G.; Tarasconi, R.; Albertini, S.; Pinelli, R.; Starcich, J. (1994). „Synthesis, spectroscopic and structural characterization, and biological activity of aquachloro (pyridoxal thiosemicarbazone) copper(II) chloride”. J. Inorg. Biochem. 53: 13. PMID 8133248. doi:10.1016/0162-0134(94)80017-0.
- Ferrari, M. B.; Fava, G. G.; Tarasconi, R.; Albertini, S.; Pinelli, R.; Starcich, J. (1994). „Synthesis, spectroscopic and structural characterization, and biological activity of aquachloro (pyridoxal thiosemicarbazone) copper(II) chloride”. J. Inorg. Biochem. 53: 13. PMID 8133248. doi:10.1016/0162-0134(94)80017-0.
- Das K, Bauman JD, Rim AS, Dharia C, Clark AD Jr, Camarasa MJ, Balzarini J, Arnold E (28. 04. 2011). „Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket”. J Med Chem. 54 (8): 2727—37. PMID 21446702. doi:10.1021/jm101536x.
- Spence, R. A.; Kati, W. M.; Anderson, K. S.; Johnson, K. A. (1995). „Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors”. Science. 267: 988—993. PMID 7532321. doi:10.1038/nsb0495-303.
- West, M. L.; Fairlie, D. P. (1995). „Targeting HIV-1 protease: a test of drug-design methodologies”. Trends Pharmacol. Sci. 16: 67—75. PMID 7762084. doi:10.1016/S0165-6147(00)88980-4.
- Serra, M.; Pintar, A.; Casella, L.; Sabbioni, E. (1992). „Vanadium effect on the activity of horseradish peroxidase, catalase, glutathione peroxidase, and superoxide dismutase in vitro”. J. Inorg. Biochem. 46: 161—174. PMID 1325536. doi:10.1016/0162-0134(92)80027-S.
- DeZwart, M.; vanderGoot, H.; Timmerman, H. (1991). „Influence of Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) on growth inhibition and enzyme activity of Mycoplasma gallisepticum in the absence or presence of a 2,2′-bipyridyl type ligand”. Eur. J. Med. Chem. 26: 101—108. doi:10.1016/0223-5234(91)90218-C.
- Wells, T. N. C.; Scully, P.; Paravicini, G.; Proudfoot, A. E. I.; Payton, M. A. (1995). „Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine”. Biochemistry. 34: 7896—7903. PMID 7794901. doi:10.1021/bi00024a014.
- Cunningham, M. L.; Zvelebil, M. J. J. M.; Fairlamb, A. H. (1994). „Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals”. Eur. J. Biochem. 221: 285—295. PMID 8168518. doi:10.1111/j.1432-1033.1994.tb18740.x.
- Su, J. J.; Mansour, J. M.; Mansour, T. E. (1996). „Purification, kinetics and inhibition by antimonials of recombinant phosphofructokinase from Schistosoma mansoni”. Mol. Biochem. Parasitol. 81: 171—178. PMID 8898332. doi:10.1016/0166-6851(96)02702-8.
- Bult, A. (1983). Sigel, H., ur. Metal ions in biological systems. 16. New York: Marcel Dekker. doi:10.1080/00945718208063132.
- Hueso-Urena, F.; Moreno-Carretero, M. N.; Romero-Molina, M. A.; Salas-Peregrin, J. M.; Sanchez-Sanchez, M. P.; Cienfuegos-Lopez, G. A. D.; Faure, R. J. (1993). „Transition metal complexes with monodeprotonated isoorotic and 2-thioisoorotic acids: Crystal structure, spectral and magnetic study, and antimicrobial activity”. Inorg. Biochem. 51: 613—632. doi:10.1016/0162-0134(93)85033-5.
- Ibrahim, S. A.; El-Gyar, S. A.; El-Gahani, M. A. (1991). „Metal complexes of nitrogen-oxygen donor ligands as potential drugs”. Collect. Czech. Chem. Commun. 56: 1333—1339. doi:10.1135/cccc19911333.
- Beil, W.; Birkholz, C.; Wagner, S.; Sewing, K. (1995). „Bismuth subcitrate and omeprazole inhibit Helicobacter pyloriF1-ATPase”. Pharmacology. 50: 333—337. PMID 7667394. doi:10.1159/000139299.
- Schroeder, T.; Caspers, M. (1996). „Kinetics of aluminum-induced inhibition of delta-aminolevulinic acid dehydratase in vitro”. Biochem. Pharmacol. 52: 927—931. PMID 8781512. doi:10.1016/0006-2952(96)00449-2.
- Exley, C.; Price, N.; Birchall, J. (1994). „Aluminum inhibition of hexokinase activity in vitro: a study in biological availability”. J. Inorg. Biochem. 54: 297—304. PMID 8014638. doi:10.1016/0162-0134(94)80035-9.
- Canesi, L.; Ciacci, C.; Piccoli, G.; Stocchi, V.; Viarengo, A.; Gallo, G. (1998). „In vitro and in vivo effects of heavy metals on mussel digestive gland hexokinase activity: the role of glutathione”. Comp. Biochem. Physiol. C. 120 (2): 261—268. PMID 9827040. doi:10.1016/S0742-8413(98)10004-X.
- Yoshino, M.; Murakami, K.; Kawano, K. (1998). „Interaction of aluminum ion with ATP. Mechanism of the aluminum inhibition of glycerol kinase and its reversal by spermine”. Biometals. 11: 63—67. doi:10.1023/A:1009213508942.
- Yager, J. W.; Wiencke, J. K. (1997). „Inhibition of poly(ADP-ribose) polymerase by arsenite”. Mutat. Res. 386: 345—351. PMID 9219571. doi:10.1016/S1383-5742(97)00011-2.
- Hu, Y.; Su, L.; Snow, E. T. (1998). „Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes”. Mutat. Res. 408: 203—218. PMID 9806419. doi:10.1016/S0921-8777(98)00035-4.
- Tsao, D.; Maki, A. (1991). „Optically detected magnetic resonance study of the interaction of an arsenic(III) derivative of cacodylic acid with EcoRI methyltransferase”. Biochemistry. 30: 4565—4572. PMID 2021649. doi:10.1021/bi00232a029.
- Lam, W.; Tsao, D.; Maki, A.; Maegley, K.; Reich, N. (1992). „Spectroscopic studies of arsenic(III) binding to Escherichia coli RI methyltransferase and to two mutants, C223S and W183F”. Biochemistry. 31: 10438—10442. PMID 1420162. doi:10.1021/bi00158a004.
- Styblo, M.; Thomas, D. (1995). „In vitro inhibition of glutathione reductase by arsenotriglutathione”. Biochem. Pharmacol. 49: 971—977. PMID 7741769. doi:10.1016/0006-2952(95)00008-N.
- Snow, E.; Xu, L.; Kinney, P. (1993). „Effects of nickel ions on polymerase activity and fidelity during DNA replication in vitro”. Chem.-Biol. Interact. 88: 155—173. PMID 8403077. doi:10.1016/0009-2797(93)90089-H.
- Yang, S. W.; Becker, F. F.; Chan, J. Y. H. (1996). „Inhibition of human DNA ligase I activity by zinc and cadmium and the fidelity of ligation”. Environ. Health Perspect. 28: 19—25. PMID 8698042. doi:10.1002/(SICI)1098-2280(1996)28:1<19::AID-EM5>3.0.CO;2-9.
- Hartwig, A. (1994). „Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review”. Environ. Health Perspect. 102: 45—50. PMID 7843136. doi:10.2307/3431762.
- Hartwig, A. (1994). „Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review”. Environ. Health Perspect. 102: 45—50. PMID 7843136. doi:10.2307/3431762.
- Porter, D. W.; Nelson, V. C.; Fivash, M. J. J.; Kasprzak, K. S. (1996). „Mechanistic studies of the inhibition of MutT dGTPase by the carcinogenic metal Ni(II)”. Chem. Res. Toxicol. 9: 1375—1381. PMID 8951243. doi:10.1021/tx9600816.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
- O’Halloran, T. V. (1993). „Transition metals in control of gene expression”. Science. 261: 715—725. PMID 8342038. doi:10.1126/science.8342038.
drugpapers.com
- Chawla, S.; Mutenda, E.; Dixon, H.; Freeman, S.; Smith, A. (1995). „Synthesis of 3-arsonopyruvate and its interaction with phosphoenolpyruvate mutase”. Biochem. J. 308: 931—935. PMID 8948453.
- Chawla, S.; Mutenda, E.; Dixon, H.; Freeman, S.; Smith, A. (1995). „Synthesis of 3-arsonopyruvate and its interaction with phosphoenolpyruvate mutase”. Biochem. J. 308: 931—935. PMID 8948453.
drugs.com
- „Sildenafil Citrate”. The American Society of Health-System Pharmacists. Pristupljeno 01. 12. 2014.
elsevier.com
ucdavis.pure.elsevier.com
- Louie, A. Y.; Meade, T. J. (1998). „A cobalt complex that selectively disrupts the structure and function of zinc fingers”. PNAS. 95: 6663—6668. PMID 9618469. doi:10.1073/pnas.95.12.6663.
- Louie, A. Y.; Meade, T. J. (1998). „A cobalt complex that selectively disrupts the structure and function of zinc fingers”. PNAS. 95: 6663—6668. PMID 9618469. doi:10.1073/pnas.95.12.6663.
cwru.pure.elsevier.com
- Kelley, T. J.; Moghaddas, S.; Bose, R.; Basu, S. (1993). „Inhibition of immunopurified DNA polymerase-alpha from PA-3 prostate tumor cells by platinum (II) antitumor drugs”. Cancer Biochem. Biophys. 13: 135—146. PMID 8111727.
epa.gov
- „Types of Pesticides”. US Environmental Protection Agency. Pristupljeno 20. 02. 2013.
escholarship.org
- Bondy, S. C.; Guo-Ross, S. X.; Truong, A. T. (1998). „Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid”. Brain Res. 799: 91—96. PMID 9666089. doi:10.1016/S0006-8993(98)00461-2.
- Bondy, S. C.; Guo-Ross, S. X.; Truong, A. T. (1998). „Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid”. Brain Res. 799: 91—96. PMID 9666089. doi:10.1016/S0006-8993(98)00461-2.
eurekamag.com
- Ho, B. T.; Huo, Y. Y.; Lee, J. H.; Levin, V. A. (1991). „Inhibition of adenylate cyclase by tetraplatin”. Anti-Cancer Drugs. 2: 267—268. PMID 1802021. doi:10.1097/00001813-1991.
europa.eu
ecdc.europa.eu
- „Factsheet for experts”. European Centre for Disease Prevention and Control. Pristupljeno 24. 12. 2014.
europepmc.org
- Wright, J. A.; Chan, A. K.; Choy, B. K.; Hurta, R. A. R.; McClarty, G. A.; Tagger, A. Y. (1990). „Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis”. Cell. Biol. 68: 1364—1371. PMID 2085432.
- Krynetskaya, N. F.; Kubareva, E. A.; Timchenko, M. A.; Belkov, V. M.; Shabarova, Z. A. (1998). „Transition-metal complexes as inhibitors of proteins recognizing double-stranded fragments of nucleic acids”. Biochemistry (Moscow). 63: 1068—1073. PMID 9795277.
- Hintz, S. R.; Vreman, H. J.; Stevenson, D. K. (1990). „Mortality of metalloporphyrin-treated neonatal rats after light exposure”. Dev. Pharmacol. 14: 187—192. PMID 2364856.
- Nacsa, J.; Nagy, L.; Molnar, J.; Molnar, J. (1998). „Trifluoperazine and its metal complexes inhibit the Moloney leukemia virus reverse transcriptase”. Anticancer Res. 18: 1373—1376. PMID 9673343.
- Hintz, S. R.; Vreman, H. J.; Stevenson, D. K. (1990). „Mortality of metalloporphyrin-treated neonatal rats after light exposure”. Dev. Pharmacol. 14: 187—192. PMID 2364856.
- Hintz, S. R.; Vreman, H. J.; Stevenson, D. K. (1990). „Mortality of metalloporphyrin-treated neonatal rats after light exposure”. Dev. Pharmacol. 14: 187—192. PMID 2364856.
- Hintz, S. R.; Vreman, H. J.; Stevenson, D. K. (1990). „Mortality of metalloporphyrin-treated neonatal rats after light exposure”. Dev. Pharmacol. 14: 187—192. PMID 2364856.
- Hintz, S. R.; Vreman, H. J.; Stevenson, D. K. (1990). „Mortality of metalloporphyrin-treated neonatal rats after light exposure”. Dev. Pharmacol. 14: 187—192. PMID 2364856.
- Nacsa, J.; Nagy, L.; Molnar, J.; Molnar, J. (1998). „Trifluoperazine and its metal complexes inhibit the Moloney leukemia virus reverse transcriptase”. Anticancer Res. 18: 1373—1376. PMID 9673343.
- Nacsa, J.; Nagy, L.; Molnar, J.; Molnar, J. (1998). „Trifluoperazine and its metal complexes inhibit the Moloney leukemia virus reverse transcriptase”. Anticancer Res. 18: 1373—1376. PMID 9673343.
fasebj.org
- Tarrago-Litvak, L.; Andreola, M.; Nevinsky, G. A.; Sarih-Cottin, L.; Litvak, S. (1994). „The reverse transcriptase of HIV-1: from enzymology to therapeutic intervention”. FASEB J. 18: 497—503. PMID 7514143.
- Tarrago-Litvak, L.; Andreola, M.; Nevinsky, G. A.; Sarih-Cottin, L.; Litvak, S. (1994). „The reverse transcriptase of HIV-1: from enzymology to therapeutic intervention”. FASEB J. 18: 497—503. PMID 7514143.
google.co.uk
books.google.co.uk
- Brenner, G. M. (2000). Pharmacology. Philadelphia, PA: W.B. Saunders Company. ISBN 978-0-7216-7757-6.
harvard.edu
adsabs.harvard.edu
- Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I (1991). „Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein”. Science. 253 (5022): 872—9. Bibcode:1991Sci...253..872S. PMID 1678899. doi:10.1126/science.1678899.
connects.catalyst.harvard.edu
- Trakshel, G.; Sluss, P.; Maines, M. (1992). „Comparative effects of tin- and zinc-protoporphyrin on steroidogenesis: tin-protoporphyrin is a potent inhibitor of cytochrome P-450-dependent activities in the rat adrenals”. Pediatr. Res. 31: 196—201. PMID 1542552. doi:10.1203/00006450-199202000-00022.
intechopen.com
cdn.intechopen.com
- Walsh, Ryan (2012). „Ch. 17. Alternative Perspectives of Enzyme Kinetic Modeling”. Ur.: Ekinci, Deniz. Medicinal Chemistry and Drug Design (PDF). InTech. str. 357—371. ISBN 978-953-51-0513-8.
jbc.org
- Perry, D. K.; Smyth, M. J.; Stennicke, H. R.; Salvesen, G. S.; Duriez, P.; Poiriez, G. G.; Hannun, Y. A. (1997). „Zinc Is a Potent Inhibitor of the Apoptotic Protease, Caspase-3 - A novel target for zink in the inhibition of apoptosis”. J. Biol. Chem. 30: 18530—18533. PMID 9228015. doi:10.1074/jbc.272.30.18530.
- Bhasker, C. R.; Burgiel, G.; Neupert, B.; Emery-Goodman, A.; Kuhn, L. C.; May, B. K. (1993). „The Putative Iron-Responsive Element in the Human Erythroid 5-Aminolevulinate Synthase mRNA Mediates Translational Control” (PDF). JBC. 268: 12699—12705. PMID 8509404.
- Siegfried, G.; Amiel, C.; Friedlander, G. (1996). „Inhibition of Ecto-5′-nucleotidase by Nitric Oxide Donors”. J. Biol. Chem. 271: 4659—4664. PMID 8617729.
- Thomas, S.; Mohr, D.; Stocker, R. (1994). „Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes” (PDF). J. Biol. Chem. 269: 14457—14464. PMID 7514170.
- Atwood, C. S.; Moir, R. D.; Huang, X. D.; Scarpa, R. C.; Bacarra, N. M. E.; Romano, D. M.; Hartshorn, M. K.; Tanzi, R. E.; Bush, A. I. (1998). „Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis”. J. Biol. Chem. 273: 12817—12826. PMID 9582309. doi:10.1074/jbc.273.21.12817.
- Huang, X. D.; Atwood, C. S.; Moir, R. D.; Hartshorn, M. A.; Vonsattel, J. P.; Tanzi, R. E.; Bush, A. I. (1997). „Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors”. J. Biol. Chem. 272: 26464—26470. PMID 9334223. doi:10.1074/jbc.272.42.26464.
- Dyrks, T.; Dyrks, E.; Hartmann, T.; Masters, C.; Beyreuther, K. (1992). „Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation” (PDF). J. Biol. Chem. 267: 18210—18217. PMID 1517249.
- Saha, A. K.; Crans, D. C.; Pope, M. T.; Simone, C. M.; Glew, R. H. (1991). „Inhibition of human seminal fluid and Leishmania donovani phosphatases by molybdate heteropolyanions” (PDF). J. Biol. Chem. 266: 3511—3517. PMID 1995614.
- Bhasker, C. R.; Burgiel, G.; Neupert, B.; Emery-Goodman, A.; Kuhn, L. C.; May, B. K. (1993). „The Putative Iron-Responsive Element in the Human Erythroid 5-Aminolevulinate Synthase mRNA Mediates Translational Control” (PDF). JBC. 268: 12699—12705. PMID 8509404.
- Siegfried, G.; Amiel, C.; Friedlander, G. (1996). „Inhibition of Ecto-5′-nucleotidase by Nitric Oxide Donors”. J. Biol. Chem. 271: 4659—4664. PMID 8617729.
- Thomas, S.; Mohr, D.; Stocker, R. (1994). „Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes” (PDF). J. Biol. Chem. 269: 14457—14464. PMID 7514170.
- Atwood, C. S.; Moir, R. D.; Huang, X. D.; Scarpa, R. C.; Bacarra, N. M. E.; Romano, D. M.; Hartshorn, M. K.; Tanzi, R. E.; Bush, A. I. (1998). „Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis”. J. Biol. Chem. 273: 12817—12826. PMID 9582309. doi:10.1074/jbc.273.21.12817.
- Huang, X. D.; Atwood, C. S.; Moir, R. D.; Hartshorn, M. A.; Vonsattel, J. P.; Tanzi, R. E.; Bush, A. I. (1997). „Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors”. J. Biol. Chem. 272: 26464—26470. PMID 9334223. doi:10.1074/jbc.272.42.26464.
- Dyrks, T.; Dyrks, E.; Hartmann, T.; Masters, C.; Beyreuther, K. (1992). „Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation” (PDF). J. Biol. Chem. 267: 18210—18217. PMID 1517249.
- Saha, A. K.; Crans, D. C.; Pope, M. T.; Simone, C. M.; Glew, R. H. (1991). „Inhibition of human seminal fluid and Leishmania donovani phosphatases by molybdate heteropolyanions” (PDF). J. Biol. Chem. 266: 3511—3517. PMID 1995614.
jci.org
- Hashimoto, K.; Whitehurst, C. E.; Matsubara, T.; Hirohata, K.; Lipsky, P. E. (1992). „Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C”. J. Clin. Invest. 89: 1839—1848. PMID 1351061. doi:10.1172/JCI115788.
- Hashimoto, K.; Whitehurst, C. E.; Matsubara, T.; Hirohata, K.; Lipsky, P. E. (1992). „Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C”. J. Clin. Invest. 89: 1839—1848. PMID 1351061. doi:10.1172/JCI115788.
jstor.org
- E. Patrick Fuerst (1987). „Understanding the Mode of Action of the Chloroacetamide and Thiocarbamate Herbicides”. Weed Technology. 1 (4): 270—277.
- SO, Duke (1990). „Overview of herbicide mechanisms of action”. Environ. Health Perspect. Brogan. 87: 263—71. JSTOR 3431034. PMC 1567841 . PMID 1980104. doi:10.2307/3431034.
- Clauberg, M.; Joshi, J. G. (1993). „Regulation of serine protease activity by aluminum: implications for Alzheimer disease”. Proc. Natl. Acad. Sci. U.S.A. 90: 1009—1012. PMID 7679214.
- Joshi, J. G.; Dhar, M.; Clauberg, M.; Chauthaiwale, V. (1994). „Iron and aluminum homeostasis in neural disorders”. Environ. Health Perspect. 102: 207—213. PMID 7843099. doi:10.2307/3431788.
- Hall, I. H.; Chen, S. Y.; Rajendran, K. G.; Sood, A.; Spielvogel, B. F.; Shih, J. (1994). „Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes”. Environ. Health Perspect. 102: 21—30. PMID 7889876. doi:10.2307/3431958.
- Hartwig, A. (1994). „Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review”. Environ. Health Perspect. 102: 45—50. PMID 7843136. doi:10.2307/3431762.
- Clauberg, M.; Joshi, J. G. (1993). „Regulation of serine protease activity by aluminum: implications for Alzheimer disease”. Proc. Natl. Acad. Sci. U.S.A. 90: 1009—1012. PMID 7679214.
- Joshi, J. G.; Dhar, M.; Clauberg, M.; Chauthaiwale, V. (1994). „Iron and aluminum homeostasis in neural disorders”. Environ. Health Perspect. 102: 207—213. PMID 7843099. doi:10.2307/3431788.
- Hall, I. H.; Chen, S. Y.; Rajendran, K. G.; Sood, A.; Spielvogel, B. F.; Shih, J. (1994). „Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes”. Environ. Health Perspect. 102: 21—30. PMID 7889876. doi:10.2307/3431958.
- Hartwig, A. (1994). „Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review”. Environ. Health Perspect. 102: 45—50. PMID 7843136. doi:10.2307/3431762.
- Hartwig, A. (1994). „Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review”. Environ. Health Perspect. 102: 45—50. PMID 7843136. doi:10.2307/3431762.
karger.com
- Chitambar, C. R.; Narasimhan, J. (1991). „Targeting Iron-Dependent DNA Synthesis with Gallium and Transferrin-Gallium”. Pathobiology. 59: 3—10. PMID 1645976.
- Keino, H.; Banno, T.; Mimura, S.; Kashiwamata, S. (1993). „Cobalt-Mesoporphyrin Inhibits Heme Oxygenase Activity but It Does Not Induce Lipid Peroxidation in Rat Brain Membranes during Photoirradiation”. Biol. Neonate. 63: 285—289. PMID 8353156. doi:10.1159/000243943.
- Heagerty, A. M. (1991). „Functional and structural effects of ACE inhibitors on the cardiovascular system”. Cardiology. 79: 3—9. PMID 1913721. doi:10.1159/000174899.
- Beil, W.; Birkholz, C.; Wagner, S.; Sewing, K. (1995). „Bismuth subcitrate and omeprazole inhibit Helicobacter pyloriF1-ATPase”. Pharmacology. 50: 333—337. PMID 7667394. doi:10.1159/000139299.
- Heagerty, A. M. (1991). „Functional and structural effects of ACE inhibitors on the cardiovascular system”. Cardiology. 79: 3—9. PMID 1913721. doi:10.1159/000174899.
- Beil, W.; Birkholz, C.; Wagner, S.; Sewing, K. (1995). „Bismuth subcitrate and omeprazole inhibit Helicobacter pyloriF1-ATPase”. Pharmacology. 50: 333—337. PMID 7667394. doi:10.1159/000139299.
liebertpub.com
online.liebertpub.com
- Mazumder, A.; Gupta, M.; Perrin, D. M.; Sigman, C. S.; Ranbinovitz, M.; Pommier, Y. (1995). „Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor”. AIDS Res. Hum. Retroviruses. 11: 1. PMID 7734182. doi:10.1089/aid.1995.11.1.
- Mazumder, A.; Gupta, M.; Perrin, D. M.; Sigman, C. S.; Ranbinovitz, M.; Pommier, Y. (1995). „Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor”. AIDS Res. Hum. Retroviruses. 11: 1. PMID 7734182. doi:10.1089/aid.1995.11.1.
lww.com
journals.lww.com
- Bing, O.; Grundemar, L.; Ny, L.; Moller, C.; Heilig, M. (1995). „Modulation of carbon monoxide production and enhanced spatial learning by tin protoporphyrin”. Neuroreport. 6: 1369—1372. PMID 7488726. doi:10.1097/00001756-199507100-00002.
- Bing, O.; Grundemar, L.; Ny, L.; Moller, C.; Heilig, M. (1995). „Modulation of carbon monoxide production and enhanced spatial learning by tin protoporphyrin”. Neuroreport. 6: 1369—1372. PMID 7488726. doi:10.1097/00001756-199507100-00002.
medscimonit.com
- Kambiz Soltaninejad; Mohammad Abdollahi (2009). „Current opinion on the science of organophosphate pesticides and toxic stress: a systematic review”. Med Sci Monit. 15 (3): RA75—90. eISSN 1643-3750.
mysciencework.com
- Schroeder, T.; Caspers, M. (1996). „Kinetics of aluminum-induced inhibition of delta-aminolevulinic acid dehydratase in vitro”. Biochem. Pharmacol. 52: 927—931. PMID 8781512. doi:10.1016/0006-2952(96)00449-2.
- Schroeder, T.; Caspers, M. (1996). „Kinetics of aluminum-induced inhibition of delta-aminolevulinic acid dehydratase in vitro”. Biochem. Pharmacol. 52: 927—931. PMID 8781512. doi:10.1016/0006-2952(96)00449-2.
nature.com
- Waldron, K. J.; Robinson, N. J. (2009). „How do bacterial cells ensure that metalloproteins get the correct metal?”. Nat. Rev. Microbiol. 7 (1): 25—35. PMID 19079350. doi:10.1038/nrmicro2057.
- Marks, J. A.; Maines, M. D. (1992). „Tin-Protoporphyrin-Mediated Disruption In Vivo of Heme Oxygenase-2 Protein Integrity and Activity in Rat Brain” (PDF). Pediatr. Res. 32: 324—329. PMID 1408470. doi:10.1203/00006450-199209000-00016.
- Katz, B.; Clark, J.; Finer-Moore, J.; Jenkins, T.; Johnson, C.; Ross, M.; Luong, C.; Moore, W.; Stroud, R. (1998). „Design of potent selective zinc-mediated serine protease inhibitors”. Nature. 391: 608—612. PMID 9468142. doi:10.1038/35422.
- Spence, R. A.; Kati, W. M.; Anderson, K. S.; Johnson, K. A. (1995). „Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors”. Science. 267: 988—993. PMID 7532321. doi:10.1038/nsb0495-303.
- Marks, J. A.; Maines, M. D. (1992). „Tin-Protoporphyrin-Mediated Disruption In Vivo of Heme Oxygenase-2 Protein Integrity and Activity in Rat Brain” (PDF). Pediatr. Res. 32: 324—329. PMID 1408470. doi:10.1203/00006450-199209000-00016.
- Katz, B.; Clark, J.; Finer-Moore, J.; Jenkins, T.; Johnson, C.; Ross, M.; Luong, C.; Moore, W.; Stroud, R. (1998). „Design of potent selective zinc-mediated serine protease inhibitors”. Nature. 391: 608—612. PMID 9468142. doi:10.1038/35422.
- Spence, R. A.; Kati, W. M.; Anderson, K. S.; Johnson, K. A. (1995). „Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors”. Science. 267: 988—993. PMID 7532321. doi:10.1038/nsb0495-303.
neb.com
polbase.neb.com
- Chamorro, C.; Camarasa, M. J.; Perez-Perez, M. J.; Clercq, E. D.; Balzarini, J.; Felix, A. S. (1998). „An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase”. Antiviral Chem. Chemother. 9: 413—423. PMID 9875394.
- Chamorro, C.; Camarasa, M. J.; Perez-Perez, M. J.; Clercq, E. D.; Balzarini, J.; Felix, A. S. (1998). „An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase”. Antiviral Chem. Chemother. 9: 413—423. PMID 9875394.
nhs.uk
- „Antibiotics”. NHS. 05. 06. 2014. Pristupljeno 17. 01. 2015.
- Choices, N. H. S. (2014). „Atropine - Myasthenia-gravis medicines and drugs - NHS Choices”. Pristupljeno 11. 07. 2015.
nih.gov
ncbi.nlm.nih.gov
- Shapiro, R; Vallee, BL (1991). „Interaction of human placental ribonuclease with placental ribonuclease inhibitor”. Biochemistry. 30 (8): 2246—55. PMID 1998683. doi:10.1021/bi00222a030.
- Berg J.; Tymoczko J.; Stryer L. (2002). Biochemistry. W. H. Freeman and Company. ISBN 978-0-7167-4955-4.
- Cleland WW (1963). „The kinetics of enzyme-catalyzed reactions with two or more substrates or products. II. Inhibition: nomenclature and theory”. Biochim. Biophys. Acta. 67: 173—87. PMID 14021668. doi:10.1016/0926-6569(63)90226-8.
- Holdgate, GA (2001). „Making cool drugs hot: isothermal titration calorimetry as a tool to study binding energetics” (PDF). BioTechniques. 31 (1): 164—6, 168, 170. PMID 11464510.
- Leatherbarrow, RJ (1990). „Using linear and non-linear regression to fit biochemical data”. Trends in Biochemical Sciences. 15 (12): 455—8. PMID 2077683. doi:10.1016/0968-0004(90)90295-M.
- Tseng, SJ; Hsu, JP (1990). „A comparison of the parameter estimating procedures for the Michaelis-Menten model”. Journal of Theoretical Biology. 145 (4): 457—64. PMID 2246896. doi:10.1016/S0022-5193(05)80481-3.
- Walsh, R.; Martin, E.; Darvesh, S. (2011). „Limitations of conventional inhibitor classifications”. Integrative Biology. Royal Society of Chemistry. 3 (12): 1197—1201. PMID 22038120. doi:10.1039/c1ib00053e.
- Walsh, R.; Martin, E.; Darvesh, S. (2007). „A versatile equation to describe reversible enzyme inhibition and activation kinetics: Modeling β-galactosidase and butyrylcholinesterase”. Biochimica et Biophysica Acta (BBA) – General Subjects. 1770 (5): 733—746. PMID 17307293. doi:10.1016/j.bbagen.2007.01.001.
- Hsu, JT; Wang, HC; Chen, GW; Shih, SR (2006). „Antiviral drug discovery targeting to viral proteases”. Current pharmaceutical design. 12 (11): 1301—14. PMID 16611117. doi:10.2174/138161206776361110.
- Lew W, Chen X, Kim CU (2000). „Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor”. Curr. Med. Chem. 7 (6): 663—72. PMID 10702632. doi:10.2174/0929867003374886.
- PM, Fischer (2003). „The design, synthesis and application of stereochemical and directional peptide isomers: a critical review”. Curr. Protein Pept. Sci. 4 (5): 339—56. PMID 14529528. doi:10.2174/1389203033487054.
- Bogoyevitch, MA; Barr, RK; Ketterman, AJ (2005). „Peptide inhibitors of protein kinases-discovery, characterisation and use”. Biochimica et Biophysica Acta. 1754 (1—2): 79—99. PMID 16182621. doi:10.1016/j.bbapap.2005.07.025.
- Adam, GC; Cravatt, BF; Sorensen, EJ (2001). „Profiling the specific reactivity of the proteome with non-directed activity-based probes”. Chemistry & Biology. 8 (1): 81—95. PMID 11182321. doi:10.1016/S1074-5521(00)90060-7.
- Maurer, T; Fung, HL (2000). „Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: application to nitric oxide synthase”. AAPS PharmSci. 2 (1): 68—77. PMC 2751003 . PMID 11741224. doi:10.1208/ps020108.
- Loo JA, DeJohn DE, Du P, Stevenson TI, Ogorzalek LR (1999). „Application of mass spectrometry for target identification and characterization”. Med Res Rev. 19 (4): 307—19. PMID 10398927. doi:10.1002/(SICI)1098-1128(199907)19:4<307::AID-MED4>3.0.CO;2-2.
- Poulin, R; Lu, L; Ackermann, B; Bey, P; Pegg, AE (1992). „Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites”. The Journal of Biological Chemistry. 267 (1): 150—8. PMID 1730582.
- Szedlacsek, SE; Duggleby, RG (1995). „Kinetics of slow and tight-binding inhibitors”. Enzyme Kinetics and Mechanism Part D: Developments in Enzyme Dynamics. Methods in Enzymology. 249. str. 144—80. ISBN 978-0-12-182150-0. PMID 7791610. doi:10.1016/0076-6879(95)49034-5.
- Stone, SR; Morrison, JF (1986). „Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues”. Biochimica et Biophysica Acta. 869 (3): 275—85. PMID 3511964. doi:10.1016/0167-4838(86)90067-1.
- Pick, FM; McGartoll, MA; Bray, RC (1971). „Reaction of formaldehyde and of methanol with xanthine oxidase”. European Journal of Biochemistry / FEBS. 18 (1): 65—72. PMID 4322209. doi:10.1111/j.1432-1033.1971.tb01215.x.
- Reardon, JE (1989). „Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition”. The Journal of Biological Chemistry. 264 (32): 19039—44. PMID 2553730.
- Saravanamuthu, A; Vickers, TJ; Bond, CS; Peterson, MR; Hunter, WN; Fairlamb, AH (2004). „Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design”. The Journal of Biological Chemistry. 279 (28): 29493—500. PMC 3491871 . PMID 15102853. doi:10.1074/jbc.M403187200.
- Koppitz M, Eis K; Eis (2006). „Automated medicinal chemistry”. Drug Discov. Today. 11 (11—12): 561—8. PMID 16713909. doi:10.1016/j.drudis.2006.04.005.
- G, Scapin (2006). „Structural biology and drug discovery”. Curr. Pharm. Des. 12 (17): 2087—97. PMID 16796557. doi:10.2174/138161206777585201.
- Gohlke H, Klebe G; Klebe (2002). „Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors”. Angew. Chem. Int. Ed. Engl. 41 (15): 2644—76. PMID 12203463. doi:10.1002/1521-3773(20020802)41:15<2644::AID-ANIE2644>3.0.CO;2-O.
- Glen RC, Allen SC; Allen (2003). „Ligand-protein docking: cancer research at the interface between biology and chemistry”. Curr. Med. Chem. 10 (9): 763—7. PMID 12678780. doi:10.2174/0929867033457809.
- Peters GJ, van der Wilt CL, van Moorsel CJ, Kroep JR, Bergman AM, Ackland SP (2000). „Basis for effective combination cancer chemotherapy with antimetabolites”. Pharmacol. Ther. 87 (2—3): 227—53. PMID 11008002. doi:10.1016/S0163-7258(00)00086-3.
- Silvaggi, N.R.; Josephine, H.R.; Kuzin, A.P.; Nagarajan, R.; Pratt, R.F.; Kelly, J.A. (2005). „Crystal structures of complexes between the R61 DD-peptidase and peptidoglycan-mimetic beta-lactams: a non-covalent complex with a "perfect penicillin"”. J.Mol.Biol. 345: 521—533. PMID 15581896. doi:10.1016/j.jmb.2004.10.076.
- Park BK, Breckenridge AM (1981). „Clinical implications of enzyme induction and enzyme inhibition.”. Clin Pharmacokinet. 6 (1): 1—24. PMID 6113907. doi:10.2165/00003088-198106010-00001.
- Maggi, M; Filippi, S; Ledda, F; Magini, A; Forti, G (2000). „Erectile dysfunction: from biochemical pharmacology to advances in medical therapy”. European Journal of Endocrinology. Bioscientifica. 143 (2): 143—54. PMID 10913932. doi:10.1530/eje.0.1430143.
- McGuire, JJ (2003). „Anticancer antifolates: current status and future directions”. Current pharmaceutical design. 9 (31): 2593—613. PMID 14529544. doi:10.2174/1381612033453712.
- Katz, AH; Caufield, CE (2003). „Structure-based design approaches to cell wall biosynthesis inhibitors”. Current pharmaceutical design. 9 (11): 857—66. PMID 12678870. doi:10.2174/1381612033455305.
- Tan, Siang Yong; Tatsumura, Yvonne (01. 07. 2015). „Alexander Fleming (1881—1955): Discoverer of penicillin”. Singapore Medical Journal. 56 (7): 366—367. ISSN 0037-5675. PMC 4520913 . PMID 26243971. doi:10.11622/smedj.2015105.
- Srivastava A, Talaue M, Liu S, Degen D, Ebright RY, Sineva E, Chakraborty A, Druzhinin SY, Chatterjee S, Mukhopadhyay J, Ebright YW, Zozula A, Shen J, Sengupta S, Niedfeldt RR, Xin C, Kaneko T, Irschik H, Jansen R, Donadio S, Connell N, Ebright RH (2011). „New target for inhibition of bacterial RNA polymerase: 'switch region'”. Curr. Opin. Microbiol. 14 (5): 532—43. PMC 3196380 . PMID 21862392. doi:10.1016/j.mib.2011.07.030.
- Romano, AH; Conway, T (1996). „Evolution of carbohydrate metabolic pathways”. Res Microbiol. 147 (6—7): 448—55. PMID 9084754. doi:10.1016/0923-2508(96)83998-2.
- Wegener G, Krause U (2002). „Different modes of activating phosphofructokinase, a key regulatory enzyme of glycolysis, in working vertebrate muscle”. Biochem. Soc. Trans. 30 (2): 264—270. PMID 12023862. doi:10.1042/bst0300264.
- Raben N, Exelbert R, Spiegel R, Sherman JB, Nakajima H, Plotz P, Heinisch J (1995). „Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency”. Am. J. Hum. Genet. 56 (1): 131—141. PMC 1801305 . PMID 7825568.
- Okar, DA; Lange, AJ (1999). „Fructose-2,6-bisphosphate and control of carbohydrate metabolism in eukaryotes”. BioFactors (Oxford, England). 10 (1): 1—14. PMID 10475585. doi:10.1002/biof.5520100101.
- Rawlings ND, Barrett AJ (1994). „Families of serine peptidases”. Meth. Enzymol. Methods in Enzymology. 244: 19—61. ISBN 978-0-12-182145-6. PMID 7845208. doi:10.1016/0076-6879(94)44004-2.
- Levilliers, J.; Péron; Arrio; Pudles (1970). „On the mechanism of action of proteolyticinhibitors: IV. Effect of 8murea on the stability of trypsin in trypsin-lnhibitor complexes”. Archives of Biochemistry and Biophysics. 140 (2): 474—483. PMID 5528741. doi:10.1016/0003-9861(70)90091-3.
- S., Dreon M.; Ituarte S.; Heras H. (2010). „The Role of the Proteinase Inhibitor Ovorubin in Apple Snail Eggs Resembles Plant Embryo Defense against Predation”. PLoS ONE. 5 (12): e15059. PMID 21151935. doi:10.1371/journal.pone.0015059.
- Smyth, TP (2004). „Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors”. Bioorganic & Medicinal Chemistry. 12 (15): 4081—8. PMID 15246086. doi:10.1016/j.bmc.2004.05.041.
- Hartley, RW (1989). „Barnase and barstar: two small proteins to fold and fit together”. Trends in Biochemical Sciences. 14 (11): 450—4. PMID 2696173. doi:10.1016/0968-0004(89)90104-7.
- Serrano L, Kellis JT, Cann P, Matouschek A, Fersht AR (1992). „The folding of an enzyme. II. Substructure of barnase and the contribution of different interactions to protein stability”. J. Mol. Biol. 224 (3): 783—804. PMID 1569557. doi:10.1016/0022-2836(92)90562-X.
- Serrano L, Matouschek A, Fersht AR (1992). „The folding of an enzyme. III. Structure of the transition state for unfolding of barnase analysed by a protein engineering procedure”. J. Mol. Biol. 224 (3): 805—18. PMID 1569558. doi:10.1016/0022-2836(92)90563-Y.
- Matouschek A, Serrano L, Fersht AR (1992). „The folding of an enzyme. IV. Structure of an intermediate in the refolding of barnase analysed by a protein engineering procedure”. J. Mol. Biol. 224 (3): 819—35. PMID 1569559. doi:10.1016/0022-2836(92)90564-Z.
- Oliver, CJ; Shenolikar, S (1998). „Physiologic importance of protein phosphatase inhibitors”. Frontiers in Bioscience. 3: D961—72. PMID 9727084.
- Taylor P, Radić Z (1994). „The cholinesterases: from genes to proteins”. Annual Review of Pharmacology and Toxicology. 34: 281—320. PMID 8042853. doi:10.1146/annurev.pa.34.040194.001433.
- Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I (1991). „Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein”. Science. 253 (5022): 872—9. Bibcode:1991Sci...253..872S. PMID 1678899. doi:10.1126/science.1678899.
- Sussman JL, Harel M, Silman I (1993). „Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs”. Chem. Biol. Interact. 87 (1—3): 187—97. PMID 8343975. doi:10.1016/0009-2797(93)90042-W.
- Kumar, Vikas; Kaminski, Henry J. (07. 10. 2010). „Treatment of Myasthenia Gravis”. Current Neurology and Neuroscience Reports. 11 (1): 89—96. ISSN 1528-4042. PMID 20927659. doi:10.1007/s11910-010-0151-1.
- S, Tan; Evans R; Singh B (2006). „Herbicidal inhibitors of amino acid biosynthesis and herbicide-tolerant crops”. Amino Acids. 30 (2): 195—204. PMID 16547651. doi:10.1007/s00726-005-0254-1.
- Steinrücken HC, Amrhein N (1980). „The herbicide glyphosate is a potent inhibitor of 5-enolpyruvyl-shikimic acid-3-phosphate synthase”. Biochemical and Biophysical Research Communications. 94 (4): 1207—12. PMID 7396959. doi:10.1016/0006-291X(80)90547-1.
- Lamberth C, Jeanmart S, Luksch T, Plant A (2013). „Current Challenges and Trends in the Discovery of Agrochemicals”. Science. 341 (6147): 742—6. PMID 23950530. doi:10.1126/science.1237227.
- Leonard L. Saari; Josephine C. Cotterman; Michael M. Primiani (1990). „Mechanism of Sulfonylurea Herbicide Resistance in the Broadleaf Weed, Kochia scoparia” (PDF). Plant Physiology. 93 (1): 55—61. PMID 16667465.
- SO, Duke (1990). „Overview of herbicide mechanisms of action”. Environ. Health Perspect. Brogan. 87: 263—71. JSTOR 3431034. PMC 1567841 . PMID 1980104. doi:10.2307/3431034.
- Tan, G; Gyllenhaal, C; Soejarto, DD (2006). „Biodiversity as a source of anticancer drugs”. Current drug targets. 7 (3): 265—77. PMID 16515527. doi:10.2174/138945006776054942.
- Laurie C. Dolan; Ray A. Matulka; George A. Burdock (2010). „Naturally Occurring Food Toxins”. Toxins. Basel. 2 (9): 2289—2332. PMID 3153292. doi:10.3390/toxins2092289.
- Peltier, Sandra; Oger, Jean-Michel; Lagarce, Frédéric; Couet, William; Benoît, Jean-Pierre (2006). „Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules”. Pharmaceutical Research. 23 (6): 1243—50. PMID 16715372. doi:10.1007/s11095-006-0022-2.
- Abal, M; Andreu, JM; Barasoain, I (2003). „Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action”. Current cancer drug targets. 3 (3): 193—203. PMID 12769688. doi:10.2174/1568009033481967.
- Bharadwaj, Rajnish; Yu, Hongtao (2004). „The spindle checkpoint, aneuploidy, and cancer”. Oncogene. 23 (11): 2016—27. PMID 15021889. doi:10.1038/sj.onc.1207374.
- Brito, D. A.; Yang, Z.; Rieder, C. L. (2008). „Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied”. The Journal of Cell Biology. 182 (4): 623—9. PMC 2518701 . PMID 18710927. doi:10.1083/jcb.200805072.
- Defrates, LJ; Hoehns, JD; Sakornbut, EL; Glascock, DG; Tew, AR (2005). „Antimuscarinic intoxication resulting from the ingestion of moonflower seeds”. The Annals of pharmacotherapy. 39 (1): 173—6. PMID 15572604. doi:10.1345/aph.1D536.
- Hallen, H.; Luo; J.S. Scott-Craig; J.D. Walton (2007). „A gene family encoding the major toxins of lethal Amanita mushrooms.”. Proceedings of the National Academy of Sciences of the United States of America. 104 (48): 19097—19101. PMC 2141914 . PMID 18025465. doi:10.1073/pnas.0707340104.
- Vetter, J (1998). „Toxins of Amanita phalloides”. Toxicon. 36 (1): 13—24. PMID 9604278. doi:10.1016/S0041-0101(97)00074-3.
- Holmes, CF; Maynes, JT; Perreault, KR; Dawson, JF; James, MN (2002). „Molecular enzymology underlying regulation of protein phosphatase-1 by natural toxins”. Current medicinal chemistry. 9 (22): 1981—9. PMID 12369866. doi:10.2174/0929867023368827.
- Bischoff, K (2001). „The toxicology of microcystin-LR: occurrence, toxicokinetics, toxicodynamics, diagnosis and treatment”. Veterinary and human toxicology. 43 (5): 294—7. PMID 11577938.
- Henrissat B, Callebaut I, Mornon JP, Fabrega S, Lehn P, Davies G (1995). „Conserved catalytic machinery and the prediction of a common fold for several families of glycosyl hydrolases”. Proc. Natl. Acad. Sci. U.S.A. 92 (15): 7090—7094. PMC 41477 . PMID 7624375. doi:10.1073/pnas.92.15.7090.
- Henrissat B, Davies G (1995). „Structures and mechanisms of glycosyl hydrolases”. Structure. 3 (9): 853—859. PMID 8535779. doi:10.1016/S0969-2126(01)00220-9.
- Hartley, MR; Lord, JM (2004). „Cytotoxic ribosome-inactivating lectins from plants”. Biochimica et Biophysica Acta. 1701 (1—2): 1—14. PMID 15450171. doi:10.1016/j.bbapap.2004.06.004.
- Waldron, K. J.; Robinson, N. J. (2009). „How do bacterial cells ensure that metalloproteins get the correct metal?”. Nat. Rev. Microbiol. 7 (1): 25—35. PMID 19079350. doi:10.1038/nrmicro2057.
- Mital, R.; Shah, G. M.; Srivastava, T. S.; Bhattacharya, R. K. (1992). „The effect of some new platinum (II) and palladium (II) coordination complexes on rat hepatic nuclear transcription in vitro”. Life Sci. 50: 781—790. PMID 1371326. doi:10.1016/0024-3205(92)90183-P.
- Kelley, T. J.; Moghaddas, S.; Bose, R.; Basu, S. (1993). „Inhibition of immunopurified DNA polymerase-alpha from PA-3 prostate tumor cells by platinum (II) antitumor drugs”. Cancer Biochem. Biophys. 13: 135—146. PMID 8111727.
- Ganeva, R. L.; Spassovska, N. C.; Genchev, D. D. J. (1991). „The effect of some platinum compounds on the activity of the CTP synthetase of Ehrlich ascites tumor cells: in vitro and in vivo studies”. Inorg. Biochem. 43: 717—722. PMID 1779227. doi:10.1016/0162-0134(91)80042-G.
- Koch, T.; Gloddek, B. (1991). „Inhibition of adenylate-cyclase-coupled G protein complex by ototoxic diuretics and cis-platinum in the inner ear of the guinea pig”. Eur. Arch. Oto-Rhino-Laryngol. 248: 459—464. PMID 1662964. doi:10.1007/BF00627634.
- Ho, B. T.; Huo, Y. Y.; Lee, J. H.; Levin, V. A. (1991). „Inhibition of adenylate cyclase by tetraplatin”. Anti-Cancer Drugs. 2: 267—268. PMID 1802021. doi:10.1097/00001813-1991.
- Rosen, M.; Figliomeni, M.; Simpkins, H. (1992). „The interaction of platinum antitumor drugs with mouse liver mitochondria”. Int. J. Exp. Pathol. 73: 61—74. ISSN 0959-9673. PMC 2002465 .
- Wright, J. A.; Chan, A. K.; Choy, B. K.; Hurta, R. A. R.; McClarty, G. A.; Tagger, A. Y. (1990). „Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis”. Cell. Biol. 68: 1364—1371. PMID 2085432.
- Oblender, M.; Carpentieri, U. (1990). „Effects of iron, copper and zinc on the activity of ribonucleotide reductase in normal and leukemic human lymphocytes”. Anticancer Res. 10: 123—128. PMID 2185685.
- Myette, M. S.; Elford, H. L.; Chitambar, C. R. (1998). „Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells”. Cancer Lett. 129: 199—204. PMID 9719462. doi:10.1016/S0304-3835(98)00104-9.
- Chitambar, C. R.; Narasimhan, J. (1991). „Targeting Iron-Dependent DNA Synthesis with Gallium and Transferrin-Gallium”. Pathobiology. 59: 3—10. PMID 1645976.
- Chitambar, C. R.; Narasimhan, J.; Guy, J.; Sem, D. S.; O’Brien, W. J. (1991). „Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells”. Cancer Res. 51: 6199—6201. PMID 1933878.
- Nocentini, G.; Federici, F.; Grifantini, M.; Barzi, A. (1992). „2,2'-Bipyridyl-6-carbothioamide and Its Ferrous Complex: Their in Vitro Antitumoral Activity Related to the Inhibition of Ribonucleotide Reductase R2 Subunit” (PDF). Pharmacol. Res. 25: 312—313. PMID 8416745.
- Nocentini, G.; Barzi, A. (1996). „The 2,2′-Bipyridyl-6-carbothioamide copper (II) complex differs from the iron (II) complex in its biochemical effects in tumor cells, suggesting possible differences in the mechanism leading to cytotoxicity”. Biochem. Pharm. 52: 65—71. PMID 8678909. doi:10.1016/0006-2952(96)00139-6.
- West, D. X.; Liberta, A. E. (1993). „The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxides”. Coord. Chem. Rev. 123: 49— 71. PMID 8098234.
- Gopalakrishna, R.; Gundimeda, U.; Chen, Z. H. (1997). „Cancer-Preventive Selenocompounds Induce a Specific Redox Modification of Cysteine-Rich Regions in Ca2+- Dependent Isoenzymes of Protein Kinase C”. Arch. Biochem. Biophys. 348: 25—36. PMID 9390171. doi:10.1006/abbi.1997.0334.
- Gopalakrishna, R.; Chen, Z. H.; Gundimeda, U. (1997). „Selenocompounds Induce a Redox Modulation of Protein Kinase C in the Cell, Compartmentally Independent from Cytosolic Glutathione: Its Role in Inhibition of Tumor Promotion”. Arch. Biochem. Biophys. 348: 37—48. PMID 9390172. doi:10.1006/abbi.1997.0335.
- Harding, M. M.; Long, G. V. (1997). „Solution conformation of the antitumor drug streptonigrin”. Curr. Med. Chem. 4: 405—420. PMID 8230091. doi:10.1021/jm00073a003.
- Perry, D. K.; Smyth, M. J.; Stennicke, H. R.; Salvesen, G. S.; Duriez, P.; Poiriez, G. G.; Hannun, Y. A. (1997). „Zinc Is a Potent Inhibitor of the Apoptotic Protease, Caspase-3 - A novel target for zink in the inhibition of apoptosis”. J. Biol. Chem. 30: 18530—18533. PMID 9228015. doi:10.1074/jbc.272.30.18530.
- Maret, W.; Jacob, C.; Vallee, B. L.; Fischer, E. H. (1999). „Inhibitory sites in enzymes: Zinc removal and reactivation by thionein”. Proc. Natl. Acad. Sci. 96: 1936—1940. PMID 10051573. doi:10.1073/pnas.96.5.1936.
- Morinville, A.; Maysinger, D.; Shaver, A. (1998). „From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signalling”. Trends Pharmacol. Sci. 19: 452—460. PMID 9850609. doi:10.1016/S0165-6147(98)01257-7.
- Faure, R.; Vincent, M.; Dufour, M.; Shaver, A.; Posner, B. I. J. (1995). „Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: Studies on a neuronal and a glial cell line”. Cell Biochem. 58: 389—401. PMID 8567756. doi:10.1002/jcb.240590310.
- Zhuo, S.; Dixon, J. E. (1997). „Effects of sulfhydryl regents on the activity of lambda Ser/Thr phosphoprotein phosphatase and inhibition of the enzyme by zinc ion”. Protein Eng. 10: 1445—1452. PMID 9543006.
- Cha, J.; Pedersen, M. V.; Auld, D. S. (1996). „Metal and pH dependence of heptapeptide catalysis by human matrilysin”. Biochemistry. 35: 15831—13838. PMID 8961947. doi:10.1021/bi962085f.
- Nocentini, G.; Barzi, A. (1997). „Antitumor activity of 2,2′-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitor”. Gen. Pharmac. 29: 701—706. PMID 9347313. doi:10.1016/S0306-3623(97)00011-6.
- Byrnes, R. W.; Mohan, M.; Antholine, W. E.; Xe, R. X.; Petering, D. H. (1990). „Oxidative stress induced by a copper-thiosemicarbazone complex”. Biochemistry. 29: 7046—7053. PMID 2171640. doi:10.1021/bi00482a014.
- Hubbard, S. R.; Bishop, W. R.; Kirschmeier, P.; George, S. J.; Cramer, S. P.; Hendrickson, W. A. (1991). „Identification and characterization of zinc binding sites in protein kinase C”. Science. 254: 1776—1779. PMID 1763327. doi:10.1126/science.1763327.
- V. Ashutosh Raocorresponding (10. 03. 2013). „Iron Chelators with Topoisomerase-Inhibitory Activity and Their Anticancer Applications”. Antioxid Redox Signal. 18 (8): 930—955. PMC 3557438 . doi:10.1089/ars.2012.4877.
- Harding, M. M.; Prodigalidad, M.; Lynch, M. J. (1996). „Organometallic Anticancer Agents. 2. Aqueous Chemistry and Interaction of Niobocene Dichloride with Nucleic Acid Constituents and Amino Acids”. J. Med. Chem. 39: 5012—5016. PMID 8960562. doi:10.1021/jm9603678.
- Takahashi, A.; Alnemri, E. S.; Lazebnik, Y. A.; Fernandes-Alnemri, T.; Litwack, G.; Moir, R. D.; Goldman, R. D.; Poirier, G. G.; Kaufmann, S. G.; Earnshaw, W. C. (1996). „Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis”. PNAS. 93: 8395—8400. PMID 38682.
- Krynetskaya, N. F.; Kubareva, E. A.; Timchenko, M. A.; Belkov, V. M.; Shabarova, Z. A. (1998). „Transition-metal complexes as inhibitors of proteins recognizing double-stranded fragments of nucleic acids”. Biochemistry (Moscow). 63: 1068—1073. PMID 9795277.
- Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML (1989). „Treatment with Tin Prevents the Development of Hypertension in Spontaneously Hypertensive Rats”. Science. 243: 388—90. PMID 2492116.
- Maines, M.; Trakshel, G. (1992). „Tin-protoporphyrin: a potent inhibitor of hemoprotein-dependent steroidogenesis in rat adrenals and testes”. J. Pharmacol. Exp. Ther. 260: 909—916. PMID 1371161.
- Trakshel, G.; Sluss, P.; Maines, M. (1992). „Comparative effects of tin- and zinc-protoporphyrin on steroidogenesis: tin-protoporphyrin is a potent inhibitor of cytochrome P-450-dependent activities in the rat adrenals”. Pediatr. Res. 31: 196—201. PMID 1542552. doi:10.1203/00006450-199202000-00022.
- Maines, M.; Trakshel, G. (1992). „Differential regulation of heme oxygenase isozymes by Sn- and Zn-protoporphyrins: possible relevance to suppression of hyperbilirubinemia”. Biochim. Biophys. Acta. 1131: 166—174. PMID 1610897. doi:10.1016/0167-4781(92)90072-8.
- Böni, R. E.; Boni, R. A.; Galbraith, R. A.; Drummond, G. S.; Kappas, A. (1993). „Tin-mesoporphyrin inhibits heme oxygenase activity and heme-iron absorption in the intestine”. Pharmacology. 47: 318—329. PMID 8265722.
- Robert A. Johnson; Manuel Lavesa; Bardia Askari; Nader G. Abraham; Alberto Nasjletti (1995). „A Heme Oxygenase Product, Presumably Carbon Monoxide, Mediates a Vasodepressor Function in Rats”. Hypertension. 25: 166—169. PMID 7843765. doi:10.1161/01.HYP.25.2.166.
- Russo, S.; Pepe, J.; Donohue, S.; Cable, E.; Lambrecht, R.; Bonkovsy, H. (1995). „Tissue distribution of zinc-mesoporphyrin in rats: relationship to inhibition of heme oxygenase”. J. Pharmacol. Exp. Ther. 272: 766—774. PMID 7853192.
- Keino, H.; Banno, T.; Mimura, S.; Kashiwamata, S. (1993). „Cobalt-Mesoporphyrin Inhibits Heme Oxygenase Activity but It Does Not Induce Lipid Peroxidation in Rat Brain Membranes during Photoirradiation”. Biol. Neonate. 63: 285—289. PMID 8353156. doi:10.1159/000243943.
- Vallier, H.; Rodgers, P.; Stevenson, D. (1993). „Inhibition of heme oxygenase after oral vs intraperitoneal administration of chromium porphyrins”. Life Sci. 52: PL79—PL84. PMID 8445977. doi:10.1016/0024-3205(93)90521-4.
- Drummond, G.; Rosenberg, D.; Kappas, A. (1992). „Intestinal heme oxygenase inhibition and increased biliary iron excretion by metalloporphyrins”. Gastroenterology. 102: 1170—1175. PMID 1551526. doi:10.1016/0016-5085(92)70011-Y.
- Galbraith, R.; Drummond, G.; Kappas, A. (1992). „Suppression of Bilirubin Production in the Crigler-Najjar Type I Syndrome: Studies with the Heme Oxygenase Inhibitor Tin-Mesoporphyrin”. Pediatrics. 89: 175—182. PMID 1734381.
- Cannon, J. B. (1993). „Pharmaceutics and drug delivery aspects of heme and porphyrin therapy”. J. Pharm. Sci. 82: 435—446. PMID 8360819. doi:10.1002/jps.2600820502.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Marks, J. A.; Maines, M. D. (1992). „Tin-Protoporphyrin-Mediated Disruption In Vivo of Heme Oxygenase-2 Protein Integrity and Activity in Rat Brain” (PDF). Pediatr. Res. 32: 324—329. PMID 1408470. doi:10.1203/00006450-199209000-00016.
- Hintz, S. R.; Vreman, H. J.; Stevenson, D. K. (1990). „Mortality of metalloporphyrin-treated neonatal rats after light exposure”. Dev. Pharmacol. 14: 187—192. PMID 2364856.
- Cable, E.; Cable, J.; Bonkovsky, H. (1993). „Repression of hepatic δ-aminolevulinate synthase by heme and metalloporphyrins: Relationship to inhibition of heme oxygenase”. Hepatology. 18: 119—127. PMID 8325603. doi:10.1002/hep.1840180119.
- Lathrop, J. T.; Timko, M. P. (1993). „Regulation by heme of mitochondrial protein transport through a conserved amino acid moti”. Science. 259: 522—525. PMID 8424176. doi:10.1126/science.8424176.
- Bhasker, C. R.; Burgiel, G.; Neupert, B.; Emery-Goodman, A.; Kuhn, L. C.; May, B. K. (1993). „The Putative Iron-Responsive Element in the Human Erythroid 5-Aminolevulinate Synthase mRNA Mediates Translational Control” (PDF). JBC. 268: 12699—12705. PMID 8509404.
- Serfass, L.; Burstyn, J. (1998). „Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity”. Arch. Biochem. Biophys. 359: 8—16. PMID 9799554. doi:10.1006/abbi.1998.0887.
- Luo, D.; Vincent, S. (1994). „Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo”. Eur. J. Pharmacol.-Mol. Pharmacol. Sec. 267: 263—267. PMID 7522180. doi:10.1016/0922-4106(94)90149-X.
- Mariotto, S.; Cuzzolin, L.; Adami, A.; DelSoldato, P.; Suzuki, H.; Benoni, G. (1995). „Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils”. Brit. J. Pharmacol. 114: 1105—1106. PMID 7542530. doi:10.1111/j.1476-5381.1995.tb13320.x.
- Vickroy, T.; Malphurs, W. (1995). „Inhibition of nitric oxide synthase activity in cerebral cortical synaptosomes by nitric oxide donors: evidence for feedback autoregulation”. Neurochem. Res. 20: 299—304. PMID 7541898. doi:10.1007/BF00969546.
- Perry, J.; Marletta, M. (1998). „Effects of transition metals on nitric oxide synthase catalysis”. PNAS. 95: 11101—11106. PMID 9736696. doi:10.1073/pnas.95.19.11101.
- Persechini A, McMillan K, Masters BS (1995). „Inhibition of Nitric Oxide Synthase Activity by Zn2+ Ion”. Biochemistry. 34: 15091—15095. PMID 7578122. doi:10.1021/bi00046a015.
- Siegfried, G.; Amiel, C.; Friedlander, G. (1996). „Inhibition of Ecto-5′-nucleotidase by Nitric Oxide Donors”. J. Biol. Chem. 271: 4659—4664. PMID 8617729.
- Thomas, S.; Mohr, D.; Stocker, R. (1994). „Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes” (PDF). J. Biol. Chem. 269: 14457—14464. PMID 7514170.
- Nicolaou, A.; Waterfield, C.; Kenyon, S.; Gibbons, W. (1997). „The Inactivation of Methionine Synthase in Isolated Rat Hepatocytes by Sodium Nitroprusside”. Eur. J. Biochem. 244: 8876—882. PMID 9108260. doi:10.1111/j.1432-1033.1997.00876.x.
- Sato, T.; Kamata, Y.; Irifune, M.; Nishikawa, T. (1995). „Inhibition of purified (Na+,K+)-ATPase activity from porcine cerebral cortex by NO generating drugs”. Brain Res. 704: 117—120. PMID 8750971. doi:10.1016/0006-8993(95)01165-X.
- Bredt, D. S.; Snyder, S. H. (1992). „Nitric oxide, a novel neuronal messenger”. Neuron. 8: 3—11. PMID 1370373. doi:10.1016/0896-6273(92)90104-L.
- Jaffrey, S. R.; Snyder, S. H. (1996). „PIN: An associated protein inhibitor of neuronal nitric oxide synthase”. Science. 274: 774—777. PMID 8864115. doi:10.1126/science.274.5288.774.
- Marletta, M. A. (1994). „Nitric oxide synthase: Aspects concerning structure and catalysis” (PDF). Cell. 78: 927—930. PMID 7522970. doi:10.1016/0092-8674(94)90268-2.
- Moore, P. K.; Handy, R. L. C. (1997). „Selective inhibitors of neuronal nitric oxide synthase – is no NOS really good NOS for the nervous system?”. Trends Pharm. Sci. 18: 204— 211. PMID 9226999. doi:10.1016/S0165-6147(97)01064-X.
- Bredt, D. S.; Snyder, S. H. (1990). „Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme”. PNAS. 87: 682—685. PMID 1689048. doi:10.1073/pnas.87.2.682.
- Weiss, G.; Lutton, J.; Fuchs, D.; Wernerfelmayer, G.; Bock, G.; Abraham, N.; Kappas, A.; Levere, R.; Wachter, H. (1993). „Comparative Effects of Heme and Metalloporphyrins on Interferon-γ-Mediated Pathways in Monocytic Cells (THP-1)”. Proc. Soc. Exp. Biol. Med. 202: 470—475. PMID 8456113. doi:10.3181/00379727-202-43561.
- Meffert, M.; Haley, J.; Schulman, E.; Schulman, H.; Madison, D. (1994). „Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins”. Neuron. 13: 1225—1233. PMID 7524564. doi:10.1016/0896-6273(94)90060-4.
- Bing, O.; Grundemar, L.; Ny, L.; Moller, C.; Heilig, M. (1995). „Modulation of carbon monoxide production and enhanced spatial learning by tin protoporphyrin”. Neuroreport. 6: 1369—1372. PMID 7488726. doi:10.1097/00001756-199507100-00002.
- Supuran CT, Scozzafava A, Saramet I, Banciu MD (1998). „Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes”. J. Enzyme Inhib. 13: 177—194. PMID 9629536. doi:10.3109/14756369809028339.
- Turkmen H, Durgun M, Yilmaztekin S, Emul M, Innocenti A, Vullo D, Scozzafava A, Supuran CT (1997). „Carbonic anhydrase inhibitors. Part 50. Interaction of isoenzymes I and II of carbonic anhydrase with Ge(IV) and Sb(III) derivatives”. Main Group Met. Chem. 20: 641—647. PMID 15603956. doi:10.1016/j.bmcl.2004.10.070.
- Abrams MJ, Murrer BA (1993). „Metal compounds in therapy and diagnosis”. Science. 261: 725—730. PMID 8102010. doi:10.1126/science.8102010.
- Sly WS, Hu PY (1995). „Human carbonic anhydrases and carbonic anhydrase deficiencies”. Annu. Rev. Biochem. 64: 375—401. PMID 7574487. doi:10.1146/annurev.bi.64.070195.002111.
- Bergenhem, N. (1996). „Chromatographic and electrophoretic methods related to the carbonic anhydrase isozymes”. J. Chromatogr. B. 684: 289—305. PMID 8906478. doi:10.1016/0378-4347(95)00566-8.
- Heagerty, A. M. (1991). „Functional and structural effects of ACE inhibitors on the cardiovascular system”. Cardiology. 79: 3—9. PMID 1913721. doi:10.1159/000174899.
- Kureya, P.; Beevers, D. G. (1991). „The mechanisms of hypertension and the role of ACE inhibitors”. J. Human Hypertension. 5: 3—8. PMID 1791616.
- Bagger, S. (1993). „The binding of cobalt(III)-ligated amino acids and peptides to chymotrypsin and trypsin”. J. Inorg. Biochem. 52: 165—171. PMID 8254339.
- Bagger, S.; Wagner, K. J. (1998). „Molecular recognition of cobalt(III)-ligated peptides by serine proteases: the role of electrostatic effects”. Peptide Res. 52: 273—282. PMID 9832305. doi:10.1111/j.1399-3011.1998.tb01241.x.
- Takeuchi, T.; Böttcher, A.; Quezada, C. M.; Meade, T. J.; Gray, H. B. (1999). „Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes”. Bioorg. Med. Chem. 6: 1—5. PMID 10400334.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1992). „Identification of serine and histidine adducts in complexes of trypsin and trypsinogen with peptide and nonpeptide boronic acid inhibitors by proton NMR spectroscopy”. Biochemistry. 31: 12839—12846. PMID 1463754. doi:10.1021/bi00166a019.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1993). „Boron-11 NMR spectroscopy of peptide boronic acid inhibitor complexes of .alpha.-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes”. Biochemistry. 32: 12651—12655. PMID 8251483. doi:10.1021/bi00210a013.
- Geratz, J.; Tidwell, R.; Schwab, J.; Anderle, S.; Pryzwansky, K. (1990). „Sequential events in the pathogenesis of streptococcal cell wall-induced arthritis and their modulation by bis(5-amidino-2-benzimidazolyl)methane (BABIM)”. Am. J. Pathol. 136: 909—921. PMID 2327474.
- Katz, B.; Clark, J.; Finer-Moore, J.; Jenkins, T.; Johnson, C.; Ross, M.; Luong, C.; Moore, W.; Stroud, R. (1998). „Design of potent selective zinc-mediated serine protease inhibitors”. Nature. 391: 608—612. PMID 9468142. doi:10.1038/35422.
- Rice, K.; Tanaka, R.; Katz, B.; Numerof, R.; Moore, W. (1998). „Inhibitors of tryptase for the treatment of mast cell-mediated diseases”. Curr. Pharm. Des. 4: 381—396. PMID 10197050.
- Thorpe, H. H. (1998). „Bioinorganic chemistry and drug design: here comes zinc again”. Chem. Biol. 5: R125—R127. PMID 9653544. doi:10.1016/S1074-5521(98)90166-1.
- Duffy, B.; Schwietert, C.; France, A.; Mann, N.; Culbertson, K.; Harmon, B.; McCue, J. P. (1998). „Transition metals as protease inhibitors”. Biol. Trace Element Res. 64: 197—213. PMID 9845474. doi:10.1007/BF02783336.
- Babine, R. E.; Bender, S. L. (1997). „Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design”. Chem. Rev. 97: 1359—1472. PMID 11851455. doi:10.1021/cr960370z.
- Bone, R.; Frank, D.; Kettner, C. A.; Agard, D. A. (1989). „Structural analysis of specificity: .alpha.-lytic protease complexes with analogs of reaction intermediates”. Biochemistry. 28: 7600—7609. PMID 2611204. doi:10.1021/bi00445a015.
- Louie, A. Y.; Meade, T. J. (1998). „A cobalt complex that selectively disrupts the structure and function of zinc fingers”. PNAS. 95: 6663—6668. PMID 9618469. doi:10.1073/pnas.95.12.6663.
- Clauberg, M.; Joshi, J. G. (1993). „Regulation of serine protease activity by aluminum: implications for Alzheimer disease”. Proc. Natl. Acad. Sci. U.S.A. 90: 1009—1012. PMID 7679214.
- Rao, K. S. J.; Rao, G. V. (1994). „Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study”. Mol. Cell. Biochem. 137: 57—60. PMID 7845378. doi:10.1007/BF00926039.
- Nixon, R. A.; Clarke, J. F.; Logvinenko, K. B.; Tan, M. K. H.; Hoult, M.; Grynspan, F. (1990). „Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes”. J. Neurochem. 55: 1950—1959. PMID 2121904. doi:10.1111/j.1471-4159.1990.tb05781.x.
- Joshi, J. G.; Dhar, M.; Clauberg, M.; Chauthaiwale, V. (1994). „Iron and aluminum homeostasis in neural disorders”. Environ. Health Perspect. 102: 207—213. PMID 7843099. doi:10.2307/3431788.
- Lee, B. H.; Park, M. B.; Yu, B. S. (1998). „Inhibition of electric eel acetylcholinesterase by porphin compounds”. Bioinorg. Med. Chem. Lett. 8: 1467—1470. PMID 9873371. doi:10.1016/S0960-894X(98)00236-4.
- Falkous, G.; Harris, J. B.; Mantle, D. (1995). „Effect of neurotoxic metal ions in vitro on proteolytic enzyme activities in human cerebral cortex”. Clin. Chim. Acta. 238: 125—135. PMID 7586572. doi:10.1016/0009-8981(95)06081-N.
- Cuajungco, M. P.; Lees, G. K. (1997). „Zinc metabolism in the brain: relevance to human neurodegenerative disorders”. Neurobiol. Dis. 4: 137—169. PMID 9361293. doi:10.1006/nbdi.1997.0163.
- Atwood, C. S.; Moir, R. D.; Huang, X. D.; Scarpa, R. C.; Bacarra, N. M. E.; Romano, D. M.; Hartshorn, M. K.; Tanzi, R. E.; Bush, A. I. (1998). „Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis”. J. Biol. Chem. 273: 12817—12826. PMID 9582309. doi:10.1074/jbc.273.21.12817.
- Fitzgerald, D. J.; Maggio, J. E.; Esler, W. P.; Stinson, E. R.; Jennings, J. M.; Ghilardi, J. R.; Mantyh, P. W.; Bush, A. I.; Moir, R. D.; Rosenkranz, K. M.; Tanzi, R. E. (1995). „Zinc and Alzheimer's disease”. Science. 268: 1920—1923. PMID 7604268.
- Mantyh, P. W.; Ghilardi, J. R.; Rogers, S.; Demaster, E.; Allen, C. J.; Stimson, E. R.; Maggio, J. E. (1993). „Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide”. J. Neurochem. 61: 1171—1174. PMID 8360682. doi:10.1111/j.1471-4159.1993.tb03639.x.
- Huang, X. D.; Atwood, C. S.; Moir, R. D.; Hartshorn, M. A.; Vonsattel, J. P.; Tanzi, R. E.; Bush, A. I. (1997). „Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors”. J. Biol. Chem. 272: 26464—26470. PMID 9334223. doi:10.1074/jbc.272.42.26464.
- Bush, A. I.; Pettingell, W. H.; Multhaup, G.; Paradis, M. D.; Vonsattel, J. P.; Gusella, J. F.; Beyreuther, K.; Masters, C. L.; Tanzi, R. E. (1994). „Rapid induction of Alzheimer A beta amyloid formation by zinc”. Science. 265: 1464—1467. PMID 8073293.
- Dyrks, T.; Dyrks, E.; Hartmann, T.; Masters, C.; Beyreuther, K. (1992). „Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation” (PDF). J. Biol. Chem. 267: 18210—18217. PMID 1517249.
- Bondy, S. C.; Guo-Ross, S. X.; Truong, A. T. (1998). „Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid”. Brain Res. 799: 91—96. PMID 9666089. doi:10.1016/S0006-8993(98)00461-2.
- Cuajungco, M. P.; Lees, G. (1997). „Zinc and Alzheimer's disease: is there a direct link?”. J. Brain Res. Rev. 23: 219—236. PMID 9164672. doi:10.1016/S0165-0173(97)00002-7.
- Sugumoto, H.; Iimura, Y.; Yamanishi, Y.; Yamatsu, K. (1995). „Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds”. J. Med. Chem. 38: 4821—4829. PMID 7490731. doi:10.1021/jm00024a009.
- Danning, C. L.; Boumpas, D. T. (1998). „Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis: an update on mechanisms of action”. Clin. Exp. Rheumatol. 16: 595—604. PMID 9779311.
- Hashimoto, K.; Whitehurst, C. E.; Matsubara, T.; Hirohata, K.; Lipsky, P. E. (1992). „Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C”. J. Clin. Invest. 89: 1839—1848. PMID 1351061. doi:10.1172/JCI115788.
- Zhang, Z. Y.; Reardon, I. M.; Hui, J. O.; O’Connell, K. L.; Poorman, R. A.; Heinrikson, R. L. (1991). „Zinc inhibition of renin and the protease from human immunodeficiency virus type 1”. Biochemistry. 30: 8717—8721. PMID 1888732. doi:10.1021/bi00100a001.
- Hall, I. H.; Chen, S. Y.; Rajendran, K. G.; Sood, A.; Spielvogel, B. F.; Shih, J. (1994). „Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes”. Environ. Health Perspect. 102: 21—30. PMID 7889876. doi:10.2307/3431958.
- Pugh, M. C.; Pugh, C. B. (1987). „Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis”. Clin. Pharm. 6: 475—491. PMID 3319362.
- Baker, D. G.; Rabinowitz, J. L. (1986). „Current concepts in the treatment of rheumatoid arthritis”. J. Clin. Pharmacol. 26: 2—21. PMID 3512617.
- Naughton, D. P.; Knappitt, J.; Fairburn, K.; Gaffney, K.; Blake, D. R.; Grootveld, M. (1995). „Detection and investigation of the molecular nature of low-molecular-mass copper ions in isolated rheumatoid knee-joint synovial fluid”. FEBS Lett. 362: 167—172. PMID 7698317. doi:10.1016/0014-5793(95)00165-6.
- Miche, H.; Brumas, V.; Berthon, G. (1997). „Copper(II) interactions with nonsteroidal antiinflammatory agents. II. Anthranilic acid as a potential. OH-inactivating ligand”. J. Inorg. Biochem. 68: 27—38. PMID 9379178. doi:10.1016/S0162-0134(97)00005-6.
- Menard, H. A.; Amine, M. E. (1996). „The calpain-calpastatin system in rheumatoid arthritis”. Immunol. Today. 17: 545—547. PMID 8991283. doi:10.1016/S0167-5699(96)30064-9.
- Zhang, H.; Johnson, P. (1992). „Differential effects of aluminum ion on smooth muscle calpain I and calpain II activities”. Int. J. Biochem. 24: 1773—1778. PMID 1451912. doi:10.1016/0020-711X(92)90127-M.
- Frolich, J. C. (1997). „A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes”. Trends Pharm. Sci. 18: 30—34. PMID 9114728. doi:10.1016/S0165-6147(96)01017-6.
- Moore, P.; Jones, C.; Mahmood, N.; Evans, I.; Goff, M.; Cooper, R.; Hay, A. (1995). „Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase” (PDF). Biochem. J. 307: 129—134. PMID 7536411.
- Casas, J.; Rodriguez-Arguelles, M.; Russo, U.; Sanchez, A.; Sordo, J.; Vazquez-Lopez, A.; Pinelli, S.; Lunghi, P.; Bonati, A.; Albertini, R. (1998). „Diorganotin(IV) complexes of pyridoxal thiosemicarbazone: synthesis, spectroscopic properties and biological activity”. J. Inorg. Biochem. 69: 283—292. PMID 9654752. doi:10.1016/S0162-0134(98)00004-X.
- Chamorro, C.; Camarasa, M. J.; Perez-Perez, M. J.; Clercq, E. D.; Balzarini, J.; Felix, A. S. (1998). „An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase”. Antiviral Chem. Chemother. 9: 413—423. PMID 9875394.
- Nacsa, J.; Nagy, L.; Molnar, J.; Molnar, J. (1998). „Trifluoperazine and its metal complexes inhibit the Moloney leukemia virus reverse transcriptase”. Anticancer Res. 18: 1373—1376. PMID 9673343.
- Woon, T.; Brinkworth, R.; Fairlie, D. (1992). „Inhibition of HIV-1 proteinase by metal ions”. Int. J. Biochem. 24: 911—914. PMID 1612181. doi:10.1016/0020-711X(92)90096-J.
- Davis, D. A.; Branca, A. A.; Pallenberg, A. J.; Marschner, T. M.; Patt, L. M.; Chatlynne, L. G.; Humphrey, R. W.; Yarchoan, R.; Levine, R. L. (1995). „Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+”. Arch. Biochem. Biophys. 322: 127—134. PMID 7574666. doi:10.1006/abbi.1995.1444.
- York, D. M.; Darden, T. A.; Pedersen, L. G.; Anderson, M. W. (1993). „Molecular modeling studies suggest that zinc ions inhibit HIV-1 protease by binding at catalytic aspartates”. Environ. Health Perspect. 101: 246—250. PMID 8404763.
- Mazumder, A.; Gupta, M.; Perrin, D. M.; Sigman, C. S.; Ranbinovitz, M.; Pommier, Y. (1995). „Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor”. AIDS Res. Hum. Retroviruses. 11: 1. PMID 7734182. doi:10.1089/aid.1995.11.1.
- Farnet, C. M.; Wang, B.; Hansen, M.; Lipford, J. R.; Zalkow, L.; Robinson, W. E. J.; Siegel, J.; Bushman, F. (1998). „Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism”. Antimicrob. Agents Chemother. 42: 2245—2253. PMID 9736543.
- LaFemina, R. L.; Schneider, C. L.; Robbins, H. L.; Callahan, P. L.; LeGrow, K.; Roth, E.; Schleif, W. A.; Emini, E. A. (1992). „Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells”. J. Virol. 66: 7414—7419. PMID 1433523.
- Tarrago-Litvak, L.; Andreola, M.; Nevinsky, G. A.; Sarih-Cottin, L.; Litvak, S. (1994). „The reverse transcriptase of HIV-1: from enzymology to therapeutic intervention”. FASEB J. 18: 497—503. PMID 7514143.
- Huang, H.; Chopra, R.; Verdine, G. L.; Harrison, S. C. (1998). „Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance”. Science. 282: 1669—1675. PMID 9831551. doi:10.1126/science.282.5394.1669.
- Ferrari, M. B.; Fava, G. G.; Tarasconi, R.; Albertini, S.; Pinelli, R.; Starcich, J. (1994). „Synthesis, spectroscopic and structural characterization, and biological activity of aquachloro (pyridoxal thiosemicarbazone) copper(II) chloride”. J. Inorg. Biochem. 53: 13. PMID 8133248. doi:10.1016/0162-0134(94)80017-0.
- Das K, Bauman JD, Rim AS, Dharia C, Clark AD Jr, Camarasa MJ, Balzarini J, Arnold E (28. 04. 2011). „Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket”. J Med Chem. 54 (8): 2727—37. PMID 21446702. doi:10.1021/jm101536x.
- Spence, R. A.; Kati, W. M.; Anderson, K. S.; Johnson, K. A. (1995). „Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors”. Science. 267: 988—993. PMID 7532321. doi:10.1038/nsb0495-303.
- West, M. L.; Fairlie, D. P. (1995). „Targeting HIV-1 protease: a test of drug-design methodologies”. Trends Pharmacol. Sci. 16: 67—75. PMID 7762084. doi:10.1016/S0165-6147(00)88980-4.
- Serra, M.; Pintar, A.; Casella, L.; Sabbioni, E. (1992). „Vanadium effect on the activity of horseradish peroxidase, catalase, glutathione peroxidase, and superoxide dismutase in vitro”. J. Inorg. Biochem. 46: 161—174. PMID 1325536. doi:10.1016/0162-0134(92)80027-S.
- Karlstrom, A. R.; Levine, R. L. (1991). „Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms” (PDF). PNAS. 88: 5552—5556. PMC 51915 .
- Hazuda, D. J.; Felock, P. J.; Hastings, J. C.; Prmanik, B.; Wolfe, A. L. (1997). „Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase” (PDF). J. Virol. 71: 7005—7011. PMID 9261430.
- Wells, T. N. C.; Scully, P.; Paravicini, G.; Proudfoot, A. E. I.; Payton, M. A. (1995). „Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine”. Biochemistry. 34: 7896—7903. PMID 7794901. doi:10.1021/bi00024a014.
- Cunningham, M. L.; Zvelebil, M. J. J. M.; Fairlamb, A. H. (1994). „Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals”. Eur. J. Biochem. 221: 285—295. PMID 8168518. doi:10.1111/j.1432-1033.1994.tb18740.x.
- Saha, A. K.; Crans, D. C.; Pope, M. T.; Simone, C. M.; Glew, R. H. (1991). „Inhibition of human seminal fluid and Leishmania donovani phosphatases by molybdate heteropolyanions” (PDF). J. Biol. Chem. 266: 3511—3517. PMID 1995614.
- Yano, S.; Inoue, S.; Nouchi, R.; Mogami, K.; Shinohara, Y.; Yasuda, Y.; Kato, M.; Tanase, T.; Kakuchi, T.; Mikata, Y.; Suzuki, T.; Yamamoto, Y. (1998). „Antifungal nickel(II) complexes derived from amino sugars against pathogenic yeast, Candida albicans”. J. Inorg. Biochem. 69: 15—23. PMID 9606935.
- Su, J. J.; Mansour, J. M.; Mansour, T. E. (1996). „Purification, kinetics and inhibition by antimonials of recombinant phosphofructokinase from Schistosoma mansoni”. Mol. Biochem. Parasitol. 81: 171—178. PMID 8898332. doi:10.1016/0166-6851(96)02702-8.
- Saenz, R. E.; Rodriguez, C. C. D.; Johnson, C. M.; Berman, J. D. (1991). „Efficacy and toxicity of pentostam against Panamanian mucosal leishmaniasis”. Am. J. Trop. Med. 44: 394—398. PMID 1645930.
- Meyer-Fernandes, J. R.; Dutra, P. M. L.; Rodrigues, C. O.; Saad-Nehme, J.; Lopes, A. H. C. S. (1997). „Mg-dependent ecto-ATPase activity in Leishmania tropica”. Arch. Biochem. Biophys. 341: 40—46. PMID 9143351.
- Fairlamb, A. H.; Henderson, G. B.; Cerami, A. (1989). „Trypanothione is the primary target for arsenical drugs against African trypanosomes” (PDF). PNAS. 86: 2607—2611. PMID 2704738.
- Tsai, H.; Dwarakanath, A.; Hart, C.; Milton, J.; Rhodes, J. (1995). „Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment” (PDF). Gut. 36: 570—576. PMID 7737566.
- Beil, W.; Birkholz, C.; Wagner, S.; Sewing, K. (1995). „Bismuth subcitrate and omeprazole inhibit Helicobacter pyloriF1-ATPase”. Pharmacology. 50: 333—337. PMID 7667394. doi:10.1159/000139299.
- Schroeder, T.; Caspers, M. (1996). „Kinetics of aluminum-induced inhibition of delta-aminolevulinic acid dehydratase in vitro”. Biochem. Pharmacol. 52: 927—931. PMID 8781512. doi:10.1016/0006-2952(96)00449-2.
- Exley, C.; Price, N.; Birchall, J. (1994). „Aluminum inhibition of hexokinase activity in vitro: a study in biological availability”. J. Inorg. Biochem. 54: 297—304. PMID 8014638. doi:10.1016/0162-0134(94)80035-9.
- Canesi, L.; Ciacci, C.; Piccoli, G.; Stocchi, V.; Viarengo, A.; Gallo, G. (1998). „In vitro and in vivo effects of heavy metals on mussel digestive gland hexokinase activity: the role of glutathione”. Comp. Biochem. Physiol. C. 120 (2): 261—268. PMID 9827040. doi:10.1016/S0742-8413(98)10004-X.
- Yager, J. W.; Wiencke, J. K. (1997). „Inhibition of poly(ADP-ribose) polymerase by arsenite”. Mutat. Res. 386: 345—351. PMID 9219571. doi:10.1016/S1383-5742(97)00011-2.
- Hu, Y.; Su, L.; Snow, E. T. (1998). „Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes”. Mutat. Res. 408: 203—218. PMID 9806419. doi:10.1016/S0921-8777(98)00035-4.
- Tsao, D.; Maki, A. (1991). „Optically detected magnetic resonance study of the interaction of an arsenic(III) derivative of cacodylic acid with EcoRI methyltransferase”. Biochemistry. 30: 4565—4572. PMID 2021649. doi:10.1021/bi00232a029.
- Lam, W.; Tsao, D.; Maki, A.; Maegley, K.; Reich, N. (1992). „Spectroscopic studies of arsenic(III) binding to Escherichia coli RI methyltransferase and to two mutants, C223S and W183F”. Biochemistry. 31: 10438—10442. PMID 1420162. doi:10.1021/bi00158a004.
- Styblo, M.; Thomas, D. (1995). „In vitro inhibition of glutathione reductase by arsenotriglutathione”. Biochem. Pharmacol. 49: 971—977. PMID 7741769. doi:10.1016/0006-2952(95)00008-N.
- Chawla, S.; Mutenda, E.; Dixon, H.; Freeman, S.; Smith, A. (1995). „Synthesis of 3-arsonopyruvate and its interaction with phosphoenolpyruvate mutase”. Biochem. J. 308: 931—935. PMID 8948453.
- Snow, E.; Xu, L.; Kinney, P. (1993). „Effects of nickel ions on polymerase activity and fidelity during DNA replication in vitro”. Chem.-Biol. Interact. 88: 155—173. PMID 8403077. doi:10.1016/0009-2797(93)90089-H.
- Yang, S. W.; Becker, F. F.; Chan, J. Y. H. (1996). „Inhibition of human DNA ligase I activity by zinc and cadmium and the fidelity of ligation”. Environ. Health Perspect. 28: 19—25. PMID 8698042. doi:10.1002/(SICI)1098-2280(1996)28:1<19::AID-EM5>3.0.CO;2-9.
- Hartwig, A. (1994). „Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review”. Environ. Health Perspect. 102: 45—50. PMID 7843136. doi:10.2307/3431762.
- Porter, D. W.; Nelson, V. C.; Fivash, M. J. J.; Kasprzak, K. S. (1996). „Mechanistic studies of the inhibition of MutT dGTPase by the carcinogenic metal Ni(II)”. Chem. Res. Toxicol. 9: 1375—1381. PMID 8951243. doi:10.1021/tx9600816.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
- SI, Beale (1990). „Biosynthesis of the Tetrapyrrole Pigment Precursor, delta-Aminolevulinic Acid, from Glutamate”. Plant Physiol. 93 (4): 1273—9. PMC 1062668 . PMID 16667613. doi:10.1104/pp.93.4.1273.
- Thiele, D. J. (1992). „Metal-regulated transcription in eukaryotes” (PDF). Nuc. Acids Res. 20: 1183—1191. PMID 1561077.
- O’Halloran, T. V. (1993). „Transition metals in control of gene expression”. Science. 261: 715—725. PMID 8342038. doi:10.1126/science.8342038.
- Cannon, J. B. (1993). „Pharmaceutics and drug delivery aspects of heme and porphyrin therapy”. J. Pharm. Sci. 82: 435—446. PMID 8360819. doi:10.1002/jps.2600820502.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Marks, J. A.; Maines, M. D. (1992). „Tin-Protoporphyrin-Mediated Disruption In Vivo of Heme Oxygenase-2 Protein Integrity and Activity in Rat Brain” (PDF). Pediatr. Res. 32: 324—329. PMID 1408470. doi:10.1203/00006450-199209000-00016.
- Hintz, S. R.; Vreman, H. J.; Stevenson, D. K. (1990). „Mortality of metalloporphyrin-treated neonatal rats after light exposure”. Dev. Pharmacol. 14: 187—192. PMID 2364856.
- Hintz, S. R.; Vreman, H. J.; Stevenson, D. K. (1990). „Mortality of metalloporphyrin-treated neonatal rats after light exposure”. Dev. Pharmacol. 14: 187—192. PMID 2364856.
- Hintz, S. R.; Vreman, H. J.; Stevenson, D. K. (1990). „Mortality of metalloporphyrin-treated neonatal rats after light exposure”. Dev. Pharmacol. 14: 187—192. PMID 2364856.
- Hintz, S. R.; Vreman, H. J.; Stevenson, D. K. (1990). „Mortality of metalloporphyrin-treated neonatal rats after light exposure”. Dev. Pharmacol. 14: 187—192. PMID 2364856.
- Cable, E.; Cable, J.; Bonkovsky, H. (1993). „Repression of hepatic δ-aminolevulinate synthase by heme and metalloporphyrins: Relationship to inhibition of heme oxygenase”. Hepatology. 18: 119—127. PMID 8325603. doi:10.1002/hep.1840180119.
- Lathrop, J. T.; Timko, M. P. (1993). „Regulation by heme of mitochondrial protein transport through a conserved amino acid moti”. Science. 259: 522—525. PMID 8424176. doi:10.1126/science.8424176.
- Bhasker, C. R.; Burgiel, G.; Neupert, B.; Emery-Goodman, A.; Kuhn, L. C.; May, B. K. (1993). „The Putative Iron-Responsive Element in the Human Erythroid 5-Aminolevulinate Synthase mRNA Mediates Translational Control” (PDF). JBC. 268: 12699—12705. PMID 8509404.
- Serfass, L.; Burstyn, J. (1998). „Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity”. Arch. Biochem. Biophys. 359: 8—16. PMID 9799554. doi:10.1006/abbi.1998.0887.
- Luo, D.; Vincent, S. (1994). „Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo”. Eur. J. Pharmacol.-Mol. Pharmacol. Sec. 267: 263—267. PMID 7522180. doi:10.1016/0922-4106(94)90149-X.
- Mariotto, S.; Cuzzolin, L.; Adami, A.; DelSoldato, P.; Suzuki, H.; Benoni, G. (1995). „Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils”. Brit. J. Pharmacol. 114: 1105—1106. PMID 7542530. doi:10.1111/j.1476-5381.1995.tb13320.x.
- Vickroy, T.; Malphurs, W. (1995). „Inhibition of nitric oxide synthase activity in cerebral cortical synaptosomes by nitric oxide donors: evidence for feedback autoregulation”. Neurochem. Res. 20: 299—304. PMID 7541898. doi:10.1007/BF00969546.
- Perry, J.; Marletta, M. (1998). „Effects of transition metals on nitric oxide synthase catalysis”. PNAS. 95: 11101—11106. PMID 9736696. doi:10.1073/pnas.95.19.11101.
- Persechini A, McMillan K, Masters BS (1995). „Inhibition of Nitric Oxide Synthase Activity by Zn2+ Ion”. Biochemistry. 34: 15091—15095. PMID 7578122. doi:10.1021/bi00046a015.
- Siegfried, G.; Amiel, C.; Friedlander, G. (1996). „Inhibition of Ecto-5′-nucleotidase by Nitric Oxide Donors”. J. Biol. Chem. 271: 4659—4664. PMID 8617729.
- Thomas, S.; Mohr, D.; Stocker, R. (1994). „Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes” (PDF). J. Biol. Chem. 269: 14457—14464. PMID 7514170.
- Nicolaou, A.; Waterfield, C.; Kenyon, S.; Gibbons, W. (1997). „The Inactivation of Methionine Synthase in Isolated Rat Hepatocytes by Sodium Nitroprusside”. Eur. J. Biochem. 244: 8876—882. PMID 9108260. doi:10.1111/j.1432-1033.1997.00876.x.
- Sato, T.; Kamata, Y.; Irifune, M.; Nishikawa, T. (1995). „Inhibition of purified (Na+,K+)-ATPase activity from porcine cerebral cortex by NO generating drugs”. Brain Res. 704: 117—120. PMID 8750971. doi:10.1016/0006-8993(95)01165-X.
- Bredt, D. S.; Snyder, S. H. (1992). „Nitric oxide, a novel neuronal messenger”. Neuron. 8: 3—11. PMID 1370373. doi:10.1016/0896-6273(92)90104-L.
- Jaffrey, S. R.; Snyder, S. H. (1996). „PIN: An associated protein inhibitor of neuronal nitric oxide synthase”. Science. 274: 774—777. PMID 8864115. doi:10.1126/science.274.5288.774.
- Marletta, M. A. (1994). „Nitric oxide synthase: Aspects concerning structure and catalysis” (PDF). Cell. 78: 927—930. PMID 7522970. doi:10.1016/0092-8674(94)90268-2.
- Moore, P. K.; Handy, R. L. C. (1997). „Selective inhibitors of neuronal nitric oxide synthase – is no NOS really good NOS for the nervous system?”. Trends Pharm. Sci. 18: 204— 211. PMID 9226999. doi:10.1016/S0165-6147(97)01064-X.
- Bredt, D. S.; Snyder, S. H. (1990). „Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme”. PNAS. 87: 682—685. PMID 1689048. doi:10.1073/pnas.87.2.682.
- Weiss, G.; Lutton, J.; Fuchs, D.; Wernerfelmayer, G.; Bock, G.; Abraham, N.; Kappas, A.; Levere, R.; Wachter, H. (1993). „Comparative Effects of Heme and Metalloporphyrins on Interferon-γ-Mediated Pathways in Monocytic Cells (THP-1)”. Proc. Soc. Exp. Biol. Med. 202: 470—475. PMID 8456113. doi:10.3181/00379727-202-43561.
- Meffert, M.; Haley, J.; Schulman, E.; Schulman, H.; Madison, D. (1994). „Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins”. Neuron. 13: 1225—1233. PMID 7524564. doi:10.1016/0896-6273(94)90060-4.
- Bing, O.; Grundemar, L.; Ny, L.; Moller, C.; Heilig, M. (1995). „Modulation of carbon monoxide production and enhanced spatial learning by tin protoporphyrin”. Neuroreport. 6: 1369—1372. PMID 7488726. doi:10.1097/00001756-199507100-00002.
- Supuran CT, Scozzafava A, Saramet I, Banciu MD (1998). „Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes”. J. Enzyme Inhib. 13: 177—194. PMID 9629536. doi:10.3109/14756369809028339.
- Turkmen H, Durgun M, Yilmaztekin S, Emul M, Innocenti A, Vullo D, Scozzafava A, Supuran CT (1997). „Carbonic anhydrase inhibitors. Part 50. Interaction of isoenzymes I and II of carbonic anhydrase with Ge(IV) and Sb(III) derivatives”. Main Group Met. Chem. 20: 641—647. PMID 15603956. doi:10.1016/j.bmcl.2004.10.070.
- Abrams MJ, Murrer BA (1993). „Metal compounds in therapy and diagnosis”. Science. 261: 725—730. PMID 8102010. doi:10.1126/science.8102010.
- Abrams MJ, Murrer BA (1993). „Metal compounds in therapy and diagnosis”. Science. 261: 725—730. PMID 8102010. doi:10.1126/science.8102010.
- Sly WS, Hu PY (1995). „Human carbonic anhydrases and carbonic anhydrase deficiencies”. Annu. Rev. Biochem. 64: 375—401. PMID 7574487. doi:10.1146/annurev.bi.64.070195.002111.
- Bergenhem, N. (1996). „Chromatographic and electrophoretic methods related to the carbonic anhydrase isozymes”. J. Chromatogr. B. 684: 289—305. PMID 8906478. doi:10.1016/0378-4347(95)00566-8.
- Heagerty, A. M. (1991). „Functional and structural effects of ACE inhibitors on the cardiovascular system”. Cardiology. 79: 3—9. PMID 1913721. doi:10.1159/000174899.
- Kureya, P.; Beevers, D. G. (1991). „The mechanisms of hypertension and the role of ACE inhibitors”. J. Human Hypertension. 5: 3—8. PMID 1791616.
- Bagger, S. (1993). „The binding of cobalt(III)-ligated amino acids and peptides to chymotrypsin and trypsin”. J. Inorg. Biochem. 52: 165—171. PMID 8254339.
- Bagger, S.; Wagner, K. J. (1998). „Molecular recognition of cobalt(III)-ligated peptides by serine proteases: the role of electrostatic effects”. Peptide Res. 52: 273—282. PMID 9832305. doi:10.1111/j.1399-3011.1998.tb01241.x.
- Takeuchi, T.; Böttcher, A.; Quezada, C. M.; Meade, T. J.; Gray, H. B. (1999). „Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes”. Bioorg. Med. Chem. 6: 1—5. PMID 10400334.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1992). „Identification of serine and histidine adducts in complexes of trypsin and trypsinogen with peptide and nonpeptide boronic acid inhibitors by proton NMR spectroscopy”. Biochemistry. 31: 12839—12846. PMID 1463754. doi:10.1021/bi00166a019.
- Tsilikounas, E.; Kettner, C.; Bachovchin, W. (1993). „Boron-11 NMR spectroscopy of peptide boronic acid inhibitor complexes of .alpha.-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes”. Biochemistry. 32: 12651—12655. PMID 8251483. doi:10.1021/bi00210a013.
- Geratz, J.; Tidwell, R.; Schwab, J.; Anderle, S.; Pryzwansky, K. (1990). „Sequential events in the pathogenesis of streptococcal cell wall-induced arthritis and their modulation by bis(5-amidino-2-benzimidazolyl)methane (BABIM)”. Am. J. Pathol. 136: 909—921. PMID 2327474.
- Katz, B.; Clark, J.; Finer-Moore, J.; Jenkins, T.; Johnson, C.; Ross, M.; Luong, C.; Moore, W.; Stroud, R. (1998). „Design of potent selective zinc-mediated serine protease inhibitors”. Nature. 391: 608—612. PMID 9468142. doi:10.1038/35422.
- Rice, K.; Tanaka, R.; Katz, B.; Numerof, R.; Moore, W. (1998). „Inhibitors of tryptase for the treatment of mast cell-mediated diseases”. Curr. Pharm. Des. 4: 381—396. PMID 10197050.
- Thorpe, H. H. (1998). „Bioinorganic chemistry and drug design: here comes zinc again”. Chem. Biol. 5: R125—R127. PMID 9653544. doi:10.1016/S1074-5521(98)90166-1.
- Duffy, B.; Schwietert, C.; France, A.; Mann, N.; Culbertson, K.; Harmon, B.; McCue, J. P. (1998). „Transition metals as protease inhibitors”. Biol. Trace Element Res. 64: 197—213. PMID 9845474. doi:10.1007/BF02783336.
- Duffy, B.; Schwietert, C.; France, A.; Mann, N.; Culbertson, K.; Harmon, B.; McCue, J. P. (1998). „Transition metals as protease inhibitors”. Biol. Trace Element Res. 64: 197—213. PMID 9845474. doi:10.1007/BF02783336.
- Babine, R. E.; Bender, S. L. (1997). „Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design”. Chem. Rev. 97: 1359—1472. PMID 11851455. doi:10.1021/cr960370z.
- Bone, R.; Frank, D.; Kettner, C. A.; Agard, D. A. (1989). „Structural analysis of specificity: .alpha.-lytic protease complexes with analogs of reaction intermediates”. Biochemistry. 28: 7600—7609. PMID 2611204. doi:10.1021/bi00445a015.
- Louie, A. Y.; Meade, T. J. (1998). „A cobalt complex that selectively disrupts the structure and function of zinc fingers”. PNAS. 95: 6663—6668. PMID 9618469. doi:10.1073/pnas.95.12.6663.
- Clauberg, M.; Joshi, J. G. (1993). „Regulation of serine protease activity by aluminum: implications for Alzheimer disease”. Proc. Natl. Acad. Sci. U.S.A. 90: 1009—1012. PMID 7679214.
- Rao, K. S. J.; Rao, G. V. (1994). „Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study”. Mol. Cell. Biochem. 137: 57—60. PMID 7845378. doi:10.1007/BF00926039.
- Nixon, R. A.; Clarke, J. F.; Logvinenko, K. B.; Tan, M. K. H.; Hoult, M.; Grynspan, F. (1990). „Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes”. J. Neurochem. 55: 1950—1959. PMID 2121904. doi:10.1111/j.1471-4159.1990.tb05781.x.
- Joshi, J. G.; Dhar, M.; Clauberg, M.; Chauthaiwale, V. (1994). „Iron and aluminum homeostasis in neural disorders”. Environ. Health Perspect. 102: 207—213. PMID 7843099. doi:10.2307/3431788.
- Lee, B. H.; Park, M. B.; Yu, B. S. (1998). „Inhibition of electric eel acetylcholinesterase by porphin compounds”. Bioinorg. Med. Chem. Lett. 8: 1467—1470. PMID 9873371. doi:10.1016/S0960-894X(98)00236-4.
- Lee, B. H.; Park, M. B.; Yu, B. S. (1998). „Inhibition of electric eel acetylcholinesterase by porphin compounds”. Bioinorg. Med. Chem. Lett. 8: 1467—1470. PMID 9873371. doi:10.1016/S0960-894X(98)00236-4.
- Falkous, G.; Harris, J. B.; Mantle, D. (1995). „Effect of neurotoxic metal ions in vitro on proteolytic enzyme activities in human cerebral cortex”. Clin. Chim. Acta. 238: 125—135. PMID 7586572. doi:10.1016/0009-8981(95)06081-N.
- Cuajungco, M. P.; Lees, G. K. (1997). „Zinc metabolism in the brain: relevance to human neurodegenerative disorders”. Neurobiol. Dis. 4: 137—169. PMID 9361293. doi:10.1006/nbdi.1997.0163.
- Atwood, C. S.; Moir, R. D.; Huang, X. D.; Scarpa, R. C.; Bacarra, N. M. E.; Romano, D. M.; Hartshorn, M. K.; Tanzi, R. E.; Bush, A. I. (1998). „Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis”. J. Biol. Chem. 273: 12817—12826. PMID 9582309. doi:10.1074/jbc.273.21.12817.
- Fitzgerald, D. J.; Maggio, J. E.; Esler, W. P.; Stinson, E. R.; Jennings, J. M.; Ghilardi, J. R.; Mantyh, P. W.; Bush, A. I.; Moir, R. D.; Rosenkranz, K. M.; Tanzi, R. E. (1995). „Zinc and Alzheimer's disease”. Science. 268: 1920—1923. PMID 7604268.
- Mantyh, P. W.; Ghilardi, J. R.; Rogers, S.; Demaster, E.; Allen, C. J.; Stimson, E. R.; Maggio, J. E. (1993). „Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide”. J. Neurochem. 61: 1171—1174. PMID 8360682. doi:10.1111/j.1471-4159.1993.tb03639.x.
- Huang, X. D.; Atwood, C. S.; Moir, R. D.; Hartshorn, M. A.; Vonsattel, J. P.; Tanzi, R. E.; Bush, A. I. (1997). „Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors”. J. Biol. Chem. 272: 26464—26470. PMID 9334223. doi:10.1074/jbc.272.42.26464.
- Bush, A. I.; Pettingell, W. H.; Multhaup, G.; Paradis, M. D.; Vonsattel, J. P.; Gusella, J. F.; Beyreuther, K.; Masters, C. L.; Tanzi, R. E. (1994). „Rapid induction of Alzheimer A beta amyloid formation by zinc”. Science. 265: 1464—1467. PMID 8073293.
- Dyrks, T.; Dyrks, E.; Hartmann, T.; Masters, C.; Beyreuther, K. (1992). „Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation” (PDF). J. Biol. Chem. 267: 18210—18217. PMID 1517249.
- Bondy, S. C.; Guo-Ross, S. X.; Truong, A. T. (1998). „Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid”. Brain Res. 799: 91—96. PMID 9666089. doi:10.1016/S0006-8993(98)00461-2.
- Cuajungco, M. P.; Lees, G. (1997). „Zinc and Alzheimer's disease: is there a direct link?”. J. Brain Res. Rev. 23: 219—236. PMID 9164672. doi:10.1016/S0165-0173(97)00002-7.
- Sugumoto, H.; Iimura, Y.; Yamanishi, Y.; Yamatsu, K. (1995). „Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds”. J. Med. Chem. 38: 4821—4829. PMID 7490731. doi:10.1021/jm00024a009.
- Danning, C. L.; Boumpas, D. T. (1998). „Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis: an update on mechanisms of action”. Clin. Exp. Rheumatol. 16: 595—604. PMID 9779311.
- Hashimoto, K.; Whitehurst, C. E.; Matsubara, T.; Hirohata, K.; Lipsky, P. E. (1992). „Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C”. J. Clin. Invest. 89: 1839—1848. PMID 1351061. doi:10.1172/JCI115788.
- Zhang, Z. Y.; Reardon, I. M.; Hui, J. O.; O’Connell, K. L.; Poorman, R. A.; Heinrikson, R. L. (1991). „Zinc inhibition of renin and the protease from human immunodeficiency virus type 1”. Biochemistry. 30: 8717—8721. PMID 1888732. doi:10.1021/bi00100a001.
- Hall, I. H.; Chen, S. Y.; Rajendran, K. G.; Sood, A.; Spielvogel, B. F.; Shih, J. (1994). „Hypolipidemic, anti-obesity, anti-inflammatory, anti-osteoporotic, and anti-neoplastic properties of amine carboxyboranes”. Environ. Health Perspect. 102: 21—30. PMID 7889876. doi:10.2307/3431958.
- Pugh, M. C.; Pugh, C. B. (1987). „Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis”. Clin. Pharm. 6: 475—491. PMID 3319362.
- Baker, D. G.; Rabinowitz, J. L. (1986). „Current concepts in the treatment of rheumatoid arthritis”. J. Clin. Pharmacol. 26: 2—21. PMID 3512617.
- Naughton, D. P.; Knappitt, J.; Fairburn, K.; Gaffney, K.; Blake, D. R.; Grootveld, M. (1995). „Detection and investigation of the molecular nature of low-molecular-mass copper ions in isolated rheumatoid knee-joint synovial fluid”. FEBS Lett. 362: 167—172. PMID 7698317. doi:10.1016/0014-5793(95)00165-6.
- Miche, H.; Brumas, V.; Berthon, G. (1997). „Copper(II) interactions with nonsteroidal antiinflammatory agents. II. Anthranilic acid as a potential. OH-inactivating ligand”. J. Inorg. Biochem. 68: 27—38. PMID 9379178. doi:10.1016/S0162-0134(97)00005-6.
- Menard, H. A.; Amine, M. E. (1996). „The calpain-calpastatin system in rheumatoid arthritis”. Immunol. Today. 17: 545—547. PMID 8991283. doi:10.1016/S0167-5699(96)30064-9.
- Zhang, H.; Johnson, P. (1992). „Differential effects of aluminum ion on smooth muscle calpain I and calpain II activities”. Int. J. Biochem. 24: 1773—1778. PMID 1451912. doi:10.1016/0020-711X(92)90127-M.
- Frolich, J. C. (1997). „A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes”. Trends Pharm. Sci. 18: 30—34. PMID 9114728. doi:10.1016/S0165-6147(96)01017-6.
- Moore, P.; Jones, C.; Mahmood, N.; Evans, I.; Goff, M.; Cooper, R.; Hay, A. (1995). „Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase” (PDF). Biochem. J. 307: 129—134. PMID 7536411.
- Casas, J.; Rodriguez-Arguelles, M.; Russo, U.; Sanchez, A.; Sordo, J.; Vazquez-Lopez, A.; Pinelli, S.; Lunghi, P.; Bonati, A.; Albertini, R. (1998). „Diorganotin(IV) complexes of pyridoxal thiosemicarbazone: synthesis, spectroscopic properties and biological activity”. J. Inorg. Biochem. 69: 283—292. PMID 9654752. doi:10.1016/S0162-0134(98)00004-X.
- Chamorro, C.; Camarasa, M. J.; Perez-Perez, M. J.; Clercq, E. D.; Balzarini, J.; Felix, A. S. (1998). „An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase”. Antiviral Chem. Chemother. 9: 413—423. PMID 9875394.
- Nacsa, J.; Nagy, L.; Molnar, J.; Molnar, J. (1998). „Trifluoperazine and its metal complexes inhibit the Moloney leukemia virus reverse transcriptase”. Anticancer Res. 18: 1373—1376. PMID 9673343.
- Nacsa, J.; Nagy, L.; Molnar, J.; Molnar, J. (1998). „Trifluoperazine and its metal complexes inhibit the Moloney leukemia virus reverse transcriptase”. Anticancer Res. 18: 1373—1376. PMID 9673343.
- Woon, T.; Brinkworth, R.; Fairlie, D. (1992). „Inhibition of HIV-1 proteinase by metal ions”. Int. J. Biochem. 24: 911—914. PMID 1612181. doi:10.1016/0020-711X(92)90096-J.
- Davis, D. A.; Branca, A. A.; Pallenberg, A. J.; Marschner, T. M.; Patt, L. M.; Chatlynne, L. G.; Humphrey, R. W.; Yarchoan, R.; Levine, R. L. (1995). „Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+”. Arch. Biochem. Biophys. 322: 127—134. PMID 7574666. doi:10.1006/abbi.1995.1444.
- York, D. M.; Darden, T. A.; Pedersen, L. G.; Anderson, M. W. (1993). „Molecular modeling studies suggest that zinc ions inhibit HIV-1 protease by binding at catalytic aspartates”. Environ. Health Perspect. 101: 246—250. PMID 8404763.
- Mazumder, A.; Gupta, M.; Perrin, D. M.; Sigman, C. S.; Ranbinovitz, M.; Pommier, Y. (1995). „Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor”. AIDS Res. Hum. Retroviruses. 11: 1. PMID 7734182. doi:10.1089/aid.1995.11.1.
- Farnet, C. M.; Wang, B.; Hansen, M.; Lipford, J. R.; Zalkow, L.; Robinson, W. E. J.; Siegel, J.; Bushman, F. (1998). „Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism”. Antimicrob. Agents Chemother. 42: 2245—2253. PMID 9736543.
- LaFemina, R. L.; Schneider, C. L.; Robbins, H. L.; Callahan, P. L.; LeGrow, K.; Roth, E.; Schleif, W. A.; Emini, E. A. (1992). „Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells”. J. Virol. 66: 7414—7419. PMID 1433523.
- Tarrago-Litvak, L.; Andreola, M.; Nevinsky, G. A.; Sarih-Cottin, L.; Litvak, S. (1994). „The reverse transcriptase of HIV-1: from enzymology to therapeutic intervention”. FASEB J. 18: 497—503. PMID 7514143.
- Huang, H.; Chopra, R.; Verdine, G. L.; Harrison, S. C. (1998). „Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance”. Science. 282: 1669—1675. PMID 9831551. doi:10.1126/science.282.5394.1669.
- Ferrari, M. B.; Fava, G. G.; Tarasconi, R.; Albertini, S.; Pinelli, R.; Starcich, J. (1994). „Synthesis, spectroscopic and structural characterization, and biological activity of aquachloro (pyridoxal thiosemicarbazone) copper(II) chloride”. J. Inorg. Biochem. 53: 13. PMID 8133248. doi:10.1016/0162-0134(94)80017-0.
- Ferrari, M. B.; Fava, G. G.; Tarasconi, R.; Albertini, S.; Pinelli, R.; Starcich, J. (1994). „Synthesis, spectroscopic and structural characterization, and biological activity of aquachloro (pyridoxal thiosemicarbazone) copper(II) chloride”. J. Inorg. Biochem. 53: 13. PMID 8133248. doi:10.1016/0162-0134(94)80017-0.
- Das K, Bauman JD, Rim AS, Dharia C, Clark AD Jr, Camarasa MJ, Balzarini J, Arnold E (28. 04. 2011). „Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket”. J Med Chem. 54 (8): 2727—37. PMID 21446702. doi:10.1021/jm101536x.
- Spence, R. A.; Kati, W. M.; Anderson, K. S.; Johnson, K. A. (1995). „Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors”. Science. 267: 988—993. PMID 7532321. doi:10.1038/nsb0495-303.
- West, M. L.; Fairlie, D. P. (1995). „Targeting HIV-1 protease: a test of drug-design methodologies”. Trends Pharmacol. Sci. 16: 67—75. PMID 7762084. doi:10.1016/S0165-6147(00)88980-4.
- Serra, M.; Pintar, A.; Casella, L.; Sabbioni, E. (1992). „Vanadium effect on the activity of horseradish peroxidase, catalase, glutathione peroxidase, and superoxide dismutase in vitro”. J. Inorg. Biochem. 46: 161—174. PMID 1325536. doi:10.1016/0162-0134(92)80027-S.
- Karlstrom, A. R.; Levine, R. L. (1991). „Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms” (PDF). PNAS. 88: 5552—5556. PMC 51915 .
- Hazuda, D. J.; Felock, P. J.; Hastings, J. C.; Prmanik, B.; Wolfe, A. L. (1997). „Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase” (PDF). J. Virol. 71: 7005—7011. PMID 9261430.
- Wells, T. N. C.; Scully, P.; Paravicini, G.; Proudfoot, A. E. I.; Payton, M. A. (1995). „Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine”. Biochemistry. 34: 7896—7903. PMID 7794901. doi:10.1021/bi00024a014.
- Cunningham, M. L.; Zvelebil, M. J. J. M.; Fairlamb, A. H. (1994). „Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals”. Eur. J. Biochem. 221: 285—295. PMID 8168518. doi:10.1111/j.1432-1033.1994.tb18740.x.
- Saha, A. K.; Crans, D. C.; Pope, M. T.; Simone, C. M.; Glew, R. H. (1991). „Inhibition of human seminal fluid and Leishmania donovani phosphatases by molybdate heteropolyanions” (PDF). J. Biol. Chem. 266: 3511—3517. PMID 1995614.
- Yano, S.; Inoue, S.; Nouchi, R.; Mogami, K.; Shinohara, Y.; Yasuda, Y.; Kato, M.; Tanase, T.; Kakuchi, T.; Mikata, Y.; Suzuki, T.; Yamamoto, Y. (1998). „Antifungal nickel(II) complexes derived from amino sugars against pathogenic yeast, Candida albicans”. J. Inorg. Biochem. 69: 15—23. PMID 9606935.
- Su, J. J.; Mansour, J. M.; Mansour, T. E. (1996). „Purification, kinetics and inhibition by antimonials of recombinant phosphofructokinase from Schistosoma mansoni”. Mol. Biochem. Parasitol. 81: 171—178. PMID 8898332. doi:10.1016/0166-6851(96)02702-8.
- Saenz, R. E.; Rodriguez, C. C. D.; Johnson, C. M.; Berman, J. D. (1991). „Efficacy and toxicity of pentostam against Panamanian mucosal leishmaniasis”. Am. J. Trop. Med. 44: 394—398. PMID 1645930.
- Meyer-Fernandes, J. R.; Dutra, P. M. L.; Rodrigues, C. O.; Saad-Nehme, J.; Lopes, A. H. C. S. (1997). „Mg-dependent ecto-ATPase activity in Leishmania tropica”. Arch. Biochem. Biophys. 341: 40—46. PMID 9143351.
- Fairlamb, A. H.; Henderson, G. B.; Cerami, A. (1989). „Trypanothione is the primary target for arsenical drugs against African trypanosomes” (PDF). PNAS. 86: 2607—2611. PMID 2704738.
- Tsai, H.; Dwarakanath, A.; Hart, C.; Milton, J.; Rhodes, J. (1995). „Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment” (PDF). Gut. 36: 570—576. PMID 7737566.
- Beil, W.; Birkholz, C.; Wagner, S.; Sewing, K. (1995). „Bismuth subcitrate and omeprazole inhibit Helicobacter pyloriF1-ATPase”. Pharmacology. 50: 333—337. PMID 7667394. doi:10.1159/000139299.
- Schroeder, T.; Caspers, M. (1996). „Kinetics of aluminum-induced inhibition of delta-aminolevulinic acid dehydratase in vitro”. Biochem. Pharmacol. 52: 927—931. PMID 8781512. doi:10.1016/0006-2952(96)00449-2.
- Exley, C.; Price, N.; Birchall, J. (1994). „Aluminum inhibition of hexokinase activity in vitro: a study in biological availability”. J. Inorg. Biochem. 54: 297—304. PMID 8014638. doi:10.1016/0162-0134(94)80035-9.
- Canesi, L.; Ciacci, C.; Piccoli, G.; Stocchi, V.; Viarengo, A.; Gallo, G. (1998). „In vitro and in vivo effects of heavy metals on mussel digestive gland hexokinase activity: the role of glutathione”. Comp. Biochem. Physiol. C. 120 (2): 261—268. PMID 9827040. doi:10.1016/S0742-8413(98)10004-X.
- Yager, J. W.; Wiencke, J. K. (1997). „Inhibition of poly(ADP-ribose) polymerase by arsenite”. Mutat. Res. 386: 345—351. PMID 9219571. doi:10.1016/S1383-5742(97)00011-2.
- Hu, Y.; Su, L.; Snow, E. T. (1998). „Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes”. Mutat. Res. 408: 203—218. PMID 9806419. doi:10.1016/S0921-8777(98)00035-4.
- Tsao, D.; Maki, A. (1991). „Optically detected magnetic resonance study of the interaction of an arsenic(III) derivative of cacodylic acid with EcoRI methyltransferase”. Biochemistry. 30: 4565—4572. PMID 2021649. doi:10.1021/bi00232a029.
- Lam, W.; Tsao, D.; Maki, A.; Maegley, K.; Reich, N. (1992). „Spectroscopic studies of arsenic(III) binding to Escherichia coli RI methyltransferase and to two mutants, C223S and W183F”. Biochemistry. 31: 10438—10442. PMID 1420162. doi:10.1021/bi00158a004.
- Styblo, M.; Thomas, D. (1995). „In vitro inhibition of glutathione reductase by arsenotriglutathione”. Biochem. Pharmacol. 49: 971—977. PMID 7741769. doi:10.1016/0006-2952(95)00008-N.
- Chawla, S.; Mutenda, E.; Dixon, H.; Freeman, S.; Smith, A. (1995). „Synthesis of 3-arsonopyruvate and its interaction with phosphoenolpyruvate mutase”. Biochem. J. 308: 931—935. PMID 8948453.
- Snow, E.; Xu, L.; Kinney, P. (1993). „Effects of nickel ions on polymerase activity and fidelity during DNA replication in vitro”. Chem.-Biol. Interact. 88: 155—173. PMID 8403077. doi:10.1016/0009-2797(93)90089-H.
- Yang, S. W.; Becker, F. F.; Chan, J. Y. H. (1996). „Inhibition of human DNA ligase I activity by zinc and cadmium and the fidelity of ligation”. Environ. Health Perspect. 28: 19—25. PMID 8698042. doi:10.1002/(SICI)1098-2280(1996)28:1<19::AID-EM5>3.0.CO;2-9.
- Hartwig, A. (1994). „Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review”. Environ. Health Perspect. 102: 45—50. PMID 7843136. doi:10.2307/3431762.
- Hartwig, A. (1994). „Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review”. Environ. Health Perspect. 102: 45—50. PMID 7843136. doi:10.2307/3431762.
- Porter, D. W.; Nelson, V. C.; Fivash, M. J. J.; Kasprzak, K. S. (1996). „Mechanistic studies of the inhibition of MutT dGTPase by the carcinogenic metal Ni(II)”. Chem. Res. Toxicol. 9: 1375—1381. PMID 8951243. doi:10.1021/tx9600816.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
- Thiele, D. J. (1992). „Metal-regulated transcription in eukaryotes” (PDF). Nuc. Acids Res. 20: 1183—1191. PMID 1561077.
- O’Halloran, T. V. (1993). „Transition metals in control of gene expression”. Science. 261: 715—725. PMID 8342038. doi:10.1126/science.8342038.
osu.edu
chemistry.osu.edu
- Holdgate, GA (2001). „Making cool drugs hot: isothermal titration calorimetry as a tool to study binding energetics” (PDF). BioTechniques. 31 (1): 164—6, 168, 170. PMID 11464510.
oxfordjournals.org
nar.oxfordjournals.org
- Thiele, D. J. (1992). „Metal-regulated transcription in eukaryotes” (PDF). Nuc. Acids Res. 20: 1183—1191. PMID 1561077.
- Thiele, D. J. (1992). „Metal-regulated transcription in eukaryotes” (PDF). Nuc. Acids Res. 20: 1183—1191. PMID 1561077.
ceaccp.oxfordjournals.org
- V Priya Nair; Jennifer M Hunter (2004). „Anticholinesterases and anticholinergic drugs”. Contin Educ Anaesth Crit Care Pain. 4 (5): 164—168. doi:10.1093/bjaceaccp/mkh045.
paperity.org
- Zhuo, S.; Dixon, J. E. (1997). „Effects of sulfhydryl regents on the activity of lambda Ser/Thr phosphoprotein phosphatase and inhibition of the enzyme by zinc ion”. Protein Eng. 10: 1445—1452. PMID 9543006.
plantphysiol.org
- Leonard L. Saari; Josephine C. Cotterman; Michael M. Primiani (1990). „Mechanism of Sulfonylurea Herbicide Resistance in the Broadleaf Weed, Kochia scoparia” (PDF). Plant Physiology. 93 (1): 55—61. PMID 16667465.
- SI, Beale (1990). „Biosynthesis of the Tetrapyrrole Pigment Precursor, delta-Aminolevulinic Acid, from Glutamate”. Plant Physiol. 93 (4): 1273—9. PMC 1062668 . PMID 16667613. doi:10.1104/pp.93.4.1273.
pnas.org
- Hans Neurath; Kenneth A. Walsh (1976). „Biochemistry Role of proteolytic enzymes in biological regulation (A Review) (limited proteolysis/zymogen activation/control mechanisms)” (PDF). Proc. Natl. Acad. Sci. USA. 73 (11): 3825—3832.
- Hallen, H.; Luo; J.S. Scott-Craig; J.D. Walton (2007). „A gene family encoding the major toxins of lethal Amanita mushrooms.”. Proceedings of the National Academy of Sciences of the United States of America. 104 (48): 19097—19101. PMC 2141914 . PMID 18025465. doi:10.1073/pnas.0707340104.
- Maret, W.; Jacob, C.; Vallee, B. L.; Fischer, E. H. (1999). „Inhibitory sites in enzymes: Zinc removal and reactivation by thionein”. Proc. Natl. Acad. Sci. 96: 1936—1940. PMID 10051573. doi:10.1073/pnas.96.5.1936.
- Takahashi, A.; Alnemri, E. S.; Lazebnik, Y. A.; Fernandes-Alnemri, T.; Litwack, G.; Moir, R. D.; Goldman, R. D.; Poirier, G. G.; Kaufmann, S. G.; Earnshaw, W. C. (1996). „Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis”. PNAS. 93: 8395—8400. PMID 38682.
- Perry, J.; Marletta, M. (1998). „Effects of transition metals on nitric oxide synthase catalysis”. PNAS. 95: 11101—11106. PMID 9736696. doi:10.1073/pnas.95.19.11101.
- Bredt, D. S.; Snyder, S. H. (1990). „Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme”. PNAS. 87: 682—685. PMID 1689048. doi:10.1073/pnas.87.2.682.
- Karlstrom, A. R.; Levine, R. L. (1991). „Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms” (PDF). PNAS. 88: 5552—5556. PMC 51915 .
- Fairlamb, A. H.; Henderson, G. B.; Cerami, A. (1989). „Trypanothione is the primary target for arsenical drugs against African trypanosomes” (PDF). PNAS. 86: 2607—2611. PMID 2704738.
- Perry, J.; Marletta, M. (1998). „Effects of transition metals on nitric oxide synthase catalysis”. PNAS. 95: 11101—11106. PMID 9736696. doi:10.1073/pnas.95.19.11101.
- Bredt, D. S.; Snyder, S. H. (1990). „Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme”. PNAS. 87: 682—685. PMID 1689048. doi:10.1073/pnas.87.2.682.
- Karlstrom, A. R.; Levine, R. L. (1991). „Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms” (PDF). PNAS. 88: 5552—5556. PMC 51915 .
- Fairlamb, A. H.; Henderson, G. B.; Cerami, A. (1989). „Trypanothione is the primary target for arsenical drugs against African trypanosomes” (PDF). PNAS. 86: 2607—2611. PMID 2704738.
proquest.com
search.proquest.com
- Hsu, JT; Wang, HC; Chen, GW; Shih, SR (2006). „Antiviral drug discovery targeting to viral proteases”. Current pharmaceutical design. 12 (11): 1301—14. PMID 16611117. doi:10.2174/138161206776361110.
- Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD, Schwartzman ML (1989). „Treatment with Tin Prevents the Development of Hypertension in Spontaneously Hypertensive Rats”. Science. 243: 388—90. PMID 2492116.
- Jaffrey, S. R.; Snyder, S. H. (1996). „PIN: An associated protein inhibitor of neuronal nitric oxide synthase”. Science. 274: 774—777. PMID 8864115. doi:10.1126/science.274.5288.774.
- Jaffrey, S. R.; Snyder, S. H. (1996). „PIN: An associated protein inhibitor of neuronal nitric oxide synthase”. Science. 274: 774—777. PMID 8864115. doi:10.1126/science.274.5288.774.
pubfacts.com
- Bogoyevitch, MA; Barr, RK; Ketterman, AJ (2005). „Peptide inhibitors of protein kinases-discovery, characterisation and use”. Biochimica et Biophysica Acta. 1754 (1—2): 79—99. PMID 16182621. doi:10.1016/j.bbapap.2005.07.025.
- S., Dreon M.; Ituarte S.; Heras H. (2010). „The Role of the Proteinase Inhibitor Ovorubin in Apple Snail Eggs Resembles Plant Embryo Defense against Predation”. PLoS ONE. 5 (12): e15059. PMID 21151935. doi:10.1371/journal.pone.0015059.
- Böni, R. E.; Boni, R. A.; Galbraith, R. A.; Drummond, G. S.; Kappas, A. (1993). „Tin-mesoporphyrin inhibits heme oxygenase activity and heme-iron absorption in the intestine”. Pharmacology. 47: 318—329. PMID 8265722.
pubpdf.com
- Oblender, M.; Carpentieri, U. (1990). „Effects of iron, copper and zinc on the activity of ribonucleotide reductase in normal and leukemic human lymphocytes”. Anticancer Res. 10: 123—128. PMID 2185685.
rcin.org.pl
- Wisniewski, M. Z.; Surga, W. J.; Piekos, R. (1995). „Silver(I) compounds of some sulfonamides”. Polish J. Chem. 69: 987—991.
- Wisniewski, M. Z.; Surga, W. J.; Piekos, R. (1995). „Silver(I) compounds of some sulfonamides”. Polish J. Chem. 69: 987—991.
researchgate.net
- Lew W, Chen X, Kim CU (2000). „Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor”. Curr. Med. Chem. 7 (6): 663—72. PMID 10702632. doi:10.2174/0929867003374886.
- PM, Fischer (2003). „The design, synthesis and application of stereochemical and directional peptide isomers: a critical review”. Curr. Protein Pept. Sci. 4 (5): 339—56. PMID 14529528. doi:10.2174/1389203033487054.
- Silvaggi, N.R.; Josephine, H.R.; Kuzin, A.P.; Nagarajan, R.; Pratt, R.F.; Kelly, J.A. (2005). „Crystal structures of complexes between the R61 DD-peptidase and peptidoglycan-mimetic beta-lactams: a non-covalent complex with a "perfect penicillin"”. J.Mol.Biol. 345: 521—533. PMID 15581896. doi:10.1016/j.jmb.2004.10.076.
- Ganeva, R. L.; Spassovska, N. C.; Genchev, D. D. J. (1991). „The effect of some platinum compounds on the activity of the CTP synthetase of Ehrlich ascites tumor cells: in vitro and in vivo studies”. Inorg. Biochem. 43: 717—722. PMID 1779227. doi:10.1016/0162-0134(91)80042-G.
- West, D. X.; Liberta, A. E. (1993). „The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxides”. Coord. Chem. Rev. 123: 49— 71. PMID 8098234.
- Cha, J.; Pedersen, M. V.; Auld, D. S. (1996). „Metal and pH dependence of heptapeptide catalysis by human matrilysin”. Biochemistry. 35: 15831—13838. PMID 8961947. doi:10.1021/bi962085f.
- Bagger, S. (1993). „The binding of cobalt(III)-ligated amino acids and peptides to chymotrypsin and trypsin”. J. Inorg. Biochem. 52: 165—171. PMID 8254339.
- Takeuchi, T.; Böttcher, A.; Quezada, C. M.; Meade, T. J.; Gray, H. B. (1999). „Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes”. Bioorg. Med. Chem. 6: 1—5. PMID 10400334.
- Rice, K.; Tanaka, R.; Katz, B.; Numerof, R.; Moore, W. (1998). „Inhibitors of tryptase for the treatment of mast cell-mediated diseases”. Curr. Pharm. Des. 4: 381—396. PMID 10197050.
- Duffy, B.; Schwietert, C.; France, A.; Mann, N.; Culbertson, K.; Harmon, B.; McCue, J. P. (1998). „Transition metals as protease inhibitors”. Biol. Trace Element Res. 64: 197—213. PMID 9845474. doi:10.1007/BF02783336.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
- Bagger, S. (1993). „The binding of cobalt(III)-ligated amino acids and peptides to chymotrypsin and trypsin”. J. Inorg. Biochem. 52: 165—171. PMID 8254339.
- Takeuchi, T.; Böttcher, A.; Quezada, C. M.; Meade, T. J.; Gray, H. B. (1999). „Inhibition of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes”. Bioorg. Med. Chem. 6: 1—5. PMID 10400334.
- Rice, K.; Tanaka, R.; Katz, B.; Numerof, R.; Moore, W. (1998). „Inhibitors of tryptase for the treatment of mast cell-mediated diseases”. Curr. Pharm. Des. 4: 381—396. PMID 10197050.
- Duffy, B.; Schwietert, C.; France, A.; Mann, N.; Culbertson, K.; Harmon, B.; McCue, J. P. (1998). „Transition metals as protease inhibitors”. Biol. Trace Element Res. 64: 197—213. PMID 9845474. doi:10.1007/BF02783336.
- Duffy, B.; Schwietert, C.; France, A.; Mann, N.; Culbertson, K.; Harmon, B.; McCue, J. P. (1998). „Transition metals as protease inhibitors”. Biol. Trace Element Res. 64: 197—213. PMID 9845474. doi:10.1007/BF02783336.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
- Wetmur, J. G. (1994). „Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden”. Environ. Health Perspect. 102: 215—219. PMID 7843101. doi:10.2307/3431789.
rsc.org
pubs.rsc.org
- Gonzalez, E. B.; Farkas, E.; Soudi, A. A.; Tan, T.; Yanovsky, A. I.; Nolan, K. B. (1997). „Metal complexes of the angiotensin-converting enzyme inhibitor,lisinopril. Solution studies and the crystal and molecular structure ofa dimeric copper(II)-lisinopril complex”. J. Chem. Soc., Dalton Trans.: 2377—2379. doi:10.1039/A701500C.
- Suenaga, H.; Nakashima, K.; Shinkai, S. (1995). „Sugars intensify the inhibitory effect of phenylboronic acid on the hydrolytic activity of α-chymotrypsin”. J. Chem. Soc., Chem. Commun.: 29—30. doi:10.1039/C39950000029.
- Gonzalez, E. B.; Farkas, E.; Soudi, A. A.; Tan, T.; Yanovsky, A. I.; Nolan, K. B. (1997). „Metal complexes of the angiotensin-converting enzyme inhibitor,lisinopril. Solution studies and the crystal and molecular structure ofa dimeric copper(II)-lisinopril complex”. J. Chem. Soc., Dalton Trans.: 2377—2379. doi:10.1039/A701500C.
- Suenaga, H.; Nakashima, K.; Shinkai, S. (1995). „Sugars intensify the inhibitory effect of phenylboronic acid on the hydrolytic activity of α-chymotrypsin”. J. Chem. Soc., Chem. Commun.: 29—30. doi:10.1039/C39950000029.
sagepub.com
ebm.sagepub.com
- Weiss, G.; Lutton, J.; Fuchs, D.; Wernerfelmayer, G.; Bock, G.; Abraham, N.; Kappas, A.; Levere, R.; Wachter, H. (1993). „Comparative Effects of Heme and Metalloporphyrins on Interferon-γ-Mediated Pathways in Monocytic Cells (THP-1)”. Proc. Soc. Exp. Biol. Med. 202: 470—475. PMID 8456113. doi:10.3181/00379727-202-43561.
- Weiss, G.; Lutton, J.; Fuchs, D.; Wernerfelmayer, G.; Bock, G.; Abraham, N.; Kappas, A.; Levere, R.; Wachter, H. (1993). „Comparative Effects of Heme and Metalloporphyrins on Interferon-γ-Mediated Pathways in Monocytic Cells (THP-1)”. Proc. Soc. Exp. Biol. Med. 202: 470—475. PMID 8456113. doi:10.3181/00379727-202-43561.
sciencedirect.com
- Cleland WW (1963). „The kinetics of enzyme-catalyzed reactions with two or more substrates or products. II. Inhibition: nomenclature and theory”. Biochim. Biophys. Acta. 67: 173—87. PMID 14021668. doi:10.1016/0926-6569(63)90226-8.
- John F. Morrison (1982). „The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions”. Trends in Biochemical Sciences. 7 (3): 102—105. doi:10.1016/0968-0004(82)90157-8.
- J. Susan Van Dyk; Brett Pletschke (2011). „Review on the use of enzymes for the detection of organochlorine, organophosphate and carbamate pesticides in the environment”. Chemosphere. 82 (3): 291—307. doi:10.1016/j.chemosphere.2010.10.033.
- Mital, R.; Shah, G. M.; Srivastava, T. S.; Bhattacharya, R. K. (1992). „The effect of some new platinum (II) and palladium (II) coordination complexes on rat hepatic nuclear transcription in vitro”. Life Sci. 50: 781—790. PMID 1371326. doi:10.1016/0024-3205(92)90183-P.
- Myette, M. S.; Elford, H. L.; Chitambar, C. R. (1998). „Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells”. Cancer Lett. 129: 199—204. PMID 9719462. doi:10.1016/S0304-3835(98)00104-9.
- Nocentini, G.; Barzi, A. (1996). „The 2,2′-Bipyridyl-6-carbothioamide copper (II) complex differs from the iron (II) complex in its biochemical effects in tumor cells, suggesting possible differences in the mechanism leading to cytotoxicity”. Biochem. Pharm. 52: 65—71. PMID 8678909. doi:10.1016/0006-2952(96)00139-6.
- Monti, E.; Monzini, F.; Morazzoni, F.; Perletti, G.; Piccini, F. (1993). „Interaction of Cu(II) and Cu(II)-anthracycline complexes with protein kinase C. Spectromagnetic assessment of the inhibitory effect”. Inorg. Chim. Acta. 205: 181—184. doi:10.1016/S0020-1693(00)85536-X.
- Gopalakrishna, R.; Gundimeda, U.; Chen, Z. H. (1997). „Cancer-Preventive Selenocompounds Induce a Specific Redox Modification of Cysteine-Rich Regions in Ca2+- Dependent Isoenzymes of Protein Kinase C”. Arch. Biochem. Biophys. 348: 25—36. PMID 9390171. doi:10.1006/abbi.1997.0334.
- Gopalakrishna, R.; Chen, Z. H.; Gundimeda, U. (1997). „Selenocompounds Induce a Redox Modulation of Protein Kinase C in the Cell, Compartmentally Independent from Cytosolic Glutathione: Its Role in Inhibition of Tumor Promotion”. Arch. Biochem. Biophys. 348: 37—48. PMID 9390172. doi:10.1006/abbi.1997.0335.
- Morinville, A.; Maysinger, D.; Shaver, A. (1998). „From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signalling”. Trends Pharmacol. Sci. 19: 452—460. PMID 9850609. doi:10.1016/S0165-6147(98)01257-7.
- Nocentini, G.; Barzi, A. (1997). „Antitumor activity of 2,2′-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitor”. Gen. Pharmac. 29: 701—706. PMID 9347313. doi:10.1016/S0306-3623(97)00011-6.
- Drummond, G.; Rosenberg, D.; Kappas, A. (1992). „Intestinal heme oxygenase inhibition and increased biliary iron excretion by metalloporphyrins”. Gastroenterology. 102: 1170—1175. PMID 1551526. doi:10.1016/0016-5085(92)70011-Y.
- Serfass, L.; Burstyn, J. (1998). „Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity”. Arch. Biochem. Biophys. 359: 8—16. PMID 9799554. doi:10.1006/abbi.1998.0887.
- Luo, D.; Vincent, S. (1994). „Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo”. Eur. J. Pharmacol.-Mol. Pharmacol. Sec. 267: 263—267. PMID 7522180. doi:10.1016/0922-4106(94)90149-X.
- Sato, T.; Kamata, Y.; Irifune, M.; Nishikawa, T. (1995). „Inhibition of purified (Na+,K+)-ATPase activity from porcine cerebral cortex by NO generating drugs”. Brain Res. 704: 117—120. PMID 8750971. doi:10.1016/0006-8993(95)01165-X.
- Moore, P. K.; Handy, R. L. C. (1997). „Selective inhibitors of neuronal nitric oxide synthase – is no NOS really good NOS for the nervous system?”. Trends Pharm. Sci. 18: 204— 211. PMID 9226999. doi:10.1016/S0165-6147(97)01064-X.
- Meffert, M.; Haley, J.; Schulman, E.; Schulman, H.; Madison, D. (1994). „Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins”. Neuron. 13: 1225—1233. PMID 7524564. doi:10.1016/0896-6273(94)90060-4.
- Pedregosa, J. C.; Casanova, J.; Alzuet, G.; Borras, J.; Garcia-Granda, S.; Diaz, M. R.; Guttierez-Rodriguez, A. (1995). „Metal complexes of 5-tertbutyloxycarbonylamido-1,3,4-thiadiazole-2-sulfonamide (B-H2ats), a carbonic anhydrase inhibitor. Synthesis and characterization of the copper(II) complex. Crystal structures of B-H2ats and the [Cu(B-ats)(NH3)2]2 dimer complex”. Inorg. Chim. Acta. 232: 117—124. doi:10.1016/0020-1693(94)04376-7.
- Supuran, C. T.; Mincione, F.; Scozzafava, A.; Briganti, F.; Mincione, G.; Ilies, M. A. (1998). „Carbonic anhydrase inhibitors — Part 52. Metal complexes of heterocyclic sulfonamides: A new class of strong topical intraocular pressure-lowering agents in rabbits”. Eur. J. Med. Chem. 22: 247—254. doi:10.1016/S0223-5234(98)80059-7.
- Bergenhem, N. (1996). „Chromatographic and electrophoretic methods related to the carbonic anhydrase isozymes”. J. Chromatogr. B. 684: 289—305. PMID 8906478. doi:10.1016/0378-4347(95)00566-8.
- Thayer, J. S. (1984). Organometallic compounds and living organisms. New York: Academic Press. ISBN 978-0-12-686080-1.
- Lee, B. H.; Park, M. B.; Yu, B. S. (1998). „Inhibition of electric eel acetylcholinesterase by porphin compounds”. Bioinorg. Med. Chem. Lett. 8: 1467—1470. PMID 9873371. doi:10.1016/S0960-894X(98)00236-4.
- Falkous, G.; Harris, J. B.; Mantle, D. (1995). „Effect of neurotoxic metal ions in vitro on proteolytic enzyme activities in human cerebral cortex”. Clin. Chim. Acta. 238: 125—135. PMID 7586572. doi:10.1016/0009-8981(95)06081-N.
- Cuajungco, M. P.; Lees, G. K. (1997). „Zinc metabolism in the brain: relevance to human neurodegenerative disorders”. Neurobiol. Dis. 4: 137—169. PMID 9361293. doi:10.1006/nbdi.1997.0163.
- Cuajungco, M. P.; Lees, G. (1997). „Zinc and Alzheimer's disease: is there a direct link?”. J. Brain Res. Rev. 23: 219—236. PMID 9164672. doi:10.1016/S0165-0173(97)00002-7.
- Miche, H.; Brumas, V.; Berthon, G. (1997). „Copper(II) interactions with nonsteroidal antiinflammatory agents. II. Anthranilic acid as a potential. OH-inactivating ligand”. J. Inorg. Biochem. 68: 27—38. PMID 9379178. doi:10.1016/S0162-0134(97)00005-6.
- Zhang, H.; Johnson, P. (1992). „Differential effects of aluminum ion on smooth muscle calpain I and calpain II activities”. Int. J. Biochem. 24: 1773—1778. PMID 1451912. doi:10.1016/0020-711X(92)90127-M.
- Frolich, J. C. (1997). „A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes”. Trends Pharm. Sci. 18: 30—34. PMID 9114728. doi:10.1016/S0165-6147(96)01017-6.
- Casas, J.; Rodriguez-Arguelles, M.; Russo, U.; Sanchez, A.; Sordo, J.; Vazquez-Lopez, A.; Pinelli, S.; Lunghi, P.; Bonati, A.; Albertini, R. (1998). „Diorganotin(IV) complexes of pyridoxal thiosemicarbazone: synthesis, spectroscopic properties and biological activity”. J. Inorg. Biochem. 69: 283—292. PMID 9654752. doi:10.1016/S0162-0134(98)00004-X.
- Woon, T.; Brinkworth, R.; Fairlie, D. (1992). „Inhibition of HIV-1 proteinase by metal ions”. Int. J. Biochem. 24: 911—914. PMID 1612181. doi:10.1016/0020-711X(92)90096-J.
- Davis, D. A.; Branca, A. A.; Pallenberg, A. J.; Marschner, T. M.; Patt, L. M.; Chatlynne, L. G.; Humphrey, R. W.; Yarchoan, R.; Levine, R. L. (1995). „Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+”. Arch. Biochem. Biophys. 322: 127—134. PMID 7574666. doi:10.1006/abbi.1995.1444.
- Lebon, F.; deRosny, E.; Reboud-Ravauz, M.; Durant, F. (1998). „De novo drug design of a new copper chelate molecule acting as HIV-1 protease inhibitor”. Eur. J. Med. Chem. 33: 733—737. doi:10.1016/S0223-5234(98)80032-9.
- Ferrari, M. B.; Fava, G. G.; Tarasconi, R.; Albertini, S.; Pinelli, R.; Starcich, J. (1994). „Synthesis, spectroscopic and structural characterization, and biological activity of aquachloro (pyridoxal thiosemicarbazone) copper(II) chloride”. J. Inorg. Biochem. 53: 13. PMID 8133248. doi:10.1016/0162-0134(94)80017-0.
- Serra, M.; Pintar, A.; Casella, L.; Sabbioni, E. (1992). „Vanadium effect on the activity of horseradish peroxidase, catalase, glutathione peroxidase, and superoxide dismutase in vitro”. J. Inorg. Biochem. 46: 161—174. PMID 1325536. doi:10.1016/0162-0134(92)80027-S.
- DeZwart, M.; vanderGoot, H.; Timmerman, H. (1991). „Influence of Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) on growth inhibition and enzyme activity of Mycoplasma gallisepticum in the absence or presence of a 2,2′-bipyridyl type ligand”. Eur. J. Med. Chem. 26: 101—108. doi:10.1016/0223-5234(91)90218-C.
- Su, J. J.; Mansour, J. M.; Mansour, T. E. (1996). „Purification, kinetics and inhibition by antimonials of recombinant phosphofructokinase from Schistosoma mansoni”. Mol. Biochem. Parasitol. 81: 171—178. PMID 8898332. doi:10.1016/0166-6851(96)02702-8.
- Hueso-Urena, F.; Moreno-Carretero, M. N.; Romero-Molina, M. A.; Salas-Peregrin, J. M.; Sanchez-Sanchez, M. P.; Cienfuegos-Lopez, G. A. D.; Faure, R. J. (1993). „Transition metal complexes with monodeprotonated isoorotic and 2-thioisoorotic acids: Crystal structure, spectral and magnetic study, and antimicrobial activity”. Inorg. Biochem. 51: 613—632. doi:10.1016/0162-0134(93)85033-5.
- Exley, C.; Price, N.; Birchall, J. (1994). „Aluminum inhibition of hexokinase activity in vitro: a study in biological availability”. J. Inorg. Biochem. 54: 297—304. PMID 8014638. doi:10.1016/0162-0134(94)80035-9.
- Canesi, L.; Ciacci, C.; Piccoli, G.; Stocchi, V.; Viarengo, A.; Gallo, G. (1998). „In vitro and in vivo effects of heavy metals on mussel digestive gland hexokinase activity: the role of glutathione”. Comp. Biochem. Physiol. C. 120 (2): 261—268. PMID 9827040. doi:10.1016/S0742-8413(98)10004-X.
- Yager, J. W.; Wiencke, J. K. (1997). „Inhibition of poly(ADP-ribose) polymerase by arsenite”. Mutat. Res. 386: 345—351. PMID 9219571. doi:10.1016/S1383-5742(97)00011-2.
- Hu, Y.; Su, L.; Snow, E. T. (1998). „Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes”. Mutat. Res. 408: 203—218. PMID 9806419. doi:10.1016/S0921-8777(98)00035-4.
- Styblo, M.; Thomas, D. (1995). „In vitro inhibition of glutathione reductase by arsenotriglutathione”. Biochem. Pharmacol. 49: 971—977. PMID 7741769. doi:10.1016/0006-2952(95)00008-N.
- Snow, E.; Xu, L.; Kinney, P. (1993). „Effects of nickel ions on polymerase activity and fidelity during DNA replication in vitro”. Chem.-Biol. Interact. 88: 155—173. PMID 8403077. doi:10.1016/0009-2797(93)90089-H.
- Serfass, L.; Burstyn, J. (1998). „Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity”. Arch. Biochem. Biophys. 359: 8—16. PMID 9799554. doi:10.1006/abbi.1998.0887.
- Luo, D.; Vincent, S. (1994). „Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo”. Eur. J. Pharmacol.-Mol. Pharmacol. Sec. 267: 263—267. PMID 7522180. doi:10.1016/0922-4106(94)90149-X.
- Sato, T.; Kamata, Y.; Irifune, M.; Nishikawa, T. (1995). „Inhibition of purified (Na+,K+)-ATPase activity from porcine cerebral cortex by NO generating drugs”. Brain Res. 704: 117—120. PMID 8750971. doi:10.1016/0006-8993(95)01165-X.
- Moore, P. K.; Handy, R. L. C. (1997). „Selective inhibitors of neuronal nitric oxide synthase – is no NOS really good NOS for the nervous system?”. Trends Pharm. Sci. 18: 204— 211. PMID 9226999. doi:10.1016/S0165-6147(97)01064-X.
- Meffert, M.; Haley, J.; Schulman, E.; Schulman, H.; Madison, D. (1994). „Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins”. Neuron. 13: 1225—1233. PMID 7524564. doi:10.1016/0896-6273(94)90060-4.
- Pedregosa, J. C.; Casanova, J.; Alzuet, G.; Borras, J.; Garcia-Granda, S.; Diaz, M. R.; Guttierez-Rodriguez, A. (1995). „Metal complexes of 5-tertbutyloxycarbonylamido-1,3,4-thiadiazole-2-sulfonamide (B-H2ats), a carbonic anhydrase inhibitor. Synthesis and characterization of the copper(II) complex. Crystal structures of B-H2ats and the [Cu(B-ats)(NH3)2]2 dimer complex”. Inorg. Chim. Acta. 232: 117—124. doi:10.1016/0020-1693(94)04376-7.
- Supuran, C. T.; Mincione, F.; Scozzafava, A.; Briganti, F.; Mincione, G.; Ilies, M. A. (1998). „Carbonic anhydrase inhibitors — Part 52. Metal complexes of heterocyclic sulfonamides: A new class of strong topical intraocular pressure-lowering agents in rabbits”. Eur. J. Med. Chem. 22: 247—254. doi:10.1016/S0223-5234(98)80059-7.
- Bergenhem, N. (1996). „Chromatographic and electrophoretic methods related to the carbonic anhydrase isozymes”. J. Chromatogr. B. 684: 289—305. PMID 8906478. doi:10.1016/0378-4347(95)00566-8.
- Thayer, J. S. (1984). Organometallic compounds and living organisms. New York: Academic Press. ISBN 978-0-12-686080-1.
- Lee, B. H.; Park, M. B.; Yu, B. S. (1998). „Inhibition of electric eel acetylcholinesterase by porphin compounds”. Bioinorg. Med. Chem. Lett. 8: 1467—1470. PMID 9873371. doi:10.1016/S0960-894X(98)00236-4.
- Lee, B. H.; Park, M. B.; Yu, B. S. (1998). „Inhibition of electric eel acetylcholinesterase by porphin compounds”. Bioinorg. Med. Chem. Lett. 8: 1467—1470. PMID 9873371. doi:10.1016/S0960-894X(98)00236-4.
- Falkous, G.; Harris, J. B.; Mantle, D. (1995). „Effect of neurotoxic metal ions in vitro on proteolytic enzyme activities in human cerebral cortex”. Clin. Chim. Acta. 238: 125—135. PMID 7586572. doi:10.1016/0009-8981(95)06081-N.
- Cuajungco, M. P.; Lees, G. K. (1997). „Zinc metabolism in the brain: relevance to human neurodegenerative disorders”. Neurobiol. Dis. 4: 137—169. PMID 9361293. doi:10.1006/nbdi.1997.0163.
- Cuajungco, M. P.; Lees, G. (1997). „Zinc and Alzheimer's disease: is there a direct link?”. J. Brain Res. Rev. 23: 219—236. PMID 9164672. doi:10.1016/S0165-0173(97)00002-7.
- Miche, H.; Brumas, V.; Berthon, G. (1997). „Copper(II) interactions with nonsteroidal antiinflammatory agents. II. Anthranilic acid as a potential. OH-inactivating ligand”. J. Inorg. Biochem. 68: 27—38. PMID 9379178. doi:10.1016/S0162-0134(97)00005-6.
- Zhang, H.; Johnson, P. (1992). „Differential effects of aluminum ion on smooth muscle calpain I and calpain II activities”. Int. J. Biochem. 24: 1773—1778. PMID 1451912. doi:10.1016/0020-711X(92)90127-M.
- Frolich, J. C. (1997). „A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes”. Trends Pharm. Sci. 18: 30—34. PMID 9114728. doi:10.1016/S0165-6147(96)01017-6.
- Casas, J.; Rodriguez-Arguelles, M.; Russo, U.; Sanchez, A.; Sordo, J.; Vazquez-Lopez, A.; Pinelli, S.; Lunghi, P.; Bonati, A.; Albertini, R. (1998). „Diorganotin(IV) complexes of pyridoxal thiosemicarbazone: synthesis, spectroscopic properties and biological activity”. J. Inorg. Biochem. 69: 283—292. PMID 9654752. doi:10.1016/S0162-0134(98)00004-X.
- Woon, T.; Brinkworth, R.; Fairlie, D. (1992). „Inhibition of HIV-1 proteinase by metal ions”. Int. J. Biochem. 24: 911—914. PMID 1612181. doi:10.1016/0020-711X(92)90096-J.
- Davis, D. A.; Branca, A. A.; Pallenberg, A. J.; Marschner, T. M.; Patt, L. M.; Chatlynne, L. G.; Humphrey, R. W.; Yarchoan, R.; Levine, R. L. (1995). „Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+”. Arch. Biochem. Biophys. 322: 127—134. PMID 7574666. doi:10.1006/abbi.1995.1444.
- Lebon, F.; deRosny, E.; Reboud-Ravauz, M.; Durant, F. (1998). „De novo drug design of a new copper chelate molecule acting as HIV-1 protease inhibitor”. Eur. J. Med. Chem. 33: 733—737. doi:10.1016/S0223-5234(98)80032-9.
- Ferrari, M. B.; Fava, G. G.; Tarasconi, R.; Albertini, S.; Pinelli, R.; Starcich, J. (1994). „Synthesis, spectroscopic and structural characterization, and biological activity of aquachloro (pyridoxal thiosemicarbazone) copper(II) chloride”. J. Inorg. Biochem. 53: 13. PMID 8133248. doi:10.1016/0162-0134(94)80017-0.
- Ferrari, M. B.; Fava, G. G.; Tarasconi, R.; Albertini, S.; Pinelli, R.; Starcich, J. (1994). „Synthesis, spectroscopic and structural characterization, and biological activity of aquachloro (pyridoxal thiosemicarbazone) copper(II) chloride”. J. Inorg. Biochem. 53: 13. PMID 8133248. doi:10.1016/0162-0134(94)80017-0.
- Serra, M.; Pintar, A.; Casella, L.; Sabbioni, E. (1992). „Vanadium effect on the activity of horseradish peroxidase, catalase, glutathione peroxidase, and superoxide dismutase in vitro”. J. Inorg. Biochem. 46: 161—174. PMID 1325536. doi:10.1016/0162-0134(92)80027-S.
- DeZwart, M.; vanderGoot, H.; Timmerman, H. (1991). „Influence of Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) on growth inhibition and enzyme activity of Mycoplasma gallisepticum in the absence or presence of a 2,2′-bipyridyl type ligand”. Eur. J. Med. Chem. 26: 101—108. doi:10.1016/0223-5234(91)90218-C.
- Su, J. J.; Mansour, J. M.; Mansour, T. E. (1996). „Purification, kinetics and inhibition by antimonials of recombinant phosphofructokinase from Schistosoma mansoni”. Mol. Biochem. Parasitol. 81: 171—178. PMID 8898332. doi:10.1016/0166-6851(96)02702-8.
- Hueso-Urena, F.; Moreno-Carretero, M. N.; Romero-Molina, M. A.; Salas-Peregrin, J. M.; Sanchez-Sanchez, M. P.; Cienfuegos-Lopez, G. A. D.; Faure, R. J. (1993). „Transition metal complexes with monodeprotonated isoorotic and 2-thioisoorotic acids: Crystal structure, spectral and magnetic study, and antimicrobial activity”. Inorg. Biochem. 51: 613—632. doi:10.1016/0162-0134(93)85033-5.
- Exley, C.; Price, N.; Birchall, J. (1994). „Aluminum inhibition of hexokinase activity in vitro: a study in biological availability”. J. Inorg. Biochem. 54: 297—304. PMID 8014638. doi:10.1016/0162-0134(94)80035-9.
- Canesi, L.; Ciacci, C.; Piccoli, G.; Stocchi, V.; Viarengo, A.; Gallo, G. (1998). „In vitro and in vivo effects of heavy metals on mussel digestive gland hexokinase activity: the role of glutathione”. Comp. Biochem. Physiol. C. 120 (2): 261—268. PMID 9827040. doi:10.1016/S0742-8413(98)10004-X.
- Yager, J. W.; Wiencke, J. K. (1997). „Inhibition of poly(ADP-ribose) polymerase by arsenite”. Mutat. Res. 386: 345—351. PMID 9219571. doi:10.1016/S1383-5742(97)00011-2.
- Hu, Y.; Su, L.; Snow, E. T. (1998). „Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes”. Mutat. Res. 408: 203—218. PMID 9806419. doi:10.1016/S0921-8777(98)00035-4.
- Styblo, M.; Thomas, D. (1995). „In vitro inhibition of glutathione reductase by arsenotriglutathione”. Biochem. Pharmacol. 49: 971—977. PMID 7741769. doi:10.1016/0006-2952(95)00008-N.
- Snow, E.; Xu, L.; Kinney, P. (1993). „Effects of nickel ions on polymerase activity and fidelity during DNA replication in vitro”. Chem.-Biol. Interact. 88: 155—173. PMID 8403077. doi:10.1016/0009-2797(93)90089-H.
sciencemag.org
science.sciencemag.org
- Hubbard, S. R.; Bishop, W. R.; Kirschmeier, P.; George, S. J.; Cramer, S. P.; Hendrickson, W. A. (1991). „Identification and characterization of zinc binding sites in protein kinase C”. Science. 254: 1776—1779. PMID 1763327. doi:10.1126/science.1763327.
- Lathrop, J. T.; Timko, M. P. (1993). „Regulation by heme of mitochondrial protein transport through a conserved amino acid moti”. Science. 259: 522—525. PMID 8424176. doi:10.1126/science.8424176.
- Abrams MJ, Murrer BA (1993). „Metal compounds in therapy and diagnosis”. Science. 261: 725—730. PMID 8102010. doi:10.1126/science.8102010.
- Huang, H.; Chopra, R.; Verdine, G. L.; Harrison, S. C. (1998). „Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance”. Science. 282: 1669—1675. PMID 9831551. doi:10.1126/science.282.5394.1669.
- O’Halloran, T. V. (1993). „Transition metals in control of gene expression”. Science. 261: 715—725. PMID 8342038. doi:10.1126/science.8342038.
- Lathrop, J. T.; Timko, M. P. (1993). „Regulation by heme of mitochondrial protein transport through a conserved amino acid moti”. Science. 259: 522—525. PMID 8424176. doi:10.1126/science.8424176.
- Abrams MJ, Murrer BA (1993). „Metal compounds in therapy and diagnosis”. Science. 261: 725—730. PMID 8102010. doi:10.1126/science.8102010.
- Abrams MJ, Murrer BA (1993). „Metal compounds in therapy and diagnosis”. Science. 261: 725—730. PMID 8102010. doi:10.1126/science.8102010.
- Huang, H.; Chopra, R.; Verdine, G. L.; Harrison, S. C. (1998). „Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance”. Science. 282: 1669—1675. PMID 9831551. doi:10.1126/science.282.5394.1669.
- O’Halloran, T. V. (1993). „Transition metals in control of gene expression”. Science. 261: 715—725. PMID 8342038. doi:10.1126/science.8342038.
snmjournals.org
jnm.snmjournals.org
- Shao, H. S.; Meinken, G. E.; Srivastava, S. C.; Slosman, D.; Slacker, D. F.; Som, P.; Brill, A. B. (1986). „In-vitro and in-vivo characterization of ruthenium-bleomycin compared to cobalt- i copper-BLEOMYC” (PDF). J. Nucl. Med. 27: 1044—1045.
springer.com
link.springer.com
- Park BK, Breckenridge AM (1981). „Clinical implications of enzyme induction and enzyme inhibition.”. Clin Pharmacokinet. 6 (1): 1—24. PMID 6113907. doi:10.2165/00003088-198106010-00001.
- Kumar, Vikas; Kaminski, Henry J. (07. 10. 2010). „Treatment of Myasthenia Gravis”. Current Neurology and Neuroscience Reports. 11 (1): 89—96. ISSN 1528-4042. PMID 20927659. doi:10.1007/s11910-010-0151-1.
- Frosch, S.; Jabben, M.; Bergfeld, R.; H. Kleinig; H. Mohr (1979). „Inhibition of carotenoid biosynthesis by the herbicide SAN 9789 and its consequences for the action of phytochrome on plastogenesis”. Planta. 145: 497. doi:10.1007/BF00380105.
- Vickroy, T.; Malphurs, W. (1995). „Inhibition of nitric oxide synthase activity in cerebral cortical synaptosomes by nitric oxide donors: evidence for feedback autoregulation”. Neurochem. Res. 20: 299—304. PMID 7541898. doi:10.1007/BF00969546.
- Rao, K. S. J.; Rao, G. V. (1994). „Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study”. Mol. Cell. Biochem. 137: 57—60. PMID 7845378. doi:10.1007/BF00926039.
- Nagar, R.; Mohan, G. J. (1992). „Studies on mixed-ligand complexes of some transition metals of biological interest”. Therm. Anal. 38: 1415—1431.
- Yoshino, M.; Murakami, K.; Kawano, K. (1998). „Interaction of aluminum ion with ATP. Mechanism of the aluminum inhibition of glycerol kinase and its reversal by spermine”. Biometals. 11: 63—67. doi:10.1023/A:1009213508942.
- Vickroy, T.; Malphurs, W. (1995). „Inhibition of nitric oxide synthase activity in cerebral cortical synaptosomes by nitric oxide donors: evidence for feedback autoregulation”. Neurochem. Res. 20: 299—304. PMID 7541898. doi:10.1007/BF00969546.
- Rao, K. S. J.; Rao, G. V. (1994). „Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study”. Mol. Cell. Biochem. 137: 57—60. PMID 7845378. doi:10.1007/BF00926039.
- Nagar, R.; Mohan, G. J. (1992). „Studies on mixed-ligand complexes of some transition metals of biological interest”. Therm. Anal. 38: 1415—1431.
- Yoshino, M.; Murakami, K.; Kawano, K. (1998). „Interaction of aluminum ion with ATP. Mechanism of the aluminum inhibition of glycerol kinase and its reversal by spermine”. Biometals. 11: 63—67. doi:10.1023/A:1009213508942.
rd.springer.com
- Koch, T.; Gloddek, B. (1991). „Inhibition of adenylate-cyclase-coupled G protein complex by ototoxic diuretics and cis-platinum in the inner ear of the guinea pig”. Eur. Arch. Oto-Rhino-Laryngol. 248: 459—464. PMID 1662964. doi:10.1007/BF00627634.
surveyophthalmol.com
- Albert, D. M.; Jakobiec, F. M., ur. (1994). Principles and practice of ophthalmology. Philadelphia: W. B. Saunders. ISBN 978-0-7216-3416-6.
- Albert, D. M.; Jakobiec, F. M., ur. (1994). Principles and practice of ophthalmology. Philadelphia: W. B. Saunders. ISBN 978-0-7216-3416-6.
tandfonline.com
- Supuran CT, Scozzafava A, Saramet I, Banciu MD (1998). „Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes”. J. Enzyme Inhib. 13: 177—194. PMID 9629536. doi:10.3109/14756369809028339.
- Bult, A. (1983). Sigel, H., ur. Metal ions in biological systems. 16. New York: Marcel Dekker. doi:10.1080/00945718208063132.
- Supuran CT, Scozzafava A, Saramet I, Banciu MD (1998). „Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes”. J. Enzyme Inhib. 13: 177—194. PMID 9629536. doi:10.3109/14756369809028339.
- Bult, A. (1983). Sigel, H., ur. Metal ions in biological systems. 16. New York: Marcel Dekker. doi:10.1080/00945718208063132.
thesislog.net
paper.thesislog.net
- Endo, T.; Takahashi, M.; Minami, M.; Yoshioka, M.; Saito, H.; Parvez, S. H. (1993). „Effects of anticancer drugs on enzyme activities and serotonin release from ileal tissue in ferrets”. Biogen. Amines. 9: 479—489. ISSN 0168-8561.
unisa.it
pharmacologyonline.unisa.it
- Sabina E.P.; Rasool M.K.; Mathew L.; Parameswari (2009). „Studies on the protective effect of Ricinus communis leaves extract on carbon tetrachloride hepatotoxicity in albino rats”. Pharmacologyonline. 2: 905—916. ISSN 1827-8620.
wikipedia.org
en.wikipedia.org
- Dixon, M.; Webb, E.C.; Thorne, C.J.R.; Tipton K.F. (1979). Enzymes (III izd.). London: Longman. str. 126. ASIN B001MVGNNO.
wiley.com
onlinelibrary.wiley.com
- Robert A. Copeland (06. 05. 2013). Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists (II izd.). ISBN 9781118488133. doi:10.1002/9781118540398.
- Chris G Whiteley (30. 06. 2010). „Enzyme Kinetics: Partial and Complete Competitive Inhibition”. Biochemical Education. 25 (3).
- Mehndiratta, Man Mohan; Pandey, Sanjay; Kuntzer, Thierry (13. 10. 2014). Acetylcholinesterase inhibitor treatment for myasthenia gravis. John Wiley & Sons, Ltd. doi:10.1002/14651858.CD006986.pub3.
- Hugh M. Brown (1990). „Mode of action, crop selectivity, and soil relations of the sulfonylurea herbicides”. 29 (3): 263—281. doi:10.1002/ps.2780290304.
- Faure, R.; Vincent, M.; Dufour, M.; Shaver, A.; Posner, B. I. J. (1995). „Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: Studies on a neuronal and a glial cell line”. Cell Biochem. 58: 389—401. PMID 8567756. doi:10.1002/jcb.240590310.
- Cannon, J. B. (1993). „Pharmaceutics and drug delivery aspects of heme and porphyrin therapy”. J. Pharm. Sci. 82: 435—446. PMID 8360819. doi:10.1002/jps.2600820502.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Cable, E.; Cable, J.; Bonkovsky, H. (1993). „Repression of hepatic δ-aminolevulinate synthase by heme and metalloporphyrins: Relationship to inhibition of heme oxygenase”. Hepatology. 18: 119—127. PMID 8325603. doi:10.1002/hep.1840180119.
- Mariotto, S.; Cuzzolin, L.; Adami, A.; DelSoldato, P.; Suzuki, H.; Benoni, G. (1995). „Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils”. Brit. J. Pharmacol. 114: 1105—1106. PMID 7542530. doi:10.1111/j.1476-5381.1995.tb13320.x.
- Nicolaou, A.; Waterfield, C.; Kenyon, S.; Gibbons, W. (1997). „The Inactivation of Methionine Synthase in Isolated Rat Hepatocytes by Sodium Nitroprusside”. Eur. J. Biochem. 244: 8876—882. PMID 9108260. doi:10.1111/j.1432-1033.1997.00876.x.
- Koppenho¨fer, A.; Hartmann, U.; Vahrenkamp, H. (1995). „Zinc Complexes of Drugs Containing Nitrogen Heterocycles”. Chem. Ber. 128: 779—785. doi:10.1002/cber.19951280807.
- Bagger, S.; Wagner, K. J. (1998). „Molecular recognition of cobalt(III)-ligated peptides by serine proteases: the role of electrostatic effects”. Peptide Res. 52: 273—282. PMID 9832305. doi:10.1111/j.1399-3011.1998.tb01241.x.
- Mork, A. (1993). „Actions of Lithium on the Cyclic AMP Signalling System in Various Regions of the Brain - Possible Relations to its Psychotropic Actions -: A Study on the Adenylate Cyclase in Rat Cerebral Cortex, Corpus Striatum and Hippocampus”. Pharmacol. Toxicol. 71: 1—47. doi:10.1111/j.1600-0773.1993.tb01704.x.
- Nixon, R. A.; Clarke, J. F.; Logvinenko, K. B.; Tan, M. K. H.; Hoult, M.; Grynspan, F. (1990). „Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes”. J. Neurochem. 55: 1950—1959. PMID 2121904. doi:10.1111/j.1471-4159.1990.tb05781.x.
- Mantyh, P. W.; Ghilardi, J. R.; Rogers, S.; Demaster, E.; Allen, C. J.; Stimson, E. R.; Maggio, J. E. (1993). „Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide”. J. Neurochem. 61: 1171—1174. PMID 8360682. doi:10.1111/j.1471-4159.1993.tb03639.x.
- Rajendran, K. G.; Sood, A.; Spielvogel, B. F.; Hall, I. H.; III, V. M. N.; Morse, K. W. (1995). „Anti-Osteoporotic activity of metal complexes of amine carboxyboranes”. Appl. Organomet. Chem. 9: 111—119. doi:10.1002/aoc.590090204.
- Naughton, D. P.; Knappitt, J.; Fairburn, K.; Gaffney, K.; Blake, D. R.; Grootveld, M. (1995). „Detection and investigation of the molecular nature of low-molecular-mass copper ions in isolated rheumatoid knee-joint synovial fluid”. FEBS Lett. 362: 167—172. PMID 7698317. doi:10.1016/0014-5793(95)00165-6.
- Cunningham, M. L.; Zvelebil, M. J. J. M.; Fairlamb, A. H. (1994). „Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals”. Eur. J. Biochem. 221: 285—295. PMID 8168518. doi:10.1111/j.1432-1033.1994.tb18740.x.
- Cannon, J. B. (1993). „Pharmaceutics and drug delivery aspects of heme and porphyrin therapy”. J. Pharm. Sci. 82: 435—446. PMID 8360819. doi:10.1002/jps.2600820502.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Tsangaris, J. M.; Williams, D. R. (1992). „Tin in pharmacy and nutrition”. Appl. Organomet. Chem. 6: 3—18. PMID 11192741. doi:10.1002/aoc.590060103.
- Cable, E.; Cable, J.; Bonkovsky, H. (1993). „Repression of hepatic δ-aminolevulinate synthase by heme and metalloporphyrins: Relationship to inhibition of heme oxygenase”. Hepatology. 18: 119—127. PMID 8325603. doi:10.1002/hep.1840180119.
- Mariotto, S.; Cuzzolin, L.; Adami, A.; DelSoldato, P.; Suzuki, H.; Benoni, G. (1995). „Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils”. Brit. J. Pharmacol. 114: 1105—1106. PMID 7542530. doi:10.1111/j.1476-5381.1995.tb13320.x.
- Nicolaou, A.; Waterfield, C.; Kenyon, S.; Gibbons, W. (1997). „The Inactivation of Methionine Synthase in Isolated Rat Hepatocytes by Sodium Nitroprusside”. Eur. J. Biochem. 244: 8876—882. PMID 9108260. doi:10.1111/j.1432-1033.1997.00876.x.
- Koppenho¨fer, A.; Hartmann, U.; Vahrenkamp, H. (1995). „Zinc Complexes of Drugs Containing Nitrogen Heterocycles”. Chem. Ber. 128: 779—785. doi:10.1002/cber.19951280807.
- Bagger, S.; Wagner, K. J. (1998). „Molecular recognition of cobalt(III)-ligated peptides by serine proteases: the role of electrostatic effects”. Peptide Res. 52: 273—282. PMID 9832305. doi:10.1111/j.1399-3011.1998.tb01241.x.
- Mork, A. (1993). „Actions of Lithium on the Cyclic AMP Signalling System in Various Regions of the Brain - Possible Relations to its Psychotropic Actions -: A Study on the Adenylate Cyclase in Rat Cerebral Cortex, Corpus Striatum and Hippocampus”. Pharmacol. Toxicol. 71: 1—47. doi:10.1111/j.1600-0773.1993.tb01704.x.
- Nixon, R. A.; Clarke, J. F.; Logvinenko, K. B.; Tan, M. K. H.; Hoult, M.; Grynspan, F. (1990). „Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes”. J. Neurochem. 55: 1950—1959. PMID 2121904. doi:10.1111/j.1471-4159.1990.tb05781.x.
- Mantyh, P. W.; Ghilardi, J. R.; Rogers, S.; Demaster, E.; Allen, C. J.; Stimson, E. R.; Maggio, J. E. (1993). „Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide”. J. Neurochem. 61: 1171—1174. PMID 8360682. doi:10.1111/j.1471-4159.1993.tb03639.x.
- Rajendran, K. G.; Sood, A.; Spielvogel, B. F.; Hall, I. H.; III, V. M. N.; Morse, K. W. (1995). „Anti-Osteoporotic activity of metal complexes of amine carboxyboranes”. Appl. Organomet. Chem. 9: 111—119. doi:10.1002/aoc.590090204.
- Naughton, D. P.; Knappitt, J.; Fairburn, K.; Gaffney, K.; Blake, D. R.; Grootveld, M. (1995). „Detection and investigation of the molecular nature of low-molecular-mass copper ions in isolated rheumatoid knee-joint synovial fluid”. FEBS Lett. 362: 167—172. PMID 7698317. doi:10.1016/0014-5793(95)00165-6.
- Cunningham, M. L.; Zvelebil, M. J. J. M.; Fairlamb, A. H. (1994). „Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals”. Eur. J. Biochem. 221: 285—295. PMID 8168518. doi:10.1111/j.1432-1033.1994.tb18740.x.
wiley.com
- Segel, Irwin H. (1993). Enzyme Kinetics : Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems (New izd.). Wiley-Interscience. ISBN 978-0-471-30309-1.
worldcat.org
- Tan, Siang Yong; Tatsumura, Yvonne (01. 07. 2015). „Alexander Fleming (1881—1955): Discoverer of penicillin”. Singapore Medical Journal. 56 (7): 366—367. ISSN 0037-5675. PMC 4520913 . PMID 26243971. doi:10.11622/smedj.2015105.
- Kumar, Vikas; Kaminski, Henry J. (07. 10. 2010). „Treatment of Myasthenia Gravis”. Current Neurology and Neuroscience Reports. 11 (1): 89—96. ISSN 1528-4042. PMID 20927659. doi:10.1007/s11910-010-0151-1.
- Kambiz Soltaninejad; Mohammad Abdollahi (2009). „Current opinion on the science of organophosphate pesticides and toxic stress: a systematic review”. Med Sci Monit. 15 (3): RA75—90. eISSN 1643-3750.
- Waghmare; Chougule P.; Kanase A. (2004). „Extract of Ricinus communis leaves mediated alterations in liver and kidney functions against single dose of CCl
4 induced liver necrosis in albino rats.”. Journal of Ecophysiology and Occupational Health. 4 (3—4): 169—173. ISSN 0972-4397.|first1=zahteva|last1=u Authors list (pomoć) - Sabina E.P.; Rasool M.K.; Mathew L.; Parameswari (2009). „Studies on the protective effect of Ricinus communis leaves extract on carbon tetrachloride hepatotoxicity in albino rats”. Pharmacologyonline. 2: 905—916. ISSN 1827-8620.
- Banci, Lucia (2013). Sigel, Astrid; Sigel, Helmut; Sigel, Roland K. O., ur. Metallomics and the Cell. Springer. ISBN 978-94-007-5561-1. ISSN 1868-0402.
- Aull, J. L. (1980). Interactions of anticancer drugs with enzymes. New York: Marcel Dekker. ISSN 0161-5149.
- Endo, T.; Takahashi, M.; Minami, M.; Yoshioka, M.; Saito, H.; Parvez, S. H. (1993). „Effects of anticancer drugs on enzyme activities and serotonin release from ileal tissue in ferrets”. Biogen. Amines. 9: 479—489. ISSN 0168-8561.
- Rosen, M.; Figliomeni, M.; Simpkins, H. (1992). „The interaction of platinum antitumor drugs with mouse liver mitochondria”. Int. J. Exp. Pathol. 73: 61—74. ISSN 0959-9673. PMC 2002465 .
- Shlyakhovenko, V. A.; Milinevskaya, V. A.; Zagorujko, L. I.; Yanish, Y. V.; Kozak, V. V.; Kokozey, V. N.; Chernova, A. S. (1997). „Antitumor activity of some gallium-containing coordination compounds”. Exp. Oncol. 19: 348—352. ISSN 0204-3564.
- Garg, R. K.; Sharma, L. M. J. Indian Chem. Soc. (1995). „Binuclear transition metal complexes of some novel Schiff bases derived from dapsone (an antileprotic drug). Part II. Zinc(II) complexes”. 72: 231—234. ISSN 0019-4522.
- Garg, R. K.; Sharma, L. M. J. Indian Chem. Soc. (1995). „Binuclear transition metal complexes of some novel Schiff bases derived from dapsone (an antileprotic drug). Part II. Zinc(II) complexes”. 72: 231—234. ISSN 0019-4522.